BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998: Hepatic encephalopathy-Definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gast. Hepatology 2002;35:716-21. [DOI: 10.1053/jhep.2002.31250] [Cited by in Crossref: 1381] [Cited by in F6Publishing: 1195] [Article Influence: 72.7] [Reference Citation Analysis]
Number Citing Articles
1 Zheng G, Lu H, Yu W, Luo S, Liu Y, Liu W, Liu H, Wu L, Zheng L, Kong X, Zhang LJ, Lu GM. Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy. Eur Radiol 2017;27:4699-709. [PMID: 28523351 DOI: 10.1007/s00330-017-4809-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
2 Yang J, Yang LH, Zhao XX, Pu Y, Yang JH. Significance of magnetic resonance spectroscopy in diagnosis of minimal hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2015; 23(16): 2605-2609 [DOI: 10.11569/wcjd.v23.i16.2605] [Reference Citation Analysis]
3 Jalan R. Rifaximin in hepatic encephalopathy: more than just a non-absorbable antibiotic? J Hepatol 2010;53:580-2. [PMID: 20561708 DOI: 10.1016/j.jhep.2010.05.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
4 Poddar B, Saigal S, Kumar A, Singh RK, Azim A, Gurjar M, Baronia A. Factors associated with outcome in acute liver failure in an intensive care unit. Indian J Gastroenterol 2013;32:172-8. [PMID: 23054946 DOI: 10.1007/s12664-012-0252-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
5 Chen H, Zhu X, Yang M, Liu B, Zhang Y, Wang Y, Teng G. Changes in the regional homogeneity of resting-state brain activity in minimal hepatic encephalopathy. Neuroscience Letters 2012;507:5-9. [DOI: 10.1016/j.neulet.2011.11.033] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
6 Stadlbauer V, Tauss J, Portugaller HR, Stiegler P, Iberer F, Stauber RE. Hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS): management with L-ornithine-L-aspartate and stent reduction. Metab Brain Dis. 2007;22:45-50. [PMID: 17165154 DOI: 10.1007/s11011-006-9032-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
7 Nyberg SL, Hardin J, Amiot B, Argikar UA, Remmel RP, Rinaldo P. Rapid, large-scale formation of porcine hepatocyte spheroids in a novel spheroid reservoir bioartificial liver. Liver Transpl 2005;11:901-10. [DOI: 10.1002/lt.20446] [Cited by in Crossref: 96] [Cited by in F6Publishing: 91] [Article Influence: 5.6] [Reference Citation Analysis]
8 Jindal A, Sharma BC, Sachdeva S, Chawla R, Srivastava S, Maharshi S. Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients. Digestive and Liver Disease 2015;47:769-74. [DOI: 10.1016/j.dld.2015.04.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
9 Song J, Jeong S, Shin W, Jun I, Shin K, Huh I, Kim Y, Hwang G. Laboratory Variables Associated with Low Near-Infrared Cerebral Oxygen Saturation in Icteric Patients Before Liver Transplantation Surgery. Anesthesia & Analgesia 2011;112:1347-52. [DOI: 10.1213/ane.0b013e318214b2b0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
10 Perry W, Hilsabeck RC, Hassanein TI. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci. 2008;53:307-321. [PMID: 17703362 DOI: 10.1007/s10620-007-9896-z] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 6.2] [Reference Citation Analysis]
11 Guzmán-De-Villoria JA, Ferreiro-Argüelles C, Fernández-García P. Differential diagnosis of T2 hyperintense brainstem lesions: Part 2. Diffuse lesions. Semin Ultrasound CT MR. 2010;31:260-274. [PMID: 20483393 DOI: 10.1053/j.sult.2010.03.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
12 Kircheis G, Fleig WE, Görtelmeyer R, Grafe S, Häussinger D. Assessment of low-grade hepatic encephalopathy: a critical analysis. J Hepatol 2007;47:642-50. [PMID: 17869373 DOI: 10.1016/j.jhep.2007.05.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 3.4] [Reference Citation Analysis]
13 Lopes P, Mei M, Guardia A, Stucchi R, Udo E, Warwar M, Boin I. Correlation Between Serum Magnesium Levels and Hepatic Encephalopathy in Immediate Post Liver Transplantation Period. Transplantation Proceedings 2013;45:1122-5. [DOI: 10.1016/j.transproceed.2013.02.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
14 Zafiris O, Kircheis G, Rood HA, Boers F, Häussinger D, Zilles K. Neural mechanism underlying impaired visual judgement in the dysmetabolic brain: an fMRI study.Neuroimage. 2004;22:541-552. [PMID: 15193582 DOI: 10.1016/j.neuroimage.2004.01.038] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.8] [Reference Citation Analysis]
15 Wang Q, Wang Y, Yu Z, Li D, Jia B, Li J, Guan K, Zhou Y, Chen Y, Kan Q. Ammonia-induced energy disorders interfere with bilirubin metabolism in hepatocytes. Arch Biochem Biophys. 2014;555-556:16-22. [PMID: 24878366 DOI: 10.1016/j.abb.2014.05.019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
16 Spahr L, Coeytaux A, Giostra E, Hadengue A, Annoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: a randomized controlled pilot trial. Am J Gastroenterol. 2007;102:744-753. [PMID: 17222324 DOI: 10.1111/j.1572-0241.2006.01028.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
17 Duarte-Rojo A, Estradas J, Hernández-Ramos R, Ponce-de-León S, Córdoba J, Torre A. Validation of the psychometric hepatic encephalopathy score (PHES) for identifying patients with minimal hepatic encephalopathy. Dig Dis Sci. 2011;56:3014-3023. [PMID: 21461913 DOI: 10.1007/s10620-011-1684-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 4.4] [Reference Citation Analysis]
18 Yang N, Liu H, Jiang Y, Zheng J, Li DM, Ji C, Liu YY, Zuo PP. Lactulose enhances neuroplasticity to improve cognitive function in early hepatic encephalopathy. Neural Regen Res. 2015;10:1457-1462. [PMID: 26604907 DOI: 10.4103/1673-5374.165516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
19 Suresh MV, Jagadisan B, Kandasamy P, Senthilkumar GP. Stroop Test Validation to Screen for Minimal Hepatic Encephalopathy in Pediatric Extrahepatic Portal Venous Obstruction. J Pediatr Gastroenterol Nutr. 2018;66:802-807. [PMID: 29373442 DOI: 10.1097/mpg.0000000000001895] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Takuma Y, Nouso K, Makino Y, Hayashi M, Takahashi H. Clinical trial: oral zinc in hepatic encephalopathy. Aliment Pharmacol Ther. 2010;32:1080-1090. [PMID: 20822500 DOI: 10.1111/j.1365-2036.2010.04448.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 56] [Article Influence: 6.0] [Reference Citation Analysis]
21 Bai M, Yang Z, Qi X, Fan D, Han G. l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2013;28:783-792. [PMID: 23425108 DOI: 10.1111/jgh.12142] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 6.4] [Reference Citation Analysis]
22 Kawaguchi T, Konishi M, Kato A, Kato M, Kooka Y, Sawara K, Endo R, Torimura T, Suzuki K, Takikawa Y. Updating the neuropsychological test system in Japan for the elderly and in a modern touch screen tablet society by resetting the cut-off values. Hepatol Res. 2017;47:1335-1339. [PMID: 28066966 DOI: 10.1111/hepr.12864] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
23 Ahluwalia V, Wade JB, White MB, Gilles HS, Heuman DM, Fuchs M, Gavis EA, Fagan A, Thacker LR, Sterling RK, Stravitz RT, Puri P, Sanyal AJ, Siddiqui MS, Matherly S, Luketic V, Steinberg J, Moeller FG, Bajaj JS. Brain Integrity Changes Underlying Cognitive and Functional Recovery Postliver Transplant Continue to Evolve Over 1 Year. Transplantation 2018;102:461-70. [PMID: 29087971 DOI: 10.1097/TP.0000000000001991] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhou Y, Dong Q, Zhang R, Zhou S, Li L, Cheng K, Kong R, Yu Q, Xu S, Li J, Li S, Feng J, Wu L, Liu T, Lu X, Chen K, Xia Y, Lu J, Zhou Y, Guo C. Cerebral Hemodynamics and Cognitive Function in Cirrhotic Patients with Hepatic Encephalopathy. Gastroenterol Res Pract 2016;2016:8485032. [PMID: 28096811 DOI: 10.1155/2016/8485032] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
25 Mechtcheriakov S, Graziadei IW, Kugener A, Schuster I, Mueller J, Hinterhuber H, Vogel W, Marksteiner J. Motor dysfunction in patients with liver cirrhosis: impairment of handwriting. J Neurol 2006;253:349-56. [DOI: 10.1007/s00415-005-0995-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
26 Singhal A, Vadlamudi S, Stokes K, Cassidy FP, Corn A, Shrago SS, Wright HI, Kohli V. Liver histology as predictor of outcome in patients with acute liver failure. Transpl Int. 2012;25:658-662. [PMID: 22487361 DOI: 10.1111/j.1432-2277.2012.01470.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
27 Wu D, Zhang S, Xie Z, Chen E, Rao Q, Liu X, Huang K, Yang J, Xiao L, Ji F, Jiang Z, Zhao Y, Ouyang X, Zhu D, Dai X, Hou Z, Liu B, Deng B, Zhou N, Gao H, Sun Z, Li L. Plasminogen as a prognostic biomarker for HBV-related acute-on-chronic liver failure. J Clin Invest 2020;130:2069-80. [PMID: 32175919 DOI: 10.1172/JCI130197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
28 Kim M, Liotta EM, Maas MB, Braun RI, Garcia-Canga B, Ganger DR, Ladner DP, Reid KJ, Zee PC. Rest-activity rhythm disturbance in liver cirrhosis and association with cognitive impairment. Sleep 2021;44:zsaa288. [PMID: 33367862 DOI: 10.1093/sleep/zsaa288] [Reference Citation Analysis]
29 Sargent S. Pathophysiology and management of hepatic encephalopathy. British Journal of Nursing 2007;16:335-9. [DOI: 10.12968/bjon.2007.16.6.23003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
30 Tas A, Akbal E, Beyazit Y, Kocak E. Serum lactate level predict mortality in elderly patients with cirrhosis. Wien Klin Wochenschr. 2012;124:520-525. [PMID: 22810366 DOI: 10.1007/s00508-012-0208-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
31 Tan H, Martin P. Care of the Liver Transplant Candidate. Clinics in Liver Disease 2011;15:779-806. [DOI: 10.1016/j.cld.2011.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
32 Kim KM, Kim GS, Ko JS, Gwak MS, Lee SK, Son MG. Factors associated with consciousness recovery time after liver transplantation in recipients with hepatic encephalopathy. Transplant Proc. 2014;46:712-715. [PMID: 24767331 DOI: 10.1016/j.transproceed.2013.12.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
33 Jia JD. Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality. J Gastroenterol Hepatol 2012;27:1262-3. [PMID: 22823914 DOI: 10.1111/j.1440-1746.2012.07177.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Amodio P, Montagnese S. Lights and Shadows in Hepatic Encephalopathy Diagnosis. J Clin Med 2021;10:341. [PMID: 33477554 DOI: 10.3390/jcm10020341] [Reference Citation Analysis]
35 Kristiansen RG, Rose CF, Fuskevåg O, Mæhre H, Revhaug A, Jalan R, Ytrebø LM. L-Ornithine phenylacetate reduces ammonia in pigs with acute liver failure through phenylacetylglycine formation: a novel ammonia-lowering pathway. American Journal of Physiology-Gastrointestinal and Liver Physiology 2014;307:G1024-31. [DOI: 10.1152/ajpgi.00244.2014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
36 Teodoro V, Bragagnolo Jr. M, Lucchesi L, Kondo M, Tufik S. Avaliação dos potenciais evocados relacionados a eventos (ERP-P300) em pacientes com cirrose hepática sem encefalopatia. Arq Gastroenterol 2008;45:82-6. [DOI: 10.1590/s0004-28032008000100015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
37 García-García R, Cruz-Gómez ÁJ, Urios A, Mangas-Losada A, Forn C, Escudero-García D, Kosenko E, Torregrosa I, Tosca J, Giner-Durán R, Serra MA, Avila C, Belloch V, Felipo V, Montoliu C. Learning and Memory Impairments in Patients with Minimal Hepatic Encephalopathy are Associated with Structural and Functional Connectivity Alterations in Hippocampus. Sci Rep 2018;8:9664. [PMID: 29941971 DOI: 10.1038/s41598-018-27978-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
38 Stinton L, Swain MG. Fatigue in Cirrhosis: Is Transplant the Answer? Clinical Gastroenterology and Hepatology 2012;10:103-5. [DOI: 10.1016/j.cgh.2011.10.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
39 Craig DG, Lee A, Hayes PC, Simpson KJ. Review article: the current management of acute liver failure. Aliment Pharmacol Ther. 2010;31:345-358. [PMID: 19845566 DOI: 10.1111/j.1365-2036.2009.04175.x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 5.2] [Reference Citation Analysis]
40 Han W, Zhang H, Han Y, Duan Z. Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy. Metab Brain Dis. 2020;35:869-881. [PMID: 32495311 DOI: 10.1007/s11011-020-00539-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Schiff S, Vallesi A, Mapelli D, Orsato R, Pellegrini A, Umiltà C, Gatta A, Amodio P. Impairment of Response Inhibition Precedes Motor Alteration in the Early Stage of Liver Cirrhosis: A Behavioral and Electrophysiological Study. Metab Brain Dis 2005;20:381-92. [DOI: 10.1007/s11011-005-7922-4] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
42 Rockey DC, Vierling JM, Mantry P, Ghabril M, Brown RS, Alexeeva O, Zupanets IA, Grinevich V, Baranovsky A, Dudar L, Fadieienko G, Kharchenko N, Klaryts'ka I, Morozov V, Grewal P, McCashland T, Reddy KG, Reddy KR, Syplyviy V, Bass NM, Dickinson K, Norris C, Coakley D, Mokhtarani M, Scharschmidt BF; HALT-HE Study Group. Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology. 2014;59:1073-1083. [PMID: 23847109 DOI: 10.1002/hep.26611] [Cited by in Crossref: 98] [Cited by in F6Publishing: 75] [Article Influence: 12.3] [Reference Citation Analysis]
43 Palomero-Gallagher N, Zilles K. Neurotransmitter receptor alterations in hepatic encephalopathy: a review. Arch Biochem Biophys 2013;536:109-21. [PMID: 23466244 DOI: 10.1016/j.abb.2013.02.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
44 Snehavardhan P, Lal BB, Sood V, Khanna R, Alam S. Efficacy and Safety of Sodium Benzoate in The Management of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood—A Double-blind Randomized Controlled Trial. Journal of Pediatric Gastroenterology & Nutrition 2020;70:165-70. [DOI: 10.1097/mpg.0000000000002521] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Hashiguchi M, Tamai T, Kiyama K, Ooi T, Yamauchi T, Kamikihara Y, Kodama T, Kawahira M, Nakamura Y, Yano H, Nakazawa J, Iwashita Y, Nasu Y, Hori T, Tsubouchi H, Ido A. Two cases of liver cirrhosis with hyperammonemic encephalopathy caused by urease-producing bacteria in the urinary tract. Clin J Gastroenterol 2021;14:650-5. [PMID: 33400189 DOI: 10.1007/s12328-020-01313-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Germanese D, Colantonio S, D'Acunto M, Romagnoli V, Salvati A, Brunetto M. An E-Nose for the Monitoring of Severe Liver Impairment: A Preliminary Study. Sensors (Basel) 2019;19:E3656. [PMID: 31443499 DOI: 10.3390/s19173656] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
47 Xu XY, Ding HG, Li WG, Jia JD, Wei L, Duan ZP, Liu YL, Ling-Hu EQ, Zhuang H, Hepatology CSO, Association CM. Chinese guidelines on management of hepatic encephalopathy in cirrhosis. World J Gastroenterol 2019; 25(36): 5403-5422 [PMID: 31576089 DOI: 10.3748/wjg.v25.i36.5403] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
48 Häussinger D, Córdoba J, Kircheis G, Vilstrup H, Fleig WE, Jones EA, Schleiss F, Blei AT. Definition and assessment of low-grade hepatic encephalopathy. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 423-32. [DOI: 10.1007/1-4020-4456-9_32] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
49 Zheng G, Zhang L, Zhang LJ, Li Q, Pan Z, Liang X, Shi D, Lu GM. Altered modular organization of functional connectivity networks in cirrhotic patients without overt hepatic encephalopathy. Biomed Res Int 2014;2014:727452. [PMID: 25165713 DOI: 10.1155/2014/727452] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
50 Prakash RK, Kanna S, Mullen KD. Evolving Concepts: The Negative Effect of Minimal Hepatic Encephalopathy and Role for Prophylaxis in Patients With Cirrhosis. Clinical Therapeutics 2013;35:1458-73. [DOI: 10.1016/j.clinthera.2013.07.421] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
51 Duan Z, Kong Y, Zhang J, Guo H. Psychological comorbidities in Chinese patients with acute-on-chronic liver failure. General Hospital Psychiatry 2012;34:276-81. [DOI: 10.1016/j.genhosppsych.2011.11.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
52 Cash W, Mcconville P, Mcdermott E, Mccormick P, Callender M, Mcdougall N. Current concepts in the assessment and treatment of Hepatic Encephalopathy. QJM 2009;103:9-16. [DOI: 10.1093/qjmed/hcp152] [Cited by in Crossref: 84] [Cited by in F6Publishing: 62] [Article Influence: 6.5] [Reference Citation Analysis]
53 Ronsoni MF, Lazzarotto C, Fayad L, Silva MC, Nogueira CL, Bazzo ML, Narciso-schiavon JL, Dantas-corrêa EB, Schiavon LDL. IGF-I and IGFBP-3 serum levels in patients hospitalized for complications of liver cirrhosis. Annals of Hepatology 2013;12:456-63. [DOI: 10.1016/s1665-2681(19)31009-9] [Cited by in Crossref: 7] [Article Influence: 0.8] [Reference Citation Analysis]
54 Lunia MK, Sharma BC, Sachdeva S. Small intestinal bacterial overgrowth and delayed orocecal transit time in patients with cirrhosis and low-grade hepatic encephalopathy. Hepatol Int. 2013;7:268-273. [PMID: 26201641 DOI: 10.1007/s12072-012-9360-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
55 Mayer LB, Krawczyk M, Grünhage F, Lammert F, Stokes CS. A genetic variant in the promoter of phosphate-activated glutaminase is associated with hepatic encephalopathy. J Intern Med 2015;278:313-22. [DOI: 10.1111/joim.12374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
56 Bajaj JS, Heuman DM, Hylemon PB, Sanyal AJ, Puri P, Sterling RK, Luketic V, Stravitz RT, Siddiqui MS, Fuchs M, Thacker LR, Wade JB, Daita K, Sistrun S, White MB, Noble NA, Thorpe C, Kakiyama G, Pandak WM, Sikaroodi M, Gillevet PM. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther 2014;39:1113-25. [PMID: 24628464 DOI: 10.1111/apt.12695] [Cited by in Crossref: 152] [Cited by in F6Publishing: 146] [Article Influence: 19.0] [Reference Citation Analysis]
57 Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK, Stravitz RT, Luketic V, White MB, Sanyal AJ. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332-2340. [PMID: 20178797 DOI: 10.1053/j.gastro.2010.02.015] [Cited by in Crossref: 197] [Cited by in F6Publishing: 161] [Article Influence: 16.4] [Reference Citation Analysis]
58 Bajaj JS, Heuman DM, Sanyal AJ, Hylemon PB, Sterling RK, Stravitz RT, Fuchs M, Ridlon JM, Daita K, Monteith P, Noble NA, White MB, Fisher A, Sikaroodi M, Rangwala H, Gillevet PM. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS One. 2013;8:e60042. [PMID: 23565181 DOI: 10.1371/journal.pone.0060042] [Cited by in Crossref: 227] [Cited by in F6Publishing: 220] [Article Influence: 25.2] [Reference Citation Analysis]
59 Ginès P, Wong F, Watson H, Milutinovic S, del Arbol LR, Olteanu D. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial. Hepatology. 2008;48:204-213. [PMID: 18508290 DOI: 10.1002/hep.22293] [Cited by in Crossref: 146] [Cited by in F6Publishing: 114] [Article Influence: 10.4] [Reference Citation Analysis]
60 Shapshak P, Somboonwit C, Drumright LN, Frost SD, Commins D, Tellinghuisen TL, Scott WK, Duncan R, McCoy C, Page JB, Giunta B, Fernandez F, Singer E, Levine A, Minagar A, Oluwadara O, Kotila T, Chiappelli F, Sinnott JT. Molecular and contextual markers of hepatitis C virus and drug abuse. Mol Diagn Ther 2009;13:153-79. [PMID: 19650670 DOI: 10.2165/01250444-200913030-00002] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
61 Sharma P, Kumar A, Singh S, Tyagi P, Kumar A. Inhibitory control test, critical flicker frequency, and psychometric tests in the diagnosis of minimal hepatic encephalopathy in cirrhosis. Saudi J Gastroenterol. 2013;19:40-44. [PMID: 23319037 DOI: 10.4103/1319-3767.105924] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
62 Torres DS, Abrantes J, Brandão-Mello CE. Cognitive and neurophysiological assessment of patients with minimal hepatic encephalopathy in Brazil. Sci Rep 2020;10:8610. [PMID: 32451417 DOI: 10.1038/s41598-020-65307-3] [Reference Citation Analysis]
63 Jacob S, Khan A, Jacobs ER, Kandiah P, Nanchal R. Prolonged Hypothermia as a Bridge to Recovery for Cerebral Edema and Intracranial Hypertension Associated with Fulminant Hepatic Failure. Neurocrit Care 2009;11:242-6. [DOI: 10.1007/s12028-009-9266-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
64 Sturgeon JP, Shawcross DL. Recent insights into the pathogenesis of hepatic encephalopathy and treatments. Expert Rev Gastroenterol Hepatol. 2014;8:83-100. [PMID: 24236755 DOI: 10.1586/17474124.2014.858598] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
65 Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol. 2007;102:754-760. [PMID: 17222319 DOI: 10.1111/j.1572-0241.2007.01048.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 94] [Article Influence: 7.2] [Reference Citation Analysis]
66 García-Cortés M, Ortega-Alonso A, Andrade RJ. Safety of treating acute liver injury and failure. Expert Opin Drug Saf 2021;:1-13. [PMID: 34254839 DOI: 10.1080/14740338.2021.1955854] [Reference Citation Analysis]
67 Ciećko-Michalska I, Szczepanek M, Słowik A, Mach T. Pathogenesis of hepatic encephalopathy. Gastroenterol Res Pract 2012;2012:642108. [PMID: 23316223 DOI: 10.1155/2012/642108] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
68 Montoliu C, Gonzalez-Escamilla G, Atienza M, Urios A, Gonzalez O, Wassel A, Aliaga R, Giner-Duran R, Serra MA, Rodrigo JM. Focal cortical damage parallels cognitive impairment in minimal hepatic encephalopathy. Neuroimage. 2012;61:1165-1175. [PMID: 22465844 DOI: 10.1016/j.neuroimage.2012.03.041] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
69 Aller MA, Arias N, Blanco-Rivero J, Arias JL, Arias J. Hepatic encephalopathy: Sometimes more portal than hepatic. J Gastroenterol Hepatol 2019;34:490-4. [PMID: 30345537 DOI: 10.1111/jgh.14514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
70 Liao LM, Zhou LX, Le HB, Yin JJ, Ma SH. Spatial working memory dysfunction in minimal hepatic encephalopathy: an ethology and BOLD-fMRI study.Brain Res. 2012;1445:62-72. [PMID: 22325099 DOI: 10.1016/j.brainres.2012.01.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
71 Figueiredo-Mello C, Casadio LVB, Avelino-Silva VI, Yeh-Li H, Sztajnbok J, Joelsons D, Antonio MB, Pinho JRR, Malta FM, Gomes-Gouvêa MS, Salles APM, Corá AP, Moreira CHV, Ribeiro AF, Nastri ACSS, Malaque CMS, Teixeira RFA, Borges LMS, Gonzalez MP, Junior LCP, Souza TNL, Song ATW, D'Albuquerque LAC, Abdala E, Andraus W, Martino RB, Ducatti L, Andrade GM, Malbouisson LMS, Souza IM, Carrilho FJ, Sabino EC, Levin AS. Efficacy of sofosbuvir as treatment for yellow fever: protocol for a randomised controlled trial in Brazil (SOFFA study). BMJ Open 2019;9:e027207. [PMID: 31772079 DOI: 10.1136/bmjopen-2018-027207] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
72 Marciano S, Haddad L, Martínez AP, Posadas ML, Piñero F, Mora GJ, Guerrero LN, Ridruejo E, Mandó OG, Giunta DH, Gadano AC. Ultra-sensitive procalcitonin may help rule out bacterial infections in patients with cirrhosis. Annals of Hepatology 2014;13:541-7. [DOI: 10.1016/s1665-2681(19)31254-2] [Cited by in Crossref: 7] [Article Influence: 0.9] [Reference Citation Analysis]
73 Elwir S, Rahimi RS. Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. J Clin Transl Hepatol. 2017;5:142-151. [PMID: 28660152 DOI: 10.14218/jcth.2016.00069] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
74 Jeong JY, Jun DW, Bai D, Kim JY, Sohn JH, Ahn SB, Kim SG, Kim TY, Kim HS, Jeong SW, Cho YK, Song DS, Kim HY, Jung YK, Yoon EL. Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea. J Korean Med Sci. 2017;32:1484-1490. [PMID: 28776344 DOI: 10.3346/jkms.2017.32.9.1484] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
75 Yadav K, Shrikhande S, Goel M. Post hepatectomy liver failure: concept of management. J Gastrointest Cancer 2014;45:405-13. [PMID: 25104504 DOI: 10.1007/s12029-014-9646-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
76 Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y. Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci. 2010;55:2381-2390. [PMID: 20508990 DOI: 10.1007/s10620-010-1249-7] [Cited by in Crossref: 128] [Cited by in F6Publishing: 119] [Article Influence: 10.7] [Reference Citation Analysis]
77 Cudalbu C, Taylor-Robinson SD. Brain Edema in Chronic Hepatic Encephalopathy. J Clin Exp Hepatol 2019;9:362-82. [PMID: 31360029 DOI: 10.1016/j.jceh.2019.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
78 Pegum N, Connor JP, Feeney GF, Young RM. Neuropsychological functioning in patients with alcohol-related liver disease before and after liver transplantation. Transplantation. 2011;92:1371-1377. [PMID: 22075529 DOI: 10.1097/tp.0b013e3182375881] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
79 Berlioux P, Robic MA, Poirson H, Métivier S, Otal P, Barret C, Lopez F, Péron JM, Vinel JP, Bureau C. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests. Hepatology 2014;59:622-9. [PMID: 24620380 DOI: 10.1002/hep.26684] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 5.1] [Reference Citation Analysis]
80 Swaminathan M, Ellul MA, Cross TJ. Hepatic encephalopathy: current challenges and future prospects. Hepat Med. 2018;10:1-11. [PMID: 29606895 DOI: 10.2147/hmer.s118964] [Cited by in Crossref: 23] [Cited by in F6Publishing: 8] [Article Influence: 5.8] [Reference Citation Analysis]
81 Umapathy S, Dhiman RK, Grover S, Duseja A, Chawla YK. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Am J Gastroenterol. 2014;109:1011-1019. [PMID: 24777152 DOI: 10.1038/ajg.2014.107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
82 Sekimoto T, Maruyama H, Kiyono S, Kondo T, Shimada T, Ishibashi H, Takahashi M, Yokosuka O, Yamaguchi T. Hepatic filling rate of a microbubble agent: a novel predictor of long-term outcomes in patients with cirrhosis. Ultrasound Med Biol 2014;40:2082-8. [PMID: 25018029 DOI: 10.1016/j.ultrasmedbio.2014.04.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
83 Felipo V. Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci. 2013;14:851-858. [PMID: 24149188 DOI: 10.1038/nrn3587] [Cited by in Crossref: 196] [Cited by in F6Publishing: 186] [Article Influence: 21.8] [Reference Citation Analysis]
84 Cookson DT, Zaman Z, Gordon-smith J, Ireland HM, Hayes PC. Management of Transjugular Intrahepatic Portosystemic Shunt (TIPS)-associated Refractory Hepatic Encephalopathy by Shunt Reduction Using the Parallel Technique: Outcomes of a Retrospective Case Series. Cardiovasc Intervent Radiol 2011;34:92-9. [DOI: 10.1007/s00270-010-0016-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
85 Sharma BC, Sharma P, Lunia MK, Srivastava S, Goyal R, Sarin SK. A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol. 2013;108:1458-1463. [PMID: 23877348 DOI: 10.1038/ajg.2013.219] [Cited by in Crossref: 164] [Cited by in F6Publishing: 127] [Article Influence: 18.2] [Reference Citation Analysis]
86 Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60:715-735. [PMID: 25042402 DOI: 10.1002/hep.27210] [Cited by in Crossref: 879] [Cited by in F6Publishing: 680] [Article Influence: 109.9] [Reference Citation Analysis]
87 Leke R, Escobar TD, Rao KV, Silveira TR, Norenberg MD, Schousboe A. Expression of glutamine transporter isoforms in cerebral cortex of rats with chronic hepatic encephalopathy. Neurochem Int 2015;88:32-7. [PMID: 25842041 DOI: 10.1016/j.neuint.2015.03.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
88 Privette TW, Carlisle MC, Palma JK. Emergencies of the Liver, Gallbladder, and Pancreas. Emergency Medicine Clinics of North America 2011;29:293-317. [DOI: 10.1016/j.emc.2011.01.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
89 Tenorio-Laranga J, Montoliu C, Urios A, Hernandez-Rabaza V, Ahabrach H, García-Horsman JA, Felipo V. The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients. J Neuroinflammation 2015;12:183. [PMID: 26420028 DOI: 10.1186/s12974-015-0404-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
90 Barbosa MED, Zaninotto AL, de Campos Mazo DF, Pessoa MG, de Oliveira CPMS, Carrilho FJ, Farias AQ. Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin. BMC Gastroenterol 2017;17:122. [PMID: 29178838 DOI: 10.1186/s12876-017-0679-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
91 Bragagnolo Jr. MA, Teodoro V, Lucchesi LM, Ribeiro TCDR, Tufik S, Kondo M. Detecção de encefalopatia hepática mínima através de testes neuropsicológicos e neurofisiológicos e o papel da amônia no seu diagnóstico. Arq Gastroenterol 2009;46:43-9. [DOI: 10.1590/s0004-28032009000100013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
92 Huda A, Gupta RK, Rajakumar N, Thomas MA. Role of Magnetic Resonance in Understanding the Pathogenesis of Hepatic Encephalopathy. Magn Reson Insights 2008;2:109-22. [PMID: 20890387 DOI: 10.4137/mri.s973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
93 Zhou PQ, Zheng SP, Yu M, He SS, Weng ZH. Prognosis of acute-on-chronic liver failure patients treated with artificial liver support system. World J Gastroenterol 2015; 21(32): 9614-9622 [PMID: 26327769 DOI: 10.3748/wjg.v21.i32.9614] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
94 Amodio P. Current Diagnosis and Classification of Hepatic Encephalopathy. J Clin Exp Hepatol 2018;8:432-7. [PMID: 30564001 DOI: 10.1016/j.jceh.2018.07.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
95 Solga SF, Diehl AM. Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 2004;39:1197-200. [PMID: 15122746 DOI: 10.1002/hep.20220] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
96 Guevara M, Baccaro ME, Gómez-Ansón B, Frisoni G, Testa C, Torre A, Molinuevo JL, Rami L, Pereira G, Sotil EU. Cerebral magnetic resonance imaging reveals marked abnormalities of brain tissue density in patients with cirrhosis without overt hepatic encephalopathy. J Hepatol. 2011;55:564-573. [PMID: 21163310 DOI: 10.1016/j.jhep.2010.12.008] [Cited by in Crossref: 76] [Cited by in F6Publishing: 73] [Article Influence: 6.3] [Reference Citation Analysis]
97 Jiang Q, Jiang XH, Zheng MH, Chen YP. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis. J Gastroenterol Hepatol. 2009;24:9-14. [PMID: 18823442 DOI: 10.1111/j.1440-1746.2008.05582.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
98 Albhaisi SAM, Bajaj JS. Cognitive Function in Liver Transplantation. Curr Transplant Rep 2020;7:31-7. [PMID: 32435574 DOI: 10.1007/s40472-020-00274-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Bosoi CR, Yang X, Huynh J, Parent-robitaille C, Jiang W, Tremblay M, Rose CF. Systemic oxidative stress is implicated in the pathogenesis of brain edema in rats with chronic liver failure. Free Radical Biology and Medicine 2012;52:1228-35. [DOI: 10.1016/j.freeradbiomed.2012.01.006] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 5.5] [Reference Citation Analysis]
100 Riggio O, Mannaioni G, Ridola L, Angeloni S, Merli M, Carlà V, Salvatori FM, Moroni F. Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy. Am J Gastroenterol. 2010;105:1374-1381. [PMID: 20125128 DOI: 10.1038/ajg.2009.738] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
101 Legaz I, Bolarin JM, Campillo JA, Moya RM, Luna A, Osuna E, Minguela A, Sanchez-Bueno F, Alvarez MR, Muro M. Pretransplant ascites and encephalopathy and their influence on survival and liver graft rejection in alcoholic cirrhosis disease. Arch Med Sci 2021;17:682-93. [PMID: 34025838 DOI: 10.5114/aoms.2018.80651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Srivastava A, Chaturvedi S, Gupta RK, Malik R, Mathias A, Jagannathan NR, Jain S, Pandey CM, Yachha SK, Rathore RKS. Minimal hepatic encephalopathy in children with chronic liver disease: Prevalence, pathogenesis and magnetic resonance-based diagnosis. Journal of Hepatology 2017;66:528-36. [DOI: 10.1016/j.jhep.2016.10.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
103 Qi R, Zhang L, Wu S, Zhong J, Zhang Z, Zhong Y, Ni L, Zhang Z, Li K, Jiao Q. Altered resting-state brain activity at functional MR imaging during the progression of hepatic encephalopathy. Radiology. 2012;264:187-195. [PMID: 22509052 DOI: 10.1148/radiol.12111429] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 6.8] [Reference Citation Analysis]
104 Li Y, Ji CX, Mei LH, Qiang JW, Ju S. Oral administration of trace element magnesium significantly improving the cognition and locomotion in hepatic encephalopathy rats. Sci Rep 2017;7:1817. [PMID: 28500320 DOI: 10.1038/s41598-017-02101-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
105 Binesh N, Huda A, Thomas MA, Wyckoff N, Bugbee M, Han S, Rasgon N, Davanzo P, Sayre J, Guze B, Martin P, Fawzy F. Hepatic encephalopathy: a neurochemical, neuroanatomical, and neuropsychological study. J Appl Clin Med Phys 2006;7:86-96. [PMID: 16518320 DOI: 10.1120/jacmp.v7i1.2151] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
106 Chen L, Xiao T, Chen W, Long Q, Li R, Fang D, Wang R. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial. Liver Int. 2009;29:1101-1109. [PMID: 19386025 DOI: 10.1111/j.1478-3231.2009.02016.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
107 Aller MA, Arias JL, Arias J. The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension. J Transl Med 2007;5:44. [PMID: 17892556 DOI: 10.1186/1479-5876-5-44] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
108 Gilg S, Sparrelid E, Saraste L, Nowak G, Wahlin S, Strömberg C, Lundell L, Isaksson B. The molecular adsorbent recirculating system in posthepatectomy liver failure: Results from a prospective phase I study. Hepatol Commun 2018;2:445-54. [PMID: 29619422 DOI: 10.1002/hep4.1167] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
109 Zhang LJ, Wen J, Ni L, Zhong J, Liang X, Zheng G, Lu GM. Predominant gray matter volume loss in patients with end-stage renal disease: a voxel-based morphometry study. Metab Brain Dis 2013;28:647-54. [PMID: 24065440 DOI: 10.1007/s11011-013-9438-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
110 Ney M, Tangri N, Dobbs B, Bajaj J, Rolfson D, Ma M, Ferguson T, Bhardwaj P, Bailey RJ, Abraldes J, Tandon P. Predicting Hepatic Encephalopathy-Related Hospitalizations Using a Composite Assessment of Cognitive Impairment and Frailty in 355 Patients With Cirrhosis. Am J Gastroenterol 2018;113:1506-15. [PMID: 30267028 DOI: 10.1038/s41395-018-0243-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
111 Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-vallée J, Duvoux C, Lerut J, Le Treut Y, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F. Model for end-stage liver disease exceptions in the context of the french model for end-stage liver disease score-based liver allocation system: Meld Exceptions in the French System. Liver Transpl 2011;17:1137-51. [DOI: 10.1002/lt.22363] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
112 Butterworth RF, Kircheis G, Hilger N, McPhail MJW. Efficacy of l-Ornithine l-Aspartate for the Treatment of Hepatic Encephalopathy and Hyperammonemia in Cirrhosis: Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Clin Exp Hepatol. 2018;8:301-313. [PMID: 30302048 DOI: 10.1016/j.jceh.2018.05.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
113 Ishikawa T, Aibe Y, Matsuda T, Iwamoto T, Takami T, Sakaida I. Plasma Glucose Level Is Predictive of Serum Ammonia Level After Retrograde Occlusion of Portosystemic Shunts. AJR Am J Roentgenol 2017;209:W169-76. [PMID: 28657848 DOI: 10.2214/AJR.16.17307] [Cited by in Crossref: 7] [Article Influence: 1.4] [Reference Citation Analysis]
114 Nietsch HH. Management of Portal Hypertension: . Journal of Clinical Gastroenterology 2005;39:232-6. [DOI: 10.1097/01.mcg.0000152783.22266.35] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
115 Wang JY, Bajaj JS, Wang JB, Shang J, Zhou XM, Guo XL, Zhu X, Meng LN, Jiang HX, Mi YQ, Xu JM, Yang JH, Wang BS, Zhang NP. Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. J Dig Dis. 2019;20:547-556. [PMID: 31448533 DOI: 10.1111/1751-2980.12816] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
116 Jinadasa SP, Ruan QZ, Bayoumi AB, Sharma SV, Boone MD, Malik R, Chen CC, Kasper EM. Hemorrhagic Complications of Invasive Intracranial Pressure Monitor Placement in Acute Liver Failure: Outcomes of a Single-Center Protocol and Comprehensive Literature Review. Neurocrit Care 2021;35:87-102. [PMID: 33205356 DOI: 10.1007/s12028-020-01143-7] [Reference Citation Analysis]
117 Sharma P, Sharma BC. Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol. 2010;16:181-187. [PMID: 20616413 DOI: 10.4103/1319-3767.65189] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
118 Loo NM, Souza FF, Garcia-Tsao G. Non-hemorrhagic acute complications associated with cirrhosis and portal hypertension. Best Pract Res Clin Gastroenterol 2013;27:665-78. [PMID: 24160926 DOI: 10.1016/j.bpg.2013.08.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
119 Zarrindast MR, Issazadeh Y, Rezaei N, Khakpai F. Possible involvement of the opioidergic system in the modulation of body temperature, jumping behavior and memory process in cholestatic and addicted mice. EXCLI J 2020;19:311-22. [PMID: 32256271 DOI: 10.17179/excli2019-2055] [Reference Citation Analysis]
120 Yadav SK, Srivastava A, Srivastava A, Thomas MA, Agarwal J, Pandey CM, Lal R, Yachha SK, Saraswat VA, Gupta RK. Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequency. J Hepatol 2010;52:348-54. [PMID: 20137823 DOI: 10.1016/j.jhep.2009.12.012] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
121 Vo N, Shivariam G, Andrews RT, Vaidya S, Healey PJ, Horslen SP. Midterm Follow-up of Transjugular Intrahepatic Portosystemic Shunts Using Polytetrafluoroethylene Endografts in Children. Journal of Vascular and Interventional Radiology 2012;23:919-24. [DOI: 10.1016/j.jvir.2012.04.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
122 Jiang Q, Jiang G, Welty TE, Zheng M. Naloxone in the management of hepatic encephalopathy. J Clin Pharm Ther. 2010;35:333-341. [PMID: 20831534 DOI: 10.1111/j.1365-2710.2009.01120.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
123 Narkewicz MR, Horslen S, Hardison RM, Shneider BL, Rodriguez-Baez N, Alonso EM, Ng VL, Leonis MA, Loomes KM, Rudnick DA, Rosenthal P, Romero R, Subbarao GC, Li R, Belle SH, Squires RH; Pediatric Acute Liver Failure Study Group. A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients. Clin Gastroenterol Hepatol 2018;16:1801-1810.e3. [PMID: 29723692 DOI: 10.1016/j.cgh.2018.04.050] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
124 Yoshimura E, Ichikawa T, Miyaaki H, Taura N, Miuma S, Shibata H, Honda T, Takeshima F, Nakao K. Screening for minimal hepatic encephalopathy in patients with cirrhosis by cirrhosis-related symptoms and a history of overt hepatic encephalopathy. Biomed Rep. 2016;5:193-198. [PMID: 27446540 DOI: 10.3892/br.2016.702] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
125 Patel AV, Wade JB, Thacker LR, Sterling RK, Siddiqui MS, Stravitz RT, Sanyal AJ, Luketic V, Puri P, Fuchs M, Matherly S, White MB, Unser A, Heuman DM, Bajaj JS. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score. Clin Gastroenterol Hepatol 2015;13:987-91. [PMID: 25445772 DOI: 10.1016/j.cgh.2014.09.049] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
126 Ma R, Chen J, Liang Y, Lin S, Zhu L, Liang X, Cai X. Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes. Biomedicine & Pharmacotherapy 2017;88:459-68. [DOI: 10.1016/j.biopha.2017.01.107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 5.6] [Reference Citation Analysis]
127 Junker AE, Als-Nielsen B, Gluud C, Gluud LL. Dopamine agents for hepatic encephalopathy. Cochrane Database Syst Rev 2014;:CD003047. [PMID: 24515383 DOI: 10.1002/14651858.CD003047.pub3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
128 Fujiwara Y, Suzuki K, Yusa K, Eizuka M, Miura M, Watanabe Y, Takahashi H, Takikawa Y. Evaluation of the Long-term Administration of Rifaximin for More than Three Years in the Treatment of Repeated and Recurrent Overt Hepatic Encephalopathy. Intern Med 2021;60:1027-33. [PMID: 33790139 DOI: 10.2169/internalmedicine.5793-20] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Butz M, Timmermann L, Braun M, Groiss SJ, Wojtecki L, Ostrowski S, Krause H, Pollok B, Gross J, Südmeyer M. Motor impairment in liver cirrhosis without and with minimal hepatic encephalopathy. Acta Neurol Scand. 2010;122:27-35. [PMID: 20003084 DOI: 10.1111/j.1600-0404.2009.01246.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 2.9] [Reference Citation Analysis]
130 Nath A, Haktanirlar G, Varga Á, Molnár MA, Albert K, Galambos I, Koris A, Vatai G. Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System. Medicina (Kaunas) 2018;54:E18. [PMID: 30344249 DOI: 10.3390/medicina54020018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
131 Grover VB, Dresner MA, Forton DM, Counsell S, Larkman DJ, Patel N, Thomas HC, Taylor-Robinson SD. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastroenterol 2006; 12(19): 2969-2978 [PMID: 16718775 DOI: 10.3748/wjg.v12.i19.2969] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
132 Forton DM, Taylor-robinson S, Gess M, Thomas HC. Central Nervous System Complications of Hepatitis C Virus Infection. In: Thomas HC, Lok AS, Locarnini SA, Zuckerman AJ, editors. Viral Hepatitis. Oxford: John Wiley & Sons, Ltd; 2013. pp. 310-24. [DOI: 10.1002/9781118637272.ch21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
133 Gomez EV, Gonzalez AT, Bertot LC, Yasells Garcia A, Rodriguez YS, Perez YM. Arterial blood pressure is closely related to ascites development in compensated HCV-related cirrhosis. PLoS One 2014;9:e95736. [PMID: 24755710 DOI: 10.1371/journal.pone.0095736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
134 Lama M, Shannon S, Davin Q. Methamphetamine Intoxication Encephalopathy Associated With Hyperammonemia. Psychosomatics 2016;57:325-9. [PMID: 26961794 DOI: 10.1016/j.psym.2015.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
135 Kondo T, Maruyama H, Sekimoto T, Shimada T, Takahashi M, Yokosuka O. Reversed portal flow: Clinical influence on the long-term outcomes in cirrhosis. World J Gastroenterol 2015; 21(29): 8894-8902 [PMID: 26269679 DOI: 10.3748/wjg.v21.i29.8894] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
136 Siotto M, Pasqualetti P, Marano M, Squitti R. Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson’s disease and in hepatic encephalopathy. J Neural Transm (Vienna). 2014;121:1281-1286. [PMID: 24663495 DOI: 10.1007/s00702-014-1196-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
137 Zhang LJ, Qi R, Zhong J, Xu Q, Zheng G, Lu GM. The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study. PLoS One. 2012;7:e42824. [PMID: 22912746 DOI: 10.1371/journal.pone.0042824] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
138 Frederick RT. Extent of reversibility of hepatic encephalopathy following liver transplantation. Clin Liver Dis 2012;16:147-58. [PMID: 22321470 DOI: 10.1016/j.cld.2011.12.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
139 Wu H, Li N, Jin R, Meng Q, Chen P, Zhao G, Wang R, Li L, Li W. Cytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activation. Sci Rep 2016;6:18528. [PMID: 26757951 DOI: 10.1038/srep18528] [Cited by in Crossref: 7] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
140 Hope AA, Morrison RS. Integrating Palliative Care with Chronic Liver Disease Care. J Palliat Care 2011;27:20-7. [DOI: 10.1177/082585971102700105] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
141 Zuccoli G, Siddiqui N, Cravo I, Bailey A, Gallucci M, Harper CG. Neuroimaging findings in alcohol-related encephalopathies. AJR Am J Roentgenol 2010;195:1378-84. [PMID: 21098198 DOI: 10.2214/AJR.09.4130] [Cited by in Crossref: 39] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
142 Riggio O, Ridola L, Pasquale C. Hepatic encephalopathy therapy: An overview. World J Gastrointest Pharmacol Ther 2010; 1(2): 54-63 [PMID: 21577297 DOI: 10.4292/wjgpt.v1.i2.54] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
143 Butterworth RF. Pathogenesis of hepatic encephalopathy: new insights from neuroimaging and molecular studies. J Hepatol. 2003;39:278-285. [PMID: 12873828 DOI: 10.1016/s0168-8278(03)00267-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
144 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;7:CD002798. [PMID: 28745801 DOI: 10.1002/14651858.CD002798.pub3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
145 Dam G, Keiding S, Munk OL, Ott P, Vilstrup H, Bak LK, Waagepetersen HS, Schousboe A, Sørensen M. Hepatic encephalopathy is associated with decreased cerebral oxygen metabolism and blood flow, not increased ammonia uptake. Hepatology. 2013;57:258-265. [PMID: 22886493 DOI: 10.1002/hep.25995] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
146 Luo M, Li L, Yang EN, Dai CY, Liang SR, Cao WK. Correlation between interleukin-6 and ammonia in patients with overt hepatic encephalopathy due to cirrhosis. Clin Res Hepatol Gastroenterol. 2013;37:384-390. [PMID: 23084463 DOI: 10.1016/j.clinre.2012.08.007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
147 Vierling JM, Mokhtarani M, Brown RS, Mantry P, Rockey DC, Ghabril M, Rowell R, Jurek M, Coakley DF, Scharschmidt BF. Fasting Blood Ammonia Predicts Risk and Frequency of Hepatic Encephalopathy Episodes in Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2016;14:903-906.e1. [PMID: 26707685 DOI: 10.1016/j.cgh.2015.11.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
148 Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, Turco L, Dragoni G, Laffi G, Marra F. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med 2020;15:37-48. [DOI: 10.1007/s11739-019-02252-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
149 Cheng Y, Shen W, Xu J, Amey RC, Huang LX, Zhang XD, Li JL, Akhavan C, Duffy BA, Simon JP, Jiang W, Liu M, Kim H. Neuromarkers from Whole-Brain Functional Connectivity Reveal the Cognitive Recovery Scheme for Overt Hepatic Encephalopathy after Liver Transplantation. eNeuro 2021;8:ENEURO. [PMID: 34376523 DOI: 10.1523/ENEURO.0114-21.2021] [Reference Citation Analysis]
150 Zhang LJ, Qi R, Zhong J, Ni L, Zheng G, Xu J, Lu GM. Disrupted functional connectivity of the anterior cingulate cortex in cirrhotic patients without overt hepatic encephalopathy: a resting state fMRI study. PLoS One. 2013;8:e53206. [PMID: 23308163 DOI: 10.1371/journal.pone.0053206] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
151 John JA, de Mattos AA, da Silva Miozzo SA, Comerlato PH, Porto M, Contiero P, da Silva RR. Survival and risk factors related to death in outpatients with cirrhosis treated in a clinic in Southern Brazil. Eur J Gastroenterol Hepatol. 2015;27:1372-1377. [PMID: 26426832 DOI: 10.1097/meg.0000000000000480] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
152 DiMartini A, Crone C, Fireman M, Dew MA. Psychiatric aspects of organ transplantation in critical care. Crit Care Clin 2008;24:949-81, x. [PMID: 18929948 DOI: 10.1016/j.ccc.2008.05.001] [Cited by in Crossref: 65] [Cited by in F6Publishing: 46] [Article Influence: 4.6] [Reference Citation Analysis]
153 Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Effect of physical exercise on sarcopaenia in patients with overt hepatic encephalopathy: a study protocol for a randomised controlled trial. BMJ Open Gastroenterol 2017;4:e000185. [PMID: 29259793 DOI: 10.1136/bmjgast-2017-000185] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
154 Madoff DC, Gaba RC, Weber CN, Clark TW, Saad WE. Portal Venous Interventions: State of the Art. Radiology. 2016;278:333-353. [PMID: 26789601 DOI: 10.1148/radiol.2015141858] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
155 Dinya T, Tornai T, Vitalis Z, Tornai I, Balogh B, Tornai D, Antal-Szalmas P, Sumegi A, Andrikovics H, Bors A, Tordai A, Papp M. Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis. Liver Int 2018;38:1242-52. [PMID: 29235260 DOI: 10.1111/liv.13664] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
156 Zhang Z, Zhang J, Wei Z, Ren H, Song W, Pan J, Liu J, Zhang Y, Qiu L. Application of tabu search-based Bayesian networks in exploring related factors of liver cirrhosis complicated with hepatic encephalopathy and disease identification. Sci Rep 2019;9:6251. [PMID: 31000773 DOI: 10.1038/s41598-019-42791-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
157 Naeshiro N, Kakizawa H, Aikata H, Kan H, Fujino H, Fukuhara T, Kobayashi T, Honda Y, Miyaki D, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Ishikawa M, Awai K, Chayama K. Percutaneous transvenous embolization for portosystemic shunts associated with encephalopathy: Long-term outcomes in 14 patients. Hepatol Res 2014;44:740-9. [PMID: 23745735 DOI: 10.1111/hepr.12181] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
158 Stange J. Extracorporeal liver support. Organogenesis 2011;7:64-73. [PMID: 21343699 DOI: 10.4161/org.7.1.14069] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
159 Lewsey JD, Dawwas M, Copley LP, Gimson A, Van der Meulen JH. Developing a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors. Transplantation. 2006;82:898-907. [PMID: 17038904 DOI: 10.1097/01.tp.0000235516.99977.95] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
160 Gluud LL, Dam G, Les I, Córdoba J, Marchesini G, Borre M, Aagaard NK, Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev 2015;:CD001939. [PMID: 26377410 DOI: 10.1002/14651858.CD001939.pub3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
161 Naderian M, Akbari H, Saeedi M, Sohrabpour AA. Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial. Middle East J Dig Dis 2017;9:12-9. [PMID: 28316761 DOI: 10.15171/mejdd.2016.46] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
162 Slack AJ, Auzinger G, Willars C, Dew T, Musto R, Corsilli D, Sherwood R, Wendon JA, Bernal W. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 2014;34:42-8. [PMID: 23786538 DOI: 10.1111/liv.12221] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 8.8] [Reference Citation Analysis]
163 Spillane AM, Haraschak JL, McMichael MA. Resolution of Severe Neurologic Signs Following Intravenous Lipid Emulsion Therapy in a Young Dog With a Portosystemic Shunt: Case Report. Front Vet Sci 2021;8:798198. [PMID: 34957288 DOI: 10.3389/fvets.2021.798198] [Reference Citation Analysis]
164 Naqvi IH, Mahmood K, Talib A. Haemorrhagic versus non haemorrhagic ascites in cirrhosis: Their relationship and impact on prognosis of liver cirrhosis. Pak J Med Sci 2020;36:603-8. [PMID: 32494241 DOI: 10.12669/pjms.36.4.2075] [Reference Citation Analysis]
165 Wu Q, Jiang H, Linghu E, Zhang L, Wang W, Zhang J, He Z, Wang J, Yang Y, Sun G, Sun G. BRTO assisted endoscopic Histoacryl injection in treating gastric varices with gastrorenal shunt. Minim Invasive Ther Allied Technol 2016;25:337-44. [PMID: 27309571 DOI: 10.1080/13645706.2016.1192552] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
166 Montoliu C, Urios A, Forn C, García-Panach J, Avila C, Gimenez-Garzó C, Wassel A, Serra MA, Giner-Durán R, Gonzalez O. Reduced white matter microstructural integrity correlates with cognitive deficits in minimal hepatic encephalopathy. Gut. 2014;63:1028-1030. [PMID: 24218171 DOI: 10.1136/gutjnl-2013-306175] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
167 Asrani SK, Simonetto DA, Kamath PS. Acute-on-Chronic Liver Failure. Clin Gastroenterol Hepatol 2015;13:2128-39. [PMID: 26188138 DOI: 10.1016/j.cgh.2015.07.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
168 Waghray N, Waghray A, Mullen K. Treatment options for covert hepatic encephalopathy. Curr Treat Options Gastroenterol. 2014;12:229-241. [PMID: 24623592 DOI: 10.1007/s11938-014-0014-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
169 A. Kobashi-margáin R, G. Gavilanes-espinar J, Gutiérrez-grabe Y, A. Gutiérrez-jiménez Á, Chávez-tapia N, Ponciano-rodríguez G, Uribe M, Méndez Sánchez N. Albumin dialysis with molecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure. Annals of Hepatology 2011;10:S70-6. [DOI: 10.1016/s1665-2681(19)31611-4] [Cited by in Crossref: 12] [Article Influence: 1.1] [Reference Citation Analysis]
170 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
171 Francisco Rivera Ramos J, Rodríguez Leal C. Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Annals of Hepatology 2011;10:S36-9. [DOI: 10.1016/s1665-2681(19)31604-7] [Cited by in Crossref: 11] [Article Influence: 1.0] [Reference Citation Analysis]
172 Montgomery JY, Bajaj JS. Advances in the evaluation and management of minimal hepatic encephalopathy. Curr Gastroenterol Rep. 2011;13:26-33. [PMID: 20924726 DOI: 10.1007/s11894-010-0150-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
173 Perry W, Carlson MD, Barakat F, Hilsabeck RC, Schiehser DM, Mathews C, Hassanein TI. Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV. AIDS 2005;19 Suppl 3:S79-84. [PMID: 16251832 DOI: 10.1097/01.aids.0000192074.18691.31] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
174 Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Song DS, Yang JM, Yoon EL;  APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019;13:353-390. [PMID: 31172417 DOI: 10.1007/s12072-019-09946-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 109] [Article Influence: 44.7] [Reference Citation Analysis]
175 Abu Faddan NH, Shehata GA, Abd Elhafeez HA, Mohamed AO, Hassan HS, Abd El Sameea F. Cognitive function and endogenous cytokine levels in children with chronic hepatitis C. J Viral Hepat. 2015;22:665-670. [PMID: 25496114 DOI: 10.1111/jvh.12373] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
176 Abdel-hady H, Zaki A, Badra G, Lotfy M, Selmi C, Giorgini A, El-sayed M, Badr R. Helicobacter pylori infection in hepatic encephalopathy: Relationship to plasma endotoxins and blood ammonia. Hepatology Research 2007;37:1026-33. [DOI: 10.1111/j.1872-034x.2007.00146.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
177 Als-nielsen B, Gluud LL, Gluud C, Als-nielsen B. Benzodiazepine receptor antagonists for hepatic encephalopathy. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd002798.pub2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
178 Bajaj JS, Saeian K, Christensen KM, Hafeezullah M, Varma RR, Franco J, Pleuss JA, Krakower G, Hoffmann RG, Binion DG. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103:1707-1715. [PMID: 18691193 DOI: 10.1111/j.1572-0241.2008.01861.x] [Cited by in Crossref: 182] [Cited by in F6Publishing: 162] [Article Influence: 13.0] [Reference Citation Analysis]
179 Kim SK, Lee KA, Sauk S, Korenblat K. Comparison of Transjugular Intrahepatic Portosystemic Shunt with Covered Stent and Balloon-Occluded Retrograde Transvenous Obliteration in Managing Isolated Gastric Varices. Korean J Radiol. 2017;18:345-354. [PMID: 28246514 DOI: 10.3348/kjr.2017.18.2.345] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 5.2] [Reference Citation Analysis]
180 Raza MA, Bhatti RS, Akram J. Effect of rectal lactulose administration with oral therapy on time to recovery from hepatic encephalopathy: a randomized study. Ann Saudi Med 2004;24:374-7. [PMID: 15573853 DOI: 10.5144/0256-4947.2004.374] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
181 Coltart I, Tranah TH, Shawcross DL. Inflammation and hepatic encephalopathy. Arch Biochem Biophys. 2013;536:189-196. [PMID: 23583306 DOI: 10.1016/j.abb.2013.03.016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 7.6] [Reference Citation Analysis]
182 Gow AG. Hepatic Encephalopathy. Vet Clin North Am Small Anim Pract 2017;47:585-99. [PMID: 28069286 DOI: 10.1016/j.cvsm.2016.11.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
183 Cook NA, Kim JU, Pasha Y, Crossey MM, Schembri AJ, Harel BT, Kimhofer T, Taylor-Robinson SD. A pilot evaluation of a computer-based psychometric test battery designed to detect impairment in patients with cirrhosis. Int J Gen Med 2017;10:281-9. [PMID: 28919805 DOI: 10.2147/IJGM.S140197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
184 Wang RR, Gu HQ, Wei YY, Yang JX, Hou YX, Liu HM, Yang ZY, Wang XB, Jiang YY. Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis. J Clin Transl Hepatol 2021;9:647-54. [PMID: 34722179 DOI: 10.14218/JCTH.2021.00031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Pantham G, Post A, Venkat D, Einstadter D, Mullen KD. A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis. Dig Dis Sci 2017;62:2166-73. [DOI: 10.1007/s10620-017-4630-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
186 Jover R, Madaria E, Felipo V, Rodrigo R, Candela A, Compañ A. Animal models in the study of episodic hepatic encephalopathy in cirrhosis. Metab Brain Dis 2005;20:399-408. [PMID: 16382350 DOI: 10.1007/s11011-005-7925-1] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
187 Qi R, Zhang LJ, Luo S, Ke J, Kong X, Xu Q, Liu C, Lu H, Lu GM. Default mode network functional connectivity: a promising biomarker for diagnosing minimal hepatic encephalopathy: CONSORT-compliant article. Medicine (Baltimore) 2014;93:e227. [PMID: 25501083 DOI: 10.1097/MD.0000000000000227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
188 D'amico G, Pasta L, Morabito A, D'amico M, Caltagirone M, Malizia G, Tinè F, Giannuoli G, Traina M, Vizzini G, Politi F, Luca A, Virdone R, Licata A, Pagliaro L. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther 2014;39:1180-93. [DOI: 10.1111/apt.12721] [Cited by in Crossref: 238] [Cited by in F6Publishing: 181] [Article Influence: 29.8] [Reference Citation Analysis]
189 Rackayova V, Braissant O, McLin VA, Berset C, Lanz B, Cudalbu C. 1H and 31P magnetic resonance spectroscopy in a rat model of chronic hepatic encephalopathy: in vivo longitudinal measurements of brain energy metabolism. Metab Brain Dis 2016;31:1303-14. [PMID: 26253240 DOI: 10.1007/s11011-015-9715-8] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
190 Sanchez W, Talwalkar JA. Palliative care for patients with end-stage liver disease ineligible for liver transplantation. Gastroenterol Clin North Am 2006;35:201-19. [PMID: 16530121 DOI: 10.1016/j.gtc.2005.12.007] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
191 Montoliu C, Rodrigo R, Monfort P, Llansola M, Cauli O, Boix J, Elmlili N, Agusti A, Felipo V. Cyclic GMP pathways in hepatic encephalopathy. Neurological and therapeutic implications. Metab Brain Dis. 2010;25:39-48. [PMID: 20195723 DOI: 10.1007/s11011-010-9184-z] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
192 Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16. [PMID: 19529896 DOI: 10.1007/s12664-009-0003-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
193 García-García R, Cruz-Gómez ÁJ, Mangas-Losada A, Urios A, Forn C, Escudero-García D, Kosenko E, Ordoño JF, Tosca J, Giner-Durán R, Serra MA, Avila C, Belloch V, Felipo V, Montoliu C. Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy. PLoS One 2017;12:e0186463. [PMID: 29023586 DOI: 10.1371/journal.pone.0186463] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
194 Kappus MR, Bajaj JS. Covert hepatic encephalopathy: Not as minimal as you might think. Clin Gastroenterol Hepatol. 2012;10:1208-1219. [PMID: 22728384 DOI: 10.1016/j.cgh.2012.05.026] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
195 Qi R, Zhang LJ, Zhong J, Zhang Z, Ni L, Zheng G, Lu GM. Disrupted thalamic resting-state functional connectivity in patients with minimal hepatic encephalopathy. Eur J Radiol. 2013;82:850-856. [PMID: 23332976 DOI: 10.1016/j.ejrad.2012.12.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
196 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver Int. 2009;29:1365-1371. [PMID: 19555401 DOI: 10.1111/j.1478-3231.2009.02067.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
197 San Martín-Valenzuela C, Borras-Barrachina A, Gallego JJ, Urios A, Mestre-Salvador V, Correa-Ghisays P, Ballester MP, Escudero-García D, Tosca J, Montón C, Ríos MP, Kosenko E, Felipo V, Tabares-Seisdedos R, Selva-Vera G, Montoliu C. Motor and Cognitive Performance in Patients with Liver Cirrhosis with Minimal Hepatic Encephalopathy. J Clin Med 2020;9:E2154. [PMID: 32650464 DOI: 10.3390/jcm9072154] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
198 Jao T, Schröter M, Chen C, Cheng Y, Lo CZ, Chou K, Patel AX, Lin W, Lin C, Bullmore ET. Functional brain network changes associated with clinical and biochemical measures of the severity of hepatic encephalopathy. NeuroImage 2015;122:332-44. [DOI: 10.1016/j.neuroimage.2015.07.068] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
199 Zacharias HD, Zacharias AP, Gluud LL, Morgan MY. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Cochrane Database Syst Rev 2019;6:CD012334. [PMID: 31204790 DOI: 10.1002/14651858.CD012334.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
200 Suzuki Y, Kakisaka K, Sato T, Mikami R, Abe H, Sasaki T, Takikawa Y. Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury. Sci Rep 2021;11:12518. [PMID: 34131241 DOI: 10.1038/s41598-021-92058-6] [Reference Citation Analysis]
201 An J, Kim KW, Han S, Lee J, Lim YS. Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy. Aliment Pharmacol Ther. 2014;39:1418-1426. [PMID: 24754260 DOI: 10.1111/apt.12771] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
202 Qi R, Zhang LJ, Zhong J, Zhu T, Zhang Z, Xu C, Zheng G, Lu GM. Grey and white matter abnormalities in minimal hepatic encephalopathy: a study combining voxel-based morphometry and tract-based spatial statistics. Eur Radiol. 2013;23:3370-3378. [PMID: 23839169 DOI: 10.1007/s00330-013-2963-2] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
203 Yuan W, Li J, Xu L, Zhang M, Lu Z, Feng S, Wang L, Li J. L-ornithine-L-aspartate for hepatic encephalopathy. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd007344] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
204 Atluri DK, Prakash R, Mullen KD. Pathogenesis, diagnosis, and treatment of hepatic encephalopathy. J Clin Exp Hepatol. 2011;1:77-86. [PMID: 25755319 DOI: 10.1016/s0973-6883(11)60126-6] [Cited by in Crossref: 40] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
205 Ferenci P, Müller C. Hepatic Encephalopathy: Treatment. In: Mcdonald JW, Burroughs AK, Feagan BG, Fennerty MB, editors. Evidence‐Based Gastroenterology and Hepatology. Wiley; 2010. pp. 636-49. [DOI: 10.1002/9781444314403.ch39] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
206 Riggio O, Efrati C, Catalano C, Pediconi F, Mecarelli O, Accornero N, Nicolao F, Angeloni S, Masini A, Ridola L, Attili AF, Merli M. High prevalence of spontaneous portal-systemic shunts in persistent hepatic encephalopathy: a case-control study. Hepatology. 2005;42:1158-1165. [PMID: 16250033 DOI: 10.1002/hep.20905] [Cited by in Crossref: 109] [Cited by in F6Publishing: 85] [Article Influence: 6.4] [Reference Citation Analysis]
207 Stewart CA, Auger RR, Enders FT, Felmlee-Devine D, Smith GE. The effects of poor sleep quality on cognitive function of patients with cirrhosis. J Clin Sleep Med 2014;10:21-6. [PMID: 24426816 DOI: 10.5664/jcsm.3350] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
208 Viramontes Hörner D, Avery A, Stow R. The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy: A Systematic Review. J Clin Gastroenterol 2017;51:312-23. [PMID: 28059938 DOI: 10.1097/MCG.0000000000000789] [Cited by in Crossref: 22] [Cited by in F6Publishing: 9] [Article Influence: 4.4] [Reference Citation Analysis]
209 Choi JM, Kim YH, Roh SY. Acute hepatic encephalopathy presenting as cortical laminar necrosis: case report. Korean J Radiol 2013;14:324-8. [PMID: 23482893 DOI: 10.3348/kjr.2013.14.2.324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
210 Emerson P, McPeake J, O'Neill A, Gilmour H, Forrest E, Puxty A, Kinsella J, Shaw M. The utility of scoring systems in critically ill cirrhotic patients admitted to a general intensive care unit. J Crit Care 2014;29:1131.e1-6. [PMID: 25175945 DOI: 10.1016/j.jcrc.2014.06.027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
211 Kamran U, Towey J, Khanna A, Chauhan A, Rajoriya N, Holt A. Nutrition in alcohol-related liver disease: Physiopathology and management. World J Gastroenterol 2020; 26(22): 2916-2930 [PMID: 32587439 DOI: 10.3748/wjg.v26.i22.2916] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
212 Chung MS, Kim HS, Lim Y, Jeon S, Kim S, Kim HJ, Hwang S, Jung SC, Choi CG, Kim SJ. Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution. Eur Radiol 2017;27:3532-41. [DOI: 10.1007/s00330-017-4741-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
213 Odeh M, Sabo E, Srugo I, Oliven A. Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure. Liver Int. 2004;24:110-116. [PMID: 15078474 DOI: 10.1111/j.1478-3231.2004.0894.x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
214 Salam M, Matherly S, Farooq IS, Stravitz RT, Sterling RK, Sanyal AJ, Gibson DP, Wade JB, Thacker LR, Heuman DM, Fuchs M, Puri P, Luketic V, Bickston SJ, Bajaj JS. Modified-orientation log to assess hepatic encephalopathy. Aliment Pharmacol Ther 2012;35:913-20. [PMID: 22348593 DOI: 10.1111/j.1365-2036.2012.05038.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
215 Fan Z, EnQiang C, Yao DL, LiBo Y, Hong L, Lang B, Ping F, Hong T. Neutrophil-lymphocyte ratio predicts short term mortality in patients with hepatitis B virus-related acute-on-chronic liver failure treated with an artificial liver support system. PLoS One 2017;12:e0175332. [PMID: 28426800 DOI: 10.1371/journal.pone.0175332] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
216 Miike H, Ohuchi H, Hayama Y, Isawa T, Sakaguchi H, Kurosaki K, Nakai M. Systemic Artery Vasoconstrictor Therapy in Fontan Patients with High Cardiac Output-Heart Failure: A Single-Center Experience. Pediatr Cardiol 2021;42:700-6. [PMID: 33416919 DOI: 10.1007/s00246-020-02532-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
217 Wunsch E, Naprawa G, Koziarska D, Milkiewicz M, Nowacki P, Milkiewicz P. Serum natremia affects health-related quality of life in patients with liver cirrhosis: a prospective, single centre study. Annals of Hepatology 2013;12:448-55. [DOI: 10.1016/s1665-2681(19)31008-7] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
218 Flower O, Phillips LE, Cameron P, Gunn K, Dunkley S, Watts A, Rajbhandari D. Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand. Blood Coagul Fibrinolysis 2010;21:207-15. [PMID: 20182351 DOI: 10.1097/MBC.0b013e3283333589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
219 Kalaitzakis E, Josefsson A, Björnsson E. Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study. BMC Gastroenterol. 2008;8:46. [PMID: 18922174 DOI: 10.1186/1471-230x-8-46] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
220 Baudry T, Hernu R, Valleix B, Jahandiez V, Faucher E, Simon M, Cour M, Argaud L. Cirrhotic Patients Admitted to the ICU With Septic Shock: Factors Predicting Short and Long-Term Outcome. Shock 2019;52:408-13. [DOI: 10.1097/shk.0000000000001282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
221 Espíritu-Ramírez P, Ortega-Balderas NY, Sevilla-Tapia L, Montiel-Martínez AG, Pastor-Flores AR, Palomares LA, Torres-Vega MA. Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy. Ann Hepatol 2018;17:1026-34. [PMID: 30600292 DOI: 10.5604/01.3001.0012.7203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
222 Rega D, Aiko M, Peñaranda N, Urios A, Gallego JJ, Giménez-Garzó C, Casanova F, Fiorillo A, Cabrera-Pastor A, San-Miguel T, Ipiens C, Escudero-García D, Tosca J, Montón C, Ballester MP, Ballester J, Aparicio L, Ríos MP, Durbán L, Mir A, Kosenko E, Cases P, Felipo V, Montoliu C. Patients with Minimal Hepatic Encephalopathy Show Altered Thermal Sensitivity and Autonomic Function. J Clin Med 2021;10:E239. [PMID: 33440769 DOI: 10.3390/jcm10020239] [Reference Citation Analysis]
223 Bersagliere A, Raduazzo ID, Nardi M, Schiff S, Gatta A, Amodio P, Achermann P, Montagnese S. Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis. Hepatology 2012;55:869-78. [PMID: 21994139 DOI: 10.1002/hep.24741] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
224 Yanny B, Winters A, Boutros S, Saab S. Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach. Clin Liver Dis 2019;23:607-23. [PMID: 31563214 DOI: 10.1016/j.cld.2019.07.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
225 Chen QF, Zhang XH, Zou TX, Huang NX, Chen HJ. Reduced Cortical Complexity in Cirrhotic Patients with Minimal Hepatic Encephalopathy. Neural Plast 2020;2020:7364649. [PMID: 32256557 DOI: 10.1155/2020/7364649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
226 Yan H, Wu W, Yang Y, Wu Y, Yang Q, Shi Y. A novel integrated Model for End-Stage Liver Disease model predicts short-term prognosis of hepatitis B virus-related acute-on-chronic liver failure patients. Hepatol Res. 2015;45:405-414. [PMID: 24849735 DOI: 10.1111/hepr.12362] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
227 Ferrarese A, Vitale A, Sgarabotto D, Russo FP, Germani G, Gambato M, Cattelan AM, Angeli P, Cillo U, Burra P, Senzolo M. Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation. Liver Transpl. 2019;25:1187-1197. [PMID: 31021050 DOI: 10.1002/lt.25479] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
228 Li H, Wang R, Méndez-Sánchez N, Peng Y, Guo X, Qi X. Impact of spider nevus and subcutaneous collateral vessel of chest/abdominal wall on outcomes of liver cirrhosis. Arch Med Sci 2019;15:434-48. [PMID: 30899297 DOI: 10.5114/aoms.2018.74788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
229 Tofteng F, Jorgensen L, Hansen BA, Ott P, Kondrup J, Larsen FS. Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology. 2002;36:1333-1340. [PMID: 12447856 DOI: 10.1002/hep.1840360607] [Cited by in Crossref: 47] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
230 Gana JC, Turner D, Mieli-Vergani G, Davenport M, Miloh T, Avitzur Y, Yap J, Morinville V, Brill H, Ling SC. A clinical prediction rule and platelet count predict esophageal varices in children. Gastroenterology. 2011;141:2009-2016. [PMID: 21925123 DOI: 10.1053/j.gastro.2011.08.049] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
231 Sharma P, Sharma BC. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Saudi J Gastroenterol 2012;18:168-72. [PMID: 22626795 DOI: 10.4103/1319-3767.96448] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
232 Stokes CS, Goh ET, Vilstrup H, Morgan MY, Gluud LL; Cochrane Hepato-Biliary Group. L-ornithine L-aspartate for people with cirrhosis and hepatic encephalopathy. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012410] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
233 Djiambou-Nganjeu H. Hepatic Encephalopathy in Patients in Lviv (Ukraine). J Transl Int Med. 2018;6:146-151. [PMID: 30425951 DOI: 10.2478/jtim-2018-0021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
234 Rajakumar A, Kaliamoorthy I, Rela M, Mandell MS. Small-for-Size Syndrome: Bridging the Gap Between Liver Transplantation and Graft Recovery. Semin Cardiothorac Vasc Anesth 2017;21:252-61. [DOI: 10.1177/1089253217699888] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
235 Dams K, Meersseman W, Wilmer A. Hyperammonemia in the Adult Critical Care Setting. Yearbook of Intensive Care and Emergency Medicine. Berlin: Springer Berlin Heidelberg; 2008. pp. 481-90. [DOI: 10.1007/978-3-540-77290-3_45] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
236 Sergeeva O, Schulz D, Doreulee N, Ponomarenko A, Selbach O, Borsch E, Kircheis G, Huston J, Häussinger D, Haas H. Deficits in cortico-striatal synaptic plasticity and behavioral habituation in rats with portacaval anastomosis. Neuroscience 2005;134:1091-8. [DOI: 10.1016/j.neuroscience.2005.05.031] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
237 Gad YZ, Zaher AA, Moussa NH, El-desoky AE, Al-Adarosy HA. Screening for minimal hepatic encephalopathy in asymptomatic drivers with liver cirrhosis. Arab J Gastroenterol. 2011;12:58-61. [PMID: 21684474 DOI: 10.1016/j.ajg.2011.04.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
238 Bai M, He C, Yin Z, Niu J, Wang Z, Qi X, Liu L, Yang Z, Guo W, Tie J, Bai W, Xia J, Cai H, Wang J, Wu K, Fan D, Han G. Randomised clinical trial: l -ornithine- l -aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther 2014;40:63-71. [DOI: 10.1111/apt.12795] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.5] [Reference Citation Analysis]
239 Sharma P, Eesa M, Scott JN. Toxic and Acquired Metabolic Encephalopathies: MRI Appearance. American Journal of Roentgenology 2009;193:879-86. [DOI: 10.2214/ajr.08.2257] [Cited by in Crossref: 73] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
240 Koch DG, Speiser JL, Durkalski V, Fontana RJ, Davern T, McGuire B, Stravitz RT, Larson AM, Liou I, Fix O, Schilsky ML, McCashland T, Hay JE, Murray N, Shaikh OS, Ganger D, Zaman A, Han SB, Chung RT, Brown RS, Munoz S, Reddy KR, Rossaro L, Satyanarayana R, Hanje AJ, Olson J, Subramanian RM, Karvellas C, Hameed B, Sherker AH, Lee WM, Reuben A. The Natural History of Severe Acute Liver Injury. Am J Gastroenterol 2017;112:1389-96. [PMID: 28440304 DOI: 10.1038/ajg.2017.98] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
241 Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis. 2007;22:125-138. [PMID: 17260161 DOI: 10.1007/s11011-006-9042-1] [Cited by in Crossref: 160] [Cited by in F6Publishing: 149] [Article Influence: 10.7] [Reference Citation Analysis]
242 van der Meulen JH, Lewsey JD, Dawwas MF, Copley LP. Adult orthotopic liver transplantation in the United Kingdom and Ireland between 1994 and 2005. Transplantation. 2007;84:572-579. [PMID: 17876268 DOI: 10.1097/01.tp.0000280540.76370.37] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
243 Rahimi RS, Singal AG, Cuthbert JA, Rockey DC. Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA Intern Med. 2014;174:1727-1733. [PMID: 25243839 DOI: 10.1001/jamainternmed.2014.4746] [Cited by in Crossref: 93] [Cited by in F6Publishing: 70] [Article Influence: 13.3] [Reference Citation Analysis]
244 Sharma P, Singh S, Sharma BC. Propofol in patients with cirrhosis and minimal hepatic encephalopathy. Journal of Hepatology 2011;54:1321-2. [DOI: 10.1016/j.jhep.2010.11.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
245 Bujold A, Dawson LA. Stereotactic radiation therapy and selective internal radiation therapy for hepatocellular carcinoma. Cancer Radiother. 2011;15:54-63. [PMID: 21239204 DOI: 10.1016/j.canrad.2010.11.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
246 Angel MJ, Chen R, Bryan Young G. Metabolic encephalopathies. Handb Clin Neurol 2008;90:115-66. [PMID: 18631820 DOI: 10.1016/S0072-9752(07)01707-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
247 Sidoryk-Wegrzynowicz M, Wegrzynowicz M, Lee E, Bowman AB, Aschner M. Role of astrocytes in brain function and disease. Toxicol Pathol 2011;39:115-23. [PMID: 21075920 DOI: 10.1177/0192623310385254] [Cited by in Crossref: 125] [Cited by in F6Publishing: 115] [Article Influence: 10.4] [Reference Citation Analysis]
248 Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol 2008;103:1674-81. [PMID: 18616657 DOI: 10.1111/j.1572-0241.2008.01814.x] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
249 Aghaei I, Saeedi Saravi SS, Ghotbi Ravandi S, Nozari M, Roudbari A, Dalili A, Shabani M, Dehpour AR. Evaluation of prepulse inhibition and memory impairments at early stage of cirrhosis may be considered as a diagnostic index for minimal hepatic encephalopathy. Physiol Behav 2017;173:87-94. [PMID: 28119160 DOI: 10.1016/j.physbeh.2017.01.033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
250 Qi R, Zhang LJ, Chen HJ, Zhong J, Luo S, Ke J, Xu Q, Kong X, Liu C, Lu GM. Role of local and distant functional connectivity density in the development of minimal hepatic encephalopathy. Sci Rep 2015;5:13720. [PMID: 26329994 DOI: 10.1038/srep13720] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
251 Leke R, de Oliveira DL, Mussulini BH, Pereira MS, Kazlauckas V, Mazzini G, Hartmann CR, Silveira TR, Simonsen M, Bak LK, Waagepetersen HS, Keiding S, Schousboe A, Portela LV. Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats. PLoS One 2012;7:e36322. [PMID: 22586467 DOI: 10.1371/journal.pone.0036322] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
252 Teh KB, Loo JH, Tam YC, Wong YJ. Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis. Dig Liver Dis 2021;53:817-23. [PMID: 34011479 DOI: 10.1016/j.dld.2021.04.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 Maruyama H, Kondo T, Sekimoto T, Kiyono S, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Hyponatremia: a significant factor in a poor prognosis for cirrhosis with Child A/B after variceal eradication. J Hepatobiliary Pancreat Sci 2015;22:771-8. [PMID: 26202665 DOI: 10.1002/jhbp.282] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
254 Fadnes LT, Aas CF, Vold JH, Leiva RA, Ohldieck C, Chalabianloo F, Skurtveit S, Lygren OJ, Dalgård O, Vickerman P, Midgard H, Løberg EM, Johansson KA; INTRO-HCV Study Group. Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV). PLoS Med 2021;18:e1003653. [PMID: 34061883 DOI: 10.1371/journal.pmed.1003653] [Reference Citation Analysis]
255 Lazar M, Butz M, Baumgarten TJ, Füllenbach ND, Jördens MS, Häussinger D, Schnitzler A, Lange J. Impaired Tactile Temporal Discrimination in Patients With Hepatic Encephalopathy. Front Psychol 2018;9:2059. [PMID: 30425672 DOI: 10.3389/fpsyg.2018.02059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
256 Forton DM, Taylor-Robinson SD, Thomas HC. Cerebral dysfunction in chronic hepatitis C infection. J Viral Hepat. 2003;10:81-86. [PMID: 12614463 DOI: 10.1046/j.1365-2893.2003.00416.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 4.2] [Reference Citation Analysis]
257 Shalimar, Sheikh MF, Mookerjee RP, Agarwal B, Acharya SK, Jalan R. Prognostic Role of Ammonia in Patients With Cirrhosis. Hepatology. 2019;70:982-994. [PMID: 30703853 DOI: 10.1002/hep.30534] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 10.3] [Reference Citation Analysis]
258 Sörös P, Böttcher J, Weissenborn K, Selberg O, Müller MJ. Malnutrition and hypermetabolism are not risk factors for the presence of hepatic encephalopathy: a cross-sectional study. J Gastroenterol Hepatol. 2008;23:606-610. [PMID: 18005013 DOI: 10.1111/j.1440-1746.2007.05222.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
259 Mullen KD, Prakash RK. Management of covert hepatic encephalopathy. Clin Liver Dis. 2012;16:91-93. [PMID: 22321467 DOI: 10.1016/j.cld.2011.12.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
260 Lu B, Wu C, Azami NLB, Xie D, Zhao C, Xu W, Hui D, Chen X, Sun R, Song J, An Y, Li K, Wang H, Ye G, Sun M. Babao Dan improves neurocognitive function by inhibiting inflammation in clinical minimal hepatic encephalopathy. Biomed Pharmacother 2021;135:111084. [PMID: 33383371 DOI: 10.1016/j.biopha.2020.111084] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
261 Botha JF, Langnas AN, Campos BD, Grant WJ, Freise CE, Ascher NL, Mercer DF, Roberts JP. Left lobe adult-to-adult living donor liver transplantation: small grafts and hemiportocaval shunts in the prevention of small-for-size syndrome. Liver Transpl. 2010;16:649-657. [PMID: 20440774 DOI: 10.1002/lt.22043] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 7.0] [Reference Citation Analysis]
262 Felipo V, Urios A, Valero P, Sánchez M, Serra MA, Pareja I, Rodríguez F, Gimenez-Garzó C, Sanmartín J, Montoliu C. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy. Liver Int. 2013;33:1478-1489. [PMID: 23714168 DOI: 10.1111/liv.12206] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
263 Heiser C, Haller B, Sohn M, Hofauer B, Knopf A, Mühling T, Freiherr J, Bender M, Tiller M, Schmidt A, Schepp W, Gundling F. Olfactory Function is Affected in Patients with Cirrhosis Depending on the Severity of Hepatic Encephalopathy. Annals of Hepatology 2018;17:822-9. [DOI: 10.5604/01.3001.0012.3143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
264 Hassanein TI, Hilsabeck RC, Perry W. Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig Dis Sci. 2008;53:529-538. [PMID: 17710551 DOI: 10.1007/s10620-007-9895-0] [Cited by in Crossref: 50] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
265 Bajaj JS, Stein AC, Dubinsky RM. What Is Driving the Legal Interest in Hepatic Encephalopathy? Clinical Gastroenterology and Hepatology 2011;9:97-8. [DOI: 10.1016/j.cgh.2010.10.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
266 Sauer IM, Zeilinger K, Pless G, Kardassis D, Theruvath T, Pascher A, Goetz M, Neuhaus P, Gerlach JC. Extracorporeal liver support based on primary human liver cells and albumin dialysis--treatment of a patient with primary graft non-function. J Hepatol. 2003;39:649-653. [PMID: 12971979 DOI: 10.1016/s0168-8278(03)00348-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
267 Martino RB, Abdala E, Villegas FC, D'Albuquerque LAC, Song ATW. Liver transplantation for acute liver failure due to antitubercular drugs - a single-center experience. Clinics (Sao Paulo) 2018;73:e344. [PMID: 30020340 DOI: 10.6061/clinics/2018/e344] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
268 Lin W, Zhang J, Liu X, Liu H, He J, Li M, Zhang S, Zhang Y, Chen H, Zhang C, Wu W, Jin C, Lee SS, Duan Z. A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure. Ann Hepatol. 2018;17:392-402. [PMID: 29735787 DOI: 10.5604/01.3001.0011.7383] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
269 Savlan I, Liakina V, Valantinas J. Concise review of current concepts on nomenclature and pathophysiology of hepatic encephalopathy. Medicina (Kaunas). 2014;50:75-81. [PMID: 25172600 DOI: 10.1016/j.medici.2014.06.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
270 Cui Y, Guan S, Ding J, He Y, Li Q, Wang S, Sun H. Establishment and evaluation of a model for predicting 3-month mortality in Chinese patients with hepatic encephalopathy. Metab Brain Dis 2019;34:213-21. [DOI: 10.1007/s11011-018-0333-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
271 Gupta A, Dhiman RK, Kumari S, Rana S, Agarwal R, Duseja A, Chawla Y. Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J Hepatol. 2010;53:849-855. [PMID: 20675008 DOI: 10.1016/j.jhep.2010.05.017] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 9.2] [Reference Citation Analysis]
272 Zhang Q, Guo X, Zhao S, Pang X, Wang Y, Zhang Y, Chi B. Prognostic performance of clinical indices and model scorings for acute-on-chronic liver failure: A study of 164 patients. Exp Ther Med 2016;11:1348-54. [PMID: 27073448 DOI: 10.3892/etm.2016.3037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
273 Stadlbauer V, Wright GAK, Jalan R. Role of artificial liver support in hepatic encephalopathy. Metab Brain Dis 2009;24:15-26. [DOI: 10.1007/s11011-008-9117-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
274 Kumar SS, Mashour GA, Picton P. Neurologic Considerations and Complications Related to Liver Transplantation. Anesthesiology 2018;128:1008-14. [PMID: 29498949 DOI: 10.1097/ALN.0000000000002148] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
275 Dagon Y, Avraham Y, Ilan Y, Mechoulam R, Berry EM. Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP‐activated protein kinase. FASEB j 2007;21:2431-41. [DOI: 10.1096/fj.06-7705com] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
276 Jung JH, Hyun B, Lee J, Koh DH, Kim JH, Park SW. Neurologic Safety of Etomidate-Based Sedation during Upper Endoscopy in Patients with Liver Cirrhosis Compared with Propofol: A Double-Blind, Randomized Controlled Trial. J Clin Med 2020;9:E2424. [PMID: 32751161 DOI: 10.3390/jcm9082424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Kim D, Shin B, Song I, Han S, Gwak M, Kim G, Kim J, Choi G, Ko J. Relationship Between Intraoperative Bispectral Index and Consciousness Recovery in Patients With Hepatic Encephalopathy Undergoing Liver Transplant: A Retrospective Analysis. Transplantation Proceedings 2019;51:798-804. [DOI: 10.1016/j.transproceed.2018.10.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
278 Li W, Li N, Wang R, Li Q, Wu H. Interferon gamma, interleukin-6, and -17a levels were correlated with minimal hepatic encephalopathy in HBV patients. Hepatol Int. 2015;9:218-223. [PMID: 25794550 DOI: 10.1007/s12072-015-9610-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
279 McPhail MJ, Leech R, Grover VP, Fitzpatrick JA, Dhanjal NS, Crossey MM, Pflugrad H, Saxby BK, Wesnes K, Dresner MA, Waldman AD, Thomas HC, Taylor-Robinson SD. Modulation of neural activation following treatment of hepatic encephalopathy.Neurology. 2013;80:1041-1047. [PMID: 23427320 DOI: 10.1212/WNL.0b013e31828726e1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
280 Bartolić M, Vovk A, Šuput D. Effects of NH4CL application and removal on astrocytes and endothelial cells. Cell Mol Biol Lett 2016;21:13. [PMID: 28536616 DOI: 10.1186/s11658-016-0011-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
281 Reuß CJ, Bernhard M, Beynon C, Hecker A, Jungk C, Michalski D, Nusshag C, Weigand MA, Brenner T. [Intensive care studies from 2016/2017]. Anaesthesist 2017;66:690-713. [PMID: 28667421 DOI: 10.1007/s00101-017-0339-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
282 Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, Mccabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, Mckane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT. Programme Grants Appl Res 2018;6:1-528. [DOI: 10.3310/pgfar06030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
283 Sharma P, Sharma BC. Management Patterns of Hepatic Encephalopathy: A Nationwide Survey in India. J Clin Exp Hepatol 2015;5:199-203. [PMID: 26628837 DOI: 10.1016/j.jceh.2015.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
284 Basu PP, Shah NJ. Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy. Clin Liver Dis. 2015;19:461-472. [PMID: 26195201 DOI: 10.1016/j.cld.2015.05.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
285 Singhal A, Nagarajan R, Kumar R, Huda A, Gupta RK, Thomas MA. Magnetic resonance T2-relaxometry and 2D L-correlated spectroscopy in patients with minimal hepatic encephalopathy. J Magn Reson Imaging 2009;30:1034-41. [PMID: 19856435 DOI: 10.1002/jmri.21943] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
286 Sharma P, Sharma BC, Puri V, Sarin SK. Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol. 2007;47:67-73. [PMID: 17459511 DOI: 10.1016/j.jhep.2007.02.022] [Cited by in Crossref: 123] [Cited by in F6Publishing: 106] [Article Influence: 8.2] [Reference Citation Analysis]
287 Zhan C, Chen HJ, Gao YQ, Zou TX. Functional Network-Based Statistics Reveal Abnormal Resting-State Functional Connectivity in Minimal Hepatic Encephalopathy.Front Neurol. 2019;10:33. [PMID: 30761070 DOI: 10.3389/fneur.2019.00033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
288 Maruyama H, Kobayashi K, Kiyono S, Ogasawara S, Suzuki E, Ooka Y, Chiba T, Yamaguchi T. Compensating effect of minor portal hypertension on the muscle mass loss-related poor prognosis in cirrhosis. Int J Med Sci 2017;14:804-10. [PMID: 28824317 DOI: 10.7150/ijms.19847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
289 Zhao J, Fan YC, Sun FK, Zhao ZH, Wang LY, Hu LH, Yin YP, Li T, Gao S, Wang K. Peripheral type I interferon receptor correlated with oxidative stress in chronic hepatitis B virus infection. J Interferon Cytokine Res 2013;33:405-14. [PMID: 23663046 DOI: 10.1089/jir.2012.0153] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
290 Córdoba J, Raguer N, Flavià M, Vargas V, Jacas C, Alonso J, Rovira A. T2 hyperintensity along the cortico-spinal tract in cirrhosis relates to functional abnormalities. Hepatology 2003;38:1026-33. [DOI: 10.1002/hep.1840380429] [Cited by in Crossref: 50] [Cited by in F6Publishing: 29] [Article Influence: 2.6] [Reference Citation Analysis]
291 Nabi E, Bajaj JS. Useful tests for hepatic encephalopathy in clinical practice. Curr Gastroenterol Rep. 2014;16:362. [PMID: 24357348 DOI: 10.1007/s11894-013-0362-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
292 Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, de Madaria E, Montoliu C, Nuñez D, Flavia M, Compañy L, Rodrigo JM, Felipo V. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 2007;45:879-85. [PMID: 17393525 DOI: 10.1002/hep.21586] [Cited by in Crossref: 212] [Cited by in F6Publishing: 183] [Article Influence: 14.1] [Reference Citation Analysis]
293 Shah NJ, Neeb H, Kircheis G, Engels P, Häussinger D, Zilles K. Quantitative cerebral water content mapping in hepatic encephalopathy. Neuroimage 2008;41:706-17. [PMID: 18456518 DOI: 10.1016/j.neuroimage.2008.02.057] [Cited by in Crossref: 101] [Cited by in F6Publishing: 89] [Article Influence: 7.2] [Reference Citation Analysis]
294 Bloom A, Mudiyansalage VW, Rhodes A, Hogg M, Jayasekera C, Gorelik A, Sood S, Nicoll A. Can adequate analgesia be achieved in patients with cirrhosis without precipitating hepatic encephalopathy? A prospective study. Clin Exp Hepatol 2020;6:243-52. [PMID: 33145431 DOI: 10.5114/ceh.2020.99521] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
295 Amodio P, Cordoba J. Smart applications for assessing minimal hepatic encephalopathy: novelty from the app revolution. Hepatology. 2013;58:844-846. [PMID: 23532934 DOI: 10.1002/hep.26416] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
296 Wu D, Wu SM, Lu J, Zhou YQ, Xu L, Guo CY. Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis. Gastroenterol Res Pract. 2013;2013:236963. [PMID: 23653636 DOI: 10.1155/2013/236963] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
297 Gluud LL, Vilstrup H, Morgan MY. Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2016;CD003044. [PMID: 27153247 DOI: 10.1002/14651858.cd003044.pub4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
298 Bajaj JS, Hafeezullah M, Hoffmann RG, Varma RR, Franco J, Binion DG, Hammeke TA, Saeian K. Navigation skill impairment: Another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology. 2008;47:596-604. [PMID: 18000989 DOI: 10.1002/hep.22032] [Cited by in Crossref: 113] [Cited by in F6Publishing: 96] [Article Influence: 8.1] [Reference Citation Analysis]
299 Gundling F, Schmidtler F, Hapfelmeier A, Schulte B, Schmidt T, Pehl C, Schepp W, Seidl H. Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. Liver Int. 2011;31:1406-1415. [PMID: 22093455 DOI: 10.1111/j.1478-3231.2011.02577.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
300 Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, Stravitz RT, Luketic V, Fuchs M, White MB, Bell DE, Gilles H, Morton K, Noble N, Puri P, Sanyal AJ. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646-1653. [PMID: 21556040 DOI: 10.1038/ajg.2011.157] [Cited by in Crossref: 201] [Cited by in F6Publishing: 173] [Article Influence: 18.3] [Reference Citation Analysis]
301 Yadav SK, Saksena S, Srivastava A, Srivastava A, Saraswat VA, Thomas MA, Rathore RK, Gupta RK. Brain MR imaging and 1H-MR spectroscopy changes in patients with extrahepatic portal vein obstruction from early childhood to adulthood. AJNR Am J Neuroradiol 2010;31:1337-42. [PMID: 20223885 DOI: 10.3174/ajnr.A2045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
302 Figorilli F, Putignano A, Roux O, Houssel-Debry P, Francoz C, Paugam-Burtz C, Soubrane O, Agarwal B, Durand F, Jalan R. Development of an organ failure score in acute liver failure for transplant selection and identification of patients at high risk of futility. PLoS One 2017;12:e0188151. [PMID: 29206839 DOI: 10.1371/journal.pone.0188151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
303 Olesen SS, Graversen C, Hansen TM, Blauenfeldt RA, Hansen JB, Steimle K, Drewes AM. Spectral and dynamic electroencephalogram abnormalities are correlated to psychometric test performance in hepatic encephalopathy. Scandinavian Journal of Gastroenterology 2011;46:988-96. [DOI: 10.3109/00365521.2011.579160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
304 Ghanta RK, Mullen KD. Placebo controlled treatment trials in hepatic encephalopathy are feasible and ethical. Hepatology 2005;42:1206-7. [PMID: 16250042 DOI: 10.1002/hep.20946] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
305 Cao Y, Wu B, Chen T, Diao W, Jia Z. Altered intrinsic brain activity in patients with hepatic encephalopathy. J Neurosci Res 2021;99:1337-53. [PMID: 33583085 DOI: 10.1002/jnr.24788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Perez I, Bolte FJ, Bigelow W, Dickson Z, Shah NL. Step by Step: Managing the Complications of Cirrhosis. Hepat Med 2021;13:45-57. [PMID: 34079394 DOI: 10.2147/HMER.S278032] [Reference Citation Analysis]
307 Orr JG, Currie CJ, Berni E, Goel A, Moriarty KJ, Sinha A, Gordon F, Dethier A, Dillon JF, Clark K, Richardson P, Middleton P, Patel V, Shawcross D, Preedy H, Aspinall RJ, Hudson M. The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-α. Liver Int 2016;36:1295-303. [PMID: 26950766 DOI: 10.1111/liv.13111] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
308 Crone CC, Gabriel GM, DiMartini A. An overview of psychiatric issues in liver disease for the consultation-liaison psychiatrist. Psychosomatics. 2006;47:188-205. [PMID: 16684936 DOI: 10.1176/appi.psy.47.3.188] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
309 Souto PA, Marcotegui AR, Orbea L, Skerl J, Perazzo JC. Hepatic encephalopathy: Ever closer to its big bang. World J Gastroenterol 2016; 22(42): 9251-9256 [PMID: 27895414 DOI: 10.3748/wjg.v22.i42.9251] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
310 Lu L, Wang J, Zhang L, Zhang Z, Ni L, Qi R, Kong X, Lu M, Sami MU, Xu K, Lu G. Disrupted metabolic and functional connectivity patterns of the posterior cingulate cortex in cirrhotic patients: a study combining magnetic resonance spectroscopy and resting-state functional magnetic resonance imaging. NeuroReport 2018;29:993-1000. [DOI: 10.1097/wnr.0000000000001063] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
311 Licata A, Mazzola A, Ingrassia D, Calvaruso V, Cammà C, Craxì A. Clinical implications of the hyperdynamic syndrome in cirrhosis. Eur J Intern Med. 2014;25:795-802. [PMID: 25245607 DOI: 10.1016/j.ejim.2014.09.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
312 Kwon KW, Nam Y, Choi WS, Kim TW, Kim GM, Sohn UD. Hepatoprotective effect of sodium hydrosulfide on hepatic encephalopathy in rats. Korean J Physiol Pharmacol 2019;23:263-70. [PMID: 31297010 DOI: 10.4196/kjpp.2019.23.4.263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
313 Lee EW, Lee AE, Saab S, Kee ST. Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy. Dig Dis Sci 2020;65:2483-91. [DOI: 10.1007/s10620-020-06050-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
314 Festi D, Vestito A, Mazzella G, Roda E, Colecchia A. Management of hepatic encephalopathy: focus on antibiotic therapy. Digestion. 2006;73 Suppl 1:94-101. [PMID: 16498257 DOI: 10.1159/000089784] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
315 Ryska O, Pantoflicek T, Laszikova E, Prazak J, Koblihova E, Ryska M. Artificial liver support system reduces intracranial pressure more effectively than bioartificial system: an experimental study. Int J Artif Organs 2012;35:503-10. [PMID: 22476878 DOI: 10.5301/ijao.5000099] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
316 Haskal ZJ, Radhakrishnan J. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy. J Vasc Interv Radiol. 2008;19:516-520. [PMID: 18375295 DOI: 10.1016/j.jvir.2007.11.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
317 Mukund A, Deogaonkar G, Rajesh S, Shasthry SM, Sarin SK. Safety and Efficacy of Sodium Tetradecyl Sulfate and Lipiodol Foam in Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Large Porto-Systemic Shunts. Cardiovasc Intervent Radiol 2017;40:1010-6. [PMID: 28180928 DOI: 10.1007/s00270-017-1593-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
318 Bajaj JS, Wade JB, Sanyal AJ. Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy. Hepatology. 2009;50:2014-2021. [PMID: 19787808 DOI: 10.1002/hep.23216] [Cited by in Crossref: 223] [Cited by in F6Publishing: 198] [Article Influence: 17.2] [Reference Citation Analysis]
319 Tsai CF, Liu CJ, Chen TJ, Chu CJ, Lin HC, Lee FY, Su TP, Lu CL. Increased incidence of orthopedic fractures in cirrhotic patients: a nationwide population-based study. J Hepatol 2013;58:706-14. [PMID: 23238105 DOI: 10.1016/j.jhep.2012.12.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
320 Kuntz K, Weinland SR, Butt Z. Psychosocial Challenges in Solid Organ Transplantation. J Clin Psychol Med Settings 2015;22:122-35. [DOI: 10.1007/s10880-015-9435-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
321 Weissenborn K, Ahl B, Fischer-Wasels D, van den Hoff J, Hecker H, Burchert W, Köstler H. Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy. Gut. 2007;56:1736-1742. [PMID: 17660226 DOI: 10.1136/gut.2006.110569] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 3.9] [Reference Citation Analysis]
322 Yu Z, Zhang Y, Cao Y, Xu M, You S, Chen Y, Zhu B, Kong M, Song F, Xin S, Duan Z, Han T. A dynamic prediction model for prognosis of acute-on-chronic liver failure based on the trend of clinical indicators. Sci Rep 2021;11:1810. [PMID: 33469110 DOI: 10.1038/s41598-021-81431-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
323 Rai R, Ahuja CK, Agrawal S, Kalra N, Duseja A, Khandelwal N, Chawla Y, Dhiman RK. Reversal of Low-Grade Cerebral Edema After Lactulose/Rifaximin Therapy in Patients with Cirrhosis and Minimal Hepatic Encephalopathy. Clin Transl Gastroenterol 2015;6:e111. [PMID: 26378384 DOI: 10.1038/ctg.2015.38] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
324 Méndez M, Méndez-López M, López L, Aller MA, Arias J, Arias JL. Acetylcholinesterase activity in an experimental rat model of Type C hepatic encephalopathy. Acta Histochem. 2011;113:358-362. [PMID: 20138653 DOI: 10.1016/j.acthis.2010.01.009] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
325 Abdel-Razik A, Mousa N, Elhelaly R, Elzehery R, Hasan AS, Abdelsalam M, Seif AS, Tawfik AM, El-Wakeel N, Eldars W. Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study. Front Med (Lausanne) 2020;7:96. [PMID: 32266280 DOI: 10.3389/fmed.2020.00096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
326 Zhang X, Qi X, Yoshida EM, Méndez-Sánchez N, Hou F, Deng H, Wang X, Qiu J, He C, Wang S, Guo X. Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes. Eur J Gastroenterol Hepatol 2018;30:233-40. [PMID: 29189394 DOI: 10.1097/MEG.0000000000001011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 2.8] [Reference Citation Analysis]
327 Elwir S, Hal H, Veith J, Schreibman I, Kadry Z, Riley T. Radiographical findings in patients with liver cirrhosis and hepatic encephalopathy. Gastroenterol Rep (Oxf) 2016;4:221-5. [PMID: 26463277 DOI: 10.1093/gastro/gov049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
328 Afsar B, Elsurer R, Sezer S, Ozdemir NF. Quality of life in hemodialysis patients: hepatitis C virus infection makes sense. Int Urol Nephrol 2009;41:1011-9. [PMID: 19430922 DOI: 10.1007/s11255-009-9576-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
329 Zhang LJ, Zheng G, Zhang L, Zhong J, Li Q, Zhao TZ, Lu GM. Disrupted small world networks in patients without overt hepatic encephalopathy: a resting state fMRI study. Eur J Radiol 2014;83:1890-9. [PMID: 25043497 DOI: 10.1016/j.ejrad.2014.06.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
330 Mousa N, Abdel-Razik A, Zaher A, Hamed M, Shiha G, Effat N, Elbaz S, Elhelaly R, Hafez M, El-Wakeel N, Eldars W. The role of antioxidants and zinc in minimal hepatic encephalopathy: a randomized trial. Therap Adv Gastroenterol. 2016;9:684-691. [PMID: 27582881 DOI: 10.1177/1756283x16645049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
331 Hsieh P, Ueng SW, Lee MS, Shih H, Huang K. Prosthetic hip infection in patients with liver cirrhosis: an outcome analysis. International Journal of Infectious Diseases 2010;14:e1054-9. [DOI: 10.1016/j.ijid.2010.06.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
332 Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, Gibson DP, Hoffmann RG, Stravitz RT, Heuman DM, Sterling RK, Shiffman M, Topaz A, Boyett S, Bell D, Sanyal AJ. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50:1175-1183. [PMID: 19670416 DOI: 10.1002/hep.23128] [Cited by in Crossref: 210] [Cited by in F6Publishing: 178] [Article Influence: 16.2] [Reference Citation Analysis]
333 Zheng G, Zhang LJ, Zhong J, Wang Z, Qi R, Shi D, Lu GM. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. Eur J Radiol. 2013;82:1981-1988. [PMID: 23849331 DOI: 10.1016/j.ejrad.2013.06.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
334 Kobayashi K, Maruyama H, Kiyono S, Sekimoto T, Kondo T, Shimada T, Takahashi M, Okugawa H, Yokosuka O. Portal response related to shunt occlusion by balloon-occluded retrograde transvenous obliteration may determine the prognosis of cirrhosis. Hepatol Res 2016;46:1321-9. [PMID: 26931092 DOI: 10.1111/hepr.12690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
335 De Silva AP, Niriella MA, Ediriweera DS, De Alwis JP, Liyanage IK, Ettickan U, Liyanapathirana KV, Undugodage C, de Silva HA, de Silva HJ. Low-dose melatonin for sleep disturbances in early-stage cirrhosis: A randomized, placebo-controlled, cross-over trial. JGH Open 2020;4:749-56. [PMID: 32782966 DOI: 10.1002/jgh3.12356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
336 Stinton LM, Jayakumar S. Minimal hepatic encephalopathy. Can J Gastroenterol 2013;27:572-4. [PMID: 24106728 DOI: 10.1155/2013/547670] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
337 Greinert R, Ripoll C, Hollenbach M, Zipprich A. Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach. Aliment Pharmacol Ther 2016;44:514-21. [PMID: 27385440 DOI: 10.1111/apt.13721] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
338 Jia L, Zhang MH. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. World J Gastroenterol 2005; 11(6): 908-911 [PMID: 15682492 DOI: 10.3748/wjg.v11.i6.908] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
339 You D, Choi G, Kim J, Kwon C, Joh J, Lee S. Long-term Outcomes for Liver Transplant Recipients in Terms of Hepatic Encephalopathy. Transplantation Proceedings 2017;49:1425-9. [DOI: 10.1016/j.transproceed.2017.02.054] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
340 Córdoba J, Lucke R. Driving under the influence of minimal hepatic encephalopathy. Hepatology 2004;39:599-601. [DOI: 10.1002/hep.20120] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
341 Sauerbruch T, Appenrodt B, Schmitz V, Spengler U. The conservative and interventional treatment of the complications of liver cirrhosis: Part 2 of a series on liver cirrhosis. Dtsch Arztebl Int 2013;110:126-32, I. [PMID: 23505400 DOI: 10.3238/arztebl.2013.0126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
342 Nicolao F, Efrati C, Masini A, Merli M, Attili AF, Riggio O. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol. 2003;38:441-446. [PMID: 12663235 DOI: 10.1016/s0168-8278(02)00436-1] [Cited by in Crossref: 75] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
343 Lewis M, Howdle PD. The neurology of liver failure. QJM. 2003;96:623-633. [PMID: 12925717 DOI: 10.1093/qjmed/hcg110] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 2.9] [Reference Citation Analysis]
344 Montoliu C, Piedrafita B, Serra MA, del Olmo JA, Ferrandez A, Rodrigo JM, Felipo V. Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients. J Mol Med (Berl). 2007;85:237-245. [PMID: 17216205 DOI: 10.1007/s00109-006-0149-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
345 Li Y, He X, Pang H. A model to predict early hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt. Turk J Gastroenterol. 2019;30:702-707. [PMID: 31418414 DOI: 10.5152/tjg.2019.18485] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
346 Arab JP, Meneses L, Pérez RM, Arrese M, Benítez C. Hepatic encephalopathy in a liver transplant recipient with stable liver function. Hepatology 2013;57:1672-4. [DOI: 10.1002/hep.26298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
347 Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS, Caldwell S, McGuire B, Nevens F. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol. 2009;104:1392-1400. [PMID: 19455117 DOI: 10.1038/ajg.2009.160] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
348 Shaw J, Bajaj JS. Covert Hepatic Encephalopathy: Can My Patient Drive? J Clin Gastroenterol 2017;51:118-26. [PMID: 28027071 DOI: 10.1097/MCG.0000000000000764] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
349 Zhang X, Cheng Y, Poon CS, Qi R, Xu Q, Chen H, Kong X, Lu G, Shen W, Zhang L. Long-and short-range functional connectivity density alteration in non-alcoholic cirrhotic patients one month after liver transplantation: A resting-state fMRI study. Brain Research 2015;1620:177-87. [DOI: 10.1016/j.brainres.2015.04.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
350 Escorsell Mañosa A, Mas Ordeig A. [Acute on chronic liver failure]. Gastroenterol Hepatol 2010;33:126-34. [PMID: 20005602 DOI: 10.1016/j.gastrohep.2009.10.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
351 Nakanishi H, Kurosaki M, Nakanishi K, Tsuchiya K, Noda T, Tamaki N, Yasui Y, Hosokawa T, Ueda K, Itakura J, Anami K, Asahina Y, Enomoto N, Higuchi T, Izumi N. Impaired brain activity in cirrhotic patients with minimal hepatic encephalopathy: Evaluation by near-infrared spectroscopy. Hepatol Res 2014;44:319-26. [PMID: 23607661 DOI: 10.1111/hepr.12127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
352 Romero-Gómez M. Critical flicker frequency: it is time to break down barriers surrounding minimal hepatic encephalopathy. J Hepatol. 2007;47:10-11. [PMID: 17507110 DOI: 10.1016/j.jhep.2007.04.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
353 Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40:247-254. [PMID: 14739095 DOI: 10.1016/j.jhep.2003.10.016] [Cited by in Crossref: 335] [Cited by in F6Publishing: 286] [Article Influence: 18.6] [Reference Citation Analysis]
354 Riggio O, Ridola L. Emerging drugs for hepatic encephalopathy. Expert Opin Emerg Drugs 2009;14:537-49. [PMID: 19552607 DOI: 10.1517/14728210903055067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
355 Shiraki M, Shimizu M, Moriwaki H, Okita K, Koike K. Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients. Hepatol Res 2017;47:321-7. [PMID: 27254133 DOI: 10.1111/hepr.12750] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
356 Stewart CA, Cerhan J. Hepatic Encephalopathy: A Dynamic or Static Condition. Metab Brain Dis 2005;20:193-204. [DOI: 10.1007/s11011-005-7207-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
357 Mendizabal M, Marciano S, Videla MG, Anders M, Zerega A, Balderramo DC, Chan D, Barrabino M, Gil O, Mastai R. Changing etiologies and outcomes of acute liver failure: perspectives from 6 transplant centers in Argentina. Liver Transpl. 2014;20:483-489. [PMID: 24425668 DOI: 10.1002/lt.23823] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
358 Lawrence KR, Klee JA. Rifaximin for the treatment of hepatic encephalopathy. Pharmacotherapy. 2008;28:1019-1032. [PMID: 18657018 DOI: 10.1592/phco.28.8.1019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
359 Tsai CF, Chu CJ, Huang YH, Wang YP, Liu PY, Lin HC, Lee FY, Lu CL. Detecting minimal hepatic encephalopathy in an endemic country for hepatitis B: the role of psychometrics and serum IL-6. PLoS One. 2015;10:e0128437. [PMID: 26039496 DOI: 10.1371/journal.pone.0128437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
360 Singh S, Trigun SK. Activation of neuronal nitric oxide synthase in cerebellum of chronic hepatic encephalopathy rats is associated with up-regulation of NADPH-producing pathway. Cerebellum 2010;9:384-97. [PMID: 20405262 DOI: 10.1007/s12311-010-0172-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
361 Chen HJ, Zhu XQ, Jiao Y, Li PC, Wang Y, Teng GJ. Abnormal baseline brain activity in low-grade hepatic encephalopathy: a resting-state fMRI study. J Neurol Sci. 2012;318:140-145. [PMID: 22541365 DOI: 10.1016/j.jns.2012.02.019] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
362 Wang JY, Zhang NP, Chi BR, Mi YQ, Meng LN, Liu YD, Wang JB, Jiang HX, Yang JH, Xu Y, Li X, Xu JM, Zhang G, Zhou XM, Zhuge YZ, Tian DA, Ye J, Liu YL. Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China. World J Gastroenterol 2013; 19(30): 4984-4991 [PMID: 23946605 DOI: 10.3748/wjg.v19.i30.4984] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
363 Kedia SK, Ali B, Jiang Y, Arshad H, Satapathy SK, Gonzalez HC. Post-liver transplant outcomes in patients with major psychiatric diagnosis in the United States. Ann Hepatol 2021;22:100311. [PMID: 33482365 DOI: 10.1016/j.aohep.2021.100311] [Reference Citation Analysis]
364 Sahney A, Sharma BC, Jindal A, Anand L, Arora V, Vijayaraghavan R, Dhamija RM, Kumar G, Bhardwaj A, Sarin SK. A double-blind randomized controlled trial to assess efficacy of bromocriptine in cirrhotic patients with hepatic parkinsonism. Liver Int. 2019;39:684-693. [PMID: 30554466 DOI: 10.1111/liv.14024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
365 Tan L, Meng Y, Zeng T, Wang Q, Long T, Wu S, Guan X, Fu H, Zheng W, Tian Y, Chen J, Yu J, Wu Y, Li H, Cao L. Clinical diagnostic significance of prealbumin, cholinesterase and retinol binding protein in liver cirrhosis combined with encephalopathy. Br J Biomed Sci 2019;76:24-8. [PMID: 30392460 DOI: 10.1080/09674845.2018.1523673] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
366 Riggio O, Ridola L, Pasquale C, Pentassuglio I, Nardelli S, Moscucci F, Merli M, Montagnese S, Amodio P, Merkel C. A simplified psychometric evaluation for the diagnosis of minimal hepatic encephalopathy. Clin Gastroenterol Hepatol. 2011;9:613-616.e1. [PMID: 21440091 DOI: 10.1016/j.cgh.2011.03.017] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
367 Rubin JB, Hameed B, Gottfried M, Lee WM, Sarkar M; Acute Liver Failure Study Group. Acetaminophen-induced Acute Liver Failure Is More Common and More Severe in Women. Clin Gastroenterol Hepatol 2018;16:936-46. [PMID: 29199145 DOI: 10.1016/j.cgh.2017.11.042] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
368 Bajaj JS. Current and future diagnosis of hepatic encephalopathy. Metab Brain Dis. 2010;25:107-110. [PMID: 20213105 DOI: 10.1007/s11011-010-9176-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
369 Xu WP, Wang ZR, Zou X, Zhao C, Wang R, Shi PM, Yuan ZL, Yang F, Zeng X, Wang PQ, Sultan S, Zhang Y, Xie WF. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein evaluates liver function and predicts prognosis in liver cirrhosis. J Dig Dis. 2018;19:242-253. [PMID: 29607614 DOI: 10.1111/1751-2980.12596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
370 Sharma P, Sharma BC, Sarin SK. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2010;22:526-531. [PMID: 20009938 DOI: 10.1097/meg.0b013e3283341b7d] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
371 Chan G, Taqi A, Marotta P, Levstik M, McAlister V, Wall W, Quan D. Long-term outcomes of emergency liver transplantation for acute liver failure. Liver Transpl. 2009;15:1696-1702. [PMID: 19938124 DOI: 10.1002/lt.21931] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
372 Alsahhar JS, Rahimi RS. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy. Current Opinion in Gastroenterology 2019;35:145-54. [DOI: 10.1097/mog.0000000000000527] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
373 Castro R, Deisanti D, Seva-pereira T, Almeida J, Yamanaka A, Boin I, Soares E. Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List. Transplantation Proceedings 2010;42:412-6. [DOI: 10.1016/j.transproceed.2010.01.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
374 Mainardi V, Rando K, Olivari D, Rey G, Castelli J, Grecco G, Leites A, Harguindeguy M, Gerona S. Mortality Analysis of Acute Liver Failure in Uruguay. Transplant Proc 2018;50:465-71. [PMID: 29579829 DOI: 10.1016/j.transproceed.2017.12.037] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
375 Schmid M, Mittermaier C, Voller B, Fialka-moser V, Gangl A, Peck-radosavljevic M. Postural control in patients with liver cirrhosis: a posturographic study: . European Journal of Gastroenterology & Hepatology 2009;21:915-22. [DOI: 10.1097/meg.0b013e328321b0fd] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
376 Stewart CA, Smith GE. Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol. 2007;4:677-685. [PMID: 18043677 DOI: 10.1038/ncpgasthep0999] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 4.1] [Reference Citation Analysis]
377 Li Y, Liu H, Yang J, Tian X, Yang H, Geng Z. Combining arterial-spin labeling with functional magnetic resonance imaging measurement for characterizing patients with minimal hepatic encephalopathy. Hepatol Res 2017;47:862-71. [PMID: 27717156 DOI: 10.1111/hepr.12827] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
378 Baldassarre M, Domenicali M, Naldi M, Laggetta M, Giannone FA, Biselli M, Patrono D, Bertucci C, Bernardi M, Caraceni P. Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule. Sci Rep 2016;6:35987. [PMID: 27782157 DOI: 10.1038/srep35987] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
379 Butterworth RF. Editorial: rifaximin and minimal hepatic encephalopathy. Am J Gastroenterol 2011;106:317-8. [PMID: 21301455 DOI: 10.1038/ajg.2010.460] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
380 Varakanahalli S, Sharma BC, Srivastava S, Sachdeva S, Dahale AS. Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo. Eur J Gastroenterol Hepatol 2018;30:951-8. [PMID: 29727385 DOI: 10.1097/MEG.0000000000001137] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
381 Mechtcheriakov S, Schocke M, Kugener A, Graziadei IW, Mattedi M, Hinterhuber H, Vogel W, Marksteiner J. Chemical shift magnetic resonance spectroscopy of cingulate grey matter in patients with minimal hepatic encephalopathy. Neuroradiology. 2005;47:27-34. [PMID: 15655660 DOI: 10.1007/s00234-004-1298-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
382 Lauridsen MM, Thiele M, Kimer N, Vilstrup H. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis 2013;28:231-4. [DOI: 10.1007/s11011-012-9373-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
383 Lodewick TM, de Jong MC, van Dam RM, Bemelmans MHA, Neumann UP, Olde Damink SWM, Dejong CHC. Effects of Postoperative Morbidity on Long-Term Outcome Following Surgery for Colorectal Liver Metastases. World J Surg 2015;39:478-86. [DOI: 10.1007/s00268-014-2799-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
384 Dávalos Moscol M, Bustios Sanchez C. The burden of hepatic encephalopathy in Latin America. Annals of Hepatology 2011;10:S31-5. [DOI: 10.1016/s1665-2681(19)31603-5] [Cited by in Crossref: 4] [Article Influence: 0.4] [Reference Citation Analysis]
385 Grover VP, Crossey MM, Fitzpatrick JA, Saxby BK, Shaw R, Waldman AD, Morgan MY, Taylor-Robinson SD. Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study. Metab Brain Dis 2016;31:1315-25. [PMID: 26251205 DOI: 10.1007/s11011-015-9716-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
386 Koul R, Lal BB, Pamecha V, Sarin S, Alam S. Liver Transplantation Reverses Hepatic Myelopathy in 2 Children With Hepatitis A Infection. Child Neurol Open 2021;8:2329048X20983763. [PMID: 33490305 DOI: 10.1177/2329048X20983763] [Reference Citation Analysis]
387 Monfort P, Cauli O, Montoliu C, Rodrigo R, Llansola M, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications. Neurochem Int 2009;55:106-12. [PMID: 19428813 DOI: 10.1016/j.neuint.2009.01.021] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
388 Zhang LJ, Lu GM, Yin JZ, Qi J. Metabolic changes of anterior cingulate cortex in patients with hepatic cirrhosis: A magnetic resonance spectroscopy study. Hepatol Res. 2010;40:777-785. [PMID: 20649817 DOI: 10.1111/j.1872-034x.2010.00681.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
389 Ishikawa T, Sasaki R, Nishimura T, Matsuda T, Maeda M, Iwamoto T, Saeki I, Hidaka I, Takami T, Sakaida I. Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliteration. Hepatol Res 2018;48:1020-30. [PMID: 29882396 DOI: 10.1111/hepr.13199] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
390 Yan S, Tu Z, Lu W, Zhang Q, He J, Li Z, Shao Y, Wang W, Zhang M, Zheng S. Clinical utility of an automated pupillometer for assessing and monitoring recipients of liver transplantation: Clinical Utility of an Automated Pupillometer. Liver Transpl 2009;15:1718-27. [DOI: 10.1002/lt.21924] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
391 Benjamin J, Singla V, Arora I, Sood S, Joshi YK. Intestinal permeability and complications in liver cirrhosis: A prospective cohort study. Hepatol Res. 2013;43:200-207. [PMID: 22726344 DOI: 10.1111/j.1872-034x.2012.01054.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
392 Koziarska D, Wunsch E, Milkiewicz M, Wójcicki M, Nowacki P, Milkiewicz P. Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study. BMC Gastroenterol 2013;13:107. [PMID: 23815160 DOI: 10.1186/1471-230X-13-107] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
393 Cao JM, Yang JQ, Ming ZQ, Wu JL, Yang LQ, Chen TW, Li R, Ou J, Zhang XM, Mu QW, Li HJ, Hu J. A radiomics model of liver CT to predict risk of hepatic encephalopathy secondary to hepatitis B related cirrhosis.Eur J Radiol. 2020;130:109201. [PMID: 32738462 DOI: 10.1016/j.ejrad.2020.109201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
394 Ahl B, Weissenborn K, van den Hoff J, Fischer-Wasels D, Köstler H, Hecker H, Burchert W. Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology. 2004;40:73-79. [PMID: 15239088 DOI: 10.1002/hep.20290] [Cited by in Crossref: 89] [Cited by in F6Publishing: 81] [Article Influence: 4.9] [Reference Citation Analysis]
395 Maruyama H, Kobayashi K, Kiyono S, Ogasawara S, Ooka Y, Suzuki E, Chiba T, Kato N. Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance. Clin Transl Gastroenterol 2018;9:154. [PMID: 29795388 DOI: 10.1038/s41424-018-0021-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
396 Ridola L, Cardinale V, Riggio O. The burden of minimal hepatic encephalopathy: From diagnosis to therapeutic strategies. Ann Gastroenterol. 2018;31:151-164. [PMID: 29507462 DOI: 10.20524/aog.2018.0232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
397 Lunia MK, Sharma BC, Sharma P, Sachdeva S, Srivastava S. Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial. Clin Gastroenterol Hepatol 2014; 12: 1003-8. e1. [PMID: 24246768 DOI: 10.1016/j.cgh.2013.11.006] [Cited by in Crossref: 96] [Cited by in F6Publishing: 88] [Article Influence: 10.7] [Reference Citation Analysis]
398 Khungar V, Poordad F. Management of overt hepatic encephalopathy. Clin Liver Dis. 2012;16:73-89. [PMID: 22321466 DOI: 10.1016/j.cld.2012.03.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
399 Malaguarnera M, Gargante MP, Malaguarnera G, Salmeri M, Mastrojeni S, Rampello L, Pennisi G, Li Volti G, Galvano F. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2010;22:199-206. [PMID: 19730107 DOI: 10.1097/meg.0b013e328330a8d3] [Cited by in Crossref: 70] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
400 Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ, Siddiqui M, Matherly S, Luketic V, Stravitz RT, Fuchs M, Thacker LR, Gilles H, White MB, Unser A, Hovermale J, Gavis E, Noble NA, Wade JB. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol. 2015;13:1828-1835.e1. [PMID: 24846278 DOI: 10.1016/j.cgh.2014.05.011] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 8.8] [Reference Citation Analysis]
401 Bajaj JS. Review article: the modern management of hepatic encephalopathy. Aliment Pharmacol Ther. 2010;31:537-547. [PMID: 20002027 DOI: 10.1111/j.1365-2036.2009.04211.x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 127] [Article Influence: 12.5] [Reference Citation Analysis]
402 Gluud LL, Dam G, Les I, Marchesini G, Borre M, Aagaard NK, Vilstrup H. Branched-chain amino acids for people with hepatic encephalopathy. Cochrane Database Syst Rev. 2017;5:CD001939. [PMID: 28518283 DOI: 10.1002/14651858.cd001939.pub4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 5.8] [Reference Citation Analysis]
403 Ćulafić Đ, Štulić M, Obrenović R, Miletić D, Mijač D, Stojković M, Jovanović M, Ćulafić M. Role of cystatin C and renal resistive index in assessment of renal function in patients with liver cirrhosis. World J Gastroenterol 2014; 20(21): 6573-6579 [PMID: 24914379 DOI: 10.3748/wjg.v20.i21.6573] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
404 Kooka Y, Sawara K, Endo R, Kato A, Suzuki K, Takikawa Y. Brain metabolism in minimal hepatic encephalopathy assessed by 3.0-Tesla magnetic resonance spectroscopy. Hepatol Res 2016;46:269-76. [PMID: 25847088 DOI: 10.1111/hepr.12519] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
405 Mullen KD, Prakash RK. Management of covert hepatic encephalopathy. Clin Liver Dis. 2012;16:91-93. [PMID: 22321467 DOI: 10.1016/j.cld.2012.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
406 Vergara-Gómez M, Flavià-Olivella M, Gil-Prades M, Dalmau-Obrador B, Córdoba-Cardona J. [Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists]. Gastroenterol Hepatol 2006;29:1-6. [PMID: 16393622 DOI: 10.1157/13083245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
407 Kitzberger R, Funk GC, Holzinger U, Miehsler W, Kramer L, Kaider A, Ferenci P, Madl C. Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure. Clin Gastroenterol Hepatol 2009;7:1000-6. [PMID: 19465152 DOI: 10.1016/j.cgh.2009.05.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
408 Cheon SY, Song J. The Association between Hepatic Encephalopathy and Diabetic Encephalopathy: The Brain-Liver Axis. Int J Mol Sci 2021;22:E463. [PMID: 33466498 DOI: 10.3390/ijms22010463] [Reference Citation Analysis]
409 Watson H, Jepsen P, Wong F, Ginès P, Córdoba J, Vilstrup H. Satavaptan treatment for ascites in patients with cirrhosis: a meta-analysis of effect on hepatic encephalopathy development. Metab Brain Dis 2013;28:301-5. [DOI: 10.1007/s11011-013-9384-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
410 Chastre A, Bélanger M, Beauchesne E, Nguyen BN, Desjardins P, Butterworth RF. Inflammatory cascades driven by tumor necrosis factor-alpha play a major role in the progression of acute liver failure and its neurological complications. PLoS One. 2012;7:e49670. [PMID: 23166746 DOI: 10.1371/journal.pone.0049670] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
411 Ahuja NK, Ally WA, Caldwell SH. Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy? Annals of Hepatology 2014;13:179-86. [DOI: 10.1016/s1665-2681(19)30880-4] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
412 Zhang G, Cheng Y, Shen W, Liu B, Huang L, Xie S. The short-term effect of liver transplantation on the low-frequency fluctuation of brain activity in cirrhotic patients with and without overt hepatic encephalopathy. Brain Imaging Behav 2017;11:1849-61. [PMID: 27917450 DOI: 10.1007/s11682-016-9659-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
413 Zhan T, Stremmel W. The diagnosis and treatment of minimal hepatic encephalopathy. Dtsch Arztebl Int. 2012;109:180-187. [PMID: 22470407 DOI: 10.3238/arztebl.2012.0180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
414 Gilg S, Sandström P, Rizell M, Lindell G, Ardnor B, Strömberg C, Isaksson B. The impact of post-hepatectomy liver failure on mortality: a population-based study. Scandinavian Journal of Gastroenterology 2018;53:1335-9. [DOI: 10.1080/00365521.2018.1501604] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
415 Schulz C, Schütte K, Kropf S, Schmitt FC, Vasapolli R, Kliegis LM, Riegger A, Malfertheiner P. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial. Trials. 2016;17:111. [PMID: 26926775 DOI: 10.1186/s13063-016-1205-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
416 Campagna F, Montagnese S, Schiff S, Biancardi A, Mapelli D, Angeli P, Poci C, Cillo U, Merkel C, Gatta A. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible? Liver Transpl. 2014;20:977-986. [PMID: 24809329 DOI: 10.1002/lt.23909] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
417 Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Haussinger D, Zilles K, Bauer A. Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis. Eur J Nucl Med Mol Imaging 2008;35:589-97. [DOI: 10.1007/s00259-007-0586-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
418 Jacques J, Carrier P, Debette-gratien M, Sobesky R, Loustaud-ratti V. Encéphalopathie hépatique. La Presse Médicale 2016;45:46-59. [DOI: 10.1016/j.lpm.2015.02.021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
419 Sanaka MR, Ong JP, Mullen KD. Challenges of designing hepatic encephalopathy treatment trials. Hepatology 2003;38:527-9. [DOI: 10.1002/hep.510380231] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
420 Riggio O, Nardelli S, Moscucci F, Pasquale C, Ridola L, Merli M. Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt. Clinics in Liver Disease 2012;16:133-46. [DOI: 10.1016/j.cld.2011.12.008] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]
421 Afifi MAE, Hussein AM, Rizk M. Low Serum 25-Hydroxy Vitamin D (25-OHD) and Hepatic Encephalopathy in HCV-Related Liver Cirrhosis. Int J Hepatol 2021;2021:6669527. [PMID: 33628512 DOI: 10.1155/2021/6669527] [Reference Citation Analysis]
422 Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres ML, Civera M, Olmo JA, Ortega J, Martinez-Valls J, Serra MA. Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis. 2012;27:51-58. [PMID: 22072427 DOI: 10.1007/s11011-011] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
423 Mechtcheriakov S, Graziadei IW, Mattedi M, Bodner T, Kugener A, Hinterhuber HH, Marksteiner J, Vogel W. Incomplete improvement of visuo-motor deficits in patients with minimal hepatic encephalopathy after liver transplantation. Liver Transpl. 2004;10:77-83. [PMID: 14755782 DOI: 10.1002/lt.20009] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 3.7] [Reference Citation Analysis]
424 Kondo T, Maruyama H, Kiyono S, Sekimoto T, Shimada T, Takahashi M, Okugawa H, Yokosuka O, Kawahira H, Yamaguchi T. Eradication of esophageal varices by sclerotherapy combined with argon plasma coagulation: Effect of portal hemodynamics and longitudinal clinical course. Dig Endosc. 2016;28:152-161. [PMID: 26505617 DOI: 10.1111/den.12562] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
425 Kim JE, Chun S, Sinn DH, Kim NJ, Kim S, Kang W, Kim JM, Choi GS, Joh JW, Cho D. Initial experience with high-volume plasma exchange in patients with acute liver failure. J Clin Apher. 2021;36:379-389. [PMID: 33400840 DOI: 10.1002/jca.21873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Goh ET, Andersen ML, Morgan MY, Gluud LL. Flumazenil versus placebo or no intervention for people with cirrhosis and hepatic encephalopathy. Cochrane Database Syst Rev 2017;8:CD002798. [PMID: 28796283 DOI: 10.1002/14651858.CD002798.pub4] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
427 Ni L, Qi R, Zhang LJ, Zhong J, Zheng G, Zhang Z, Zhong Y, Xu Q, Liao W, Jiao Q, Wu X, Fan X, Lu GM. Altered regional homogeneity in the development of minimal hepatic encephalopathy: a resting-state functional MRI study. PLoS One 2012;7:e42016. [PMID: 22848692 DOI: 10.1371/journal.pone.0042016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
428 McPhail MJ, Bajaj JS, Thomas HC, Taylor-Robinson SD. Pathogenesis and diagnosis of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2010;4:365-378. [PMID: 20528123 DOI: 10.1586/egh.10.32] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
429 Zhong WJ, Zhou ZM, Zhao JN, Wu W, Guo DJ. Abnormal spontaneous brain activity in minimal hepatic encephalopathy: resting-state fMRI study.Diagn Interv Radiol. 2016;22:196-200. [PMID: 26742646 DOI: 10.5152/dir.2015.15208] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
430 Roselló DM, Balestrasse K, Coll C, Coll S, Tallis S, Gurni A, Tomaro ML, Lemberg A, Perazzo JC. Oxidative stress and hippocampus in a low-grade hepatic encephalopathy model: protective effects of curcumin. Hepatol Res. 2008;38:1148-1153. [PMID: 19000058 DOI: 10.1111/j.1872-034x.2008.00377.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
431 Leinweber B, Möller JC, Scherag A, Reuner U, Günther P, Lang CJ, Schmidt HH, Schrader C, Bandmann O, Czlonkowska A, Oertel WH, Hefter H. Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease. Mov Disord 2008;23:54-62. [PMID: 17960799 DOI: 10.1002/mds.21761] [Cited by in Crossref: 64] [Cited by in F6Publishing: 54] [Article Influence: 4.6] [Reference Citation Analysis]
432 Nicoletti V, Gioia S, Lucatelli P, Nardelli S, Pasquale C, Nogas Sobrinho S, Pentassuglio I, Greco F, De Santis A, Merli M, Riggio O. Hepatic encephalopathy in patients with non-cirrhotic portal hypertension: Description, prevalence and risk factors. Digestive and Liver Disease 2016;48:1072-7. [DOI: 10.1016/j.dld.2016.06.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
433 Zhang QB, Chen YT, Lian GD, Qian CC, Chen SJ, Huang KH. A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis. Clin Res Hepatol Gastroenterol. 2012;36:583-591. [PMID: 22704816 DOI: 10.1016/j.clinre.2012.04.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
434 Xu J, Ma R, Chen LF, Zhao LJ, Chen K, Zhang RB. Effects of probiotic therapy on hepatic encephalopathy in patients with liver cirrhosis: an updated meta-analysis of six randomized controlled trials. Hepatobiliary Pancreat Dis Int 2014;13:354-60. [PMID: 25100119 DOI: 10.1016/s1499-3872(14)60280-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
435 Paulson D, Shah M, Miller-Matero LR, Eshelman A, Abouljoud M. Cognition Predicts Quality of Life Among Patients With End-Stage Liver Disease. Psychosomatics 2016;57:514-21. [PMID: 27184728 DOI: 10.1016/j.psym.2016.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
436 Flamm SL. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy. Am J Med Sci. 2018;356:296-303. [PMID: 30286824 DOI: 10.1016/j.amjms.2018.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
437 Zheng G, Zhang LJ, Wang Z, Qi RF, Shi D, Wang L, Fan X, Lu GM. Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: an arterial spin labeling MR study. Eur J Radiol. 2012;81:3851-3856. [PMID: 22832118 DOI: 10.1016/j.ejrad.2012.07.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
438 Binesh N, Huda A, Bugbee M, Gupta R, Rasgon N, Kumar A, Green M, Han S, Thomas MA. Adding another spectral dimension to1H magnetic resonance spectroscopy of hepatic encephalopathy. J Magn Reson Imaging 2005;21:398-405. [DOI: 10.1002/jmri.20291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
439 Vidot H, Potter A, Cheng R, Allman-Farinelli M, Shackel N. Serum 25-hydroxyvitamin D deficiency and hepatic encephalopathy in chronic liver disease. World J Hepatol 2017; 9(10): 510-518 [PMID: 28443156 DOI: 10.4254/wjh.v9.i10.510] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
440 Bajaj JS, Saeian K, Schubert CM, Franco R, Franco J, Heuman DM. Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion: Letters to the Editors. Alimentary Pharmacology & Therapeutics 2011;34:103-5. [DOI: 10.1111/j.1365-2036.2011.04681.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
441 Blei A. MARS y el tratamiento de la encefalopatía hepática. Gastroenterología y Hepatología 2005;28:100-4. [DOI: 10.1157/13070709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
442 Wang YF, Kong X, Lu GM, Zhang LJ. Diabetes Mellitus is Associated with More Severe Brain Spontaneous Activity Impairment and Gray Matter Loss in Patients with Cirrhosis. Sci Rep 2017;7:7775. [PMID: 28798299 DOI: 10.1038/s41598-017-08075-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
443 Jiang SF, Shi JY, Yang ZT, Zhang L, Chen HJ. Aberrant dynamic functional network connectivity in cirrhotic patients without overt hepatic encephalopathy.Eur J Radiol. 2020;132:109324. [PMID: 33038576 DOI: 10.1016/j.ejrad.2020.109324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
444 Chautant F, Guillaume M, Robic MA, Cadranel JF, Peron JM, Lison H, Cool C, Bureau C, Duhalde V. Lessons from “real life experience” of rifaximin use in the management of recurrent hepatic encephalopathy. World J Hepatol 2020; 12(1): 10-20 [PMID: 31984117 DOI: 10.4254/wjh.v12.i1.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
445 El-Baz FK, Elgohary R, Salama A. Amelioration of Hepatic Encephalopathy Using Dunaliella salina Microalgae in Rats: Modulation of Hyperammonemia/TLR4. Biomed Res Int 2021;2021:8843218. [PMID: 33855084 DOI: 10.1155/2021/8843218] [Reference Citation Analysis]
446 Mao W, Wei XQ, Tao J, Zhen FP, Wen ZF, Wu B. The safety of combined sedation with propofol plus fentanyl for endoscopy screening and endoscopic variceal ligation in cirrhotic patients. J Dig Dis 2014;15:124-30. [PMID: 24224839 DOI: 10.1111/1751-2980.12115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
447 Xiao T, Chen L, Chen W, Xu B, Long Q, Li R, Li L, Peng Z, Fang D, Wang R. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone vs TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. J Clin Gastroenterol. 2011;45:643-650. [PMID: 21301360 DOI: 10.1097/mcg.0b013e318203dfb3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
448 Ortiz M, Córdoba J, Doval E, Jacas C, Pujadas F, Esteban R, Guardia J. Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther. 2007;26:859-867. [PMID: 17767470 DOI: 10.1111/j.1365-2036.2007.03394.x] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 4.3] [Reference Citation Analysis]
449 Giménez-Garzó C, Fiorillo A, Ballester-Ferré MP, Gallego JJ, Casanova-Ferrer F, Urios A, Benlloch S, Martí-Aguado D, San-Miguel T, Tosca J, Ríos MP, Montón C, Durbán L, Escudero-García D, Aparicio L, Felipo V, Montoliu C. A New Score Unveils a High Prevalence of Mild Cognitive Impairment in Patients with Nonalcoholic Fatty Liver Disease. J Clin Med 2021;10:2806. [PMID: 34202269 DOI: 10.3390/jcm10132806] [Reference Citation Analysis]
450 Abd-Elsalam S, El-Kalla F, Elwan N, Badawi R, Hawash N, Soliman S, Soliman S, Elkhalawany W, ElSawaf MA, Elfert A. A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy. J Clin Gastroenterol. 2019;53:226-230. [PMID: 29668561 DOI: 10.1097/mcg.0000000000001040] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
451 King A, Masterton G, Gunson B, Olliff S, Redhead D, Mangat K, Oniscu G, Hayes P, Tripathi D. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation: Tips in Liver Transplant Recipients. Liver Transpl 2011;17:771-8. [DOI: 10.1002/lt.22281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
452 Kalaitzakis E, Rosengren A, Skommevik T, Björnsson E. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci. 2010;55:467-475. [PMID: 19242795 DOI: 10.1007/s10620-009-0738-z] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
453 Zacharias HD, Zacharias AP, Oliveira Ferreira A, Morgan MY, Gluud LL; Cochrane Hepato-Biliary Group. Ammonia scavenging agents for people with cirrhosis and hepatic encephalopathy. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd012334] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
454 Romero-gómez M, Montagnese S, Jalan R. Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure. Journal of Hepatology 2015;62:437-47. [DOI: 10.1016/j.jhep.2014.09.005] [Cited by in Crossref: 125] [Cited by in F6Publishing: 100] [Article Influence: 17.9] [Reference Citation Analysis]
455 Boixadera H, Tomasello A, Quiroga S, Cordoba J, Perez M, Segarra A. Successful embolization of a spontaneous mesocaval shunt using the Amplatzer Vascular Plug II. Cardiovasc Intervent Radiol. 2010;33:1044-1048. [PMID: 19908090 DOI: 10.1007/s00270-009-9739-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
456 Bosoi CR, Parent-Robitaille C, Anderson K, Tremblay M, Rose CF. AST-120 (spherical carbon adsorbent) lowers ammonia levels and attenuates brain edema in bile duct-ligated rats. Hepatology. 2011;53:1995-2002. [PMID: 21384402 DOI: 10.1002/hep.24273] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.9] [Reference Citation Analysis]
457 Nadim MK, Durand F, Kellum JA, Levitsky J, O’leary JG, Karvellas CJ, Bajaj JS, Davenport A, Jalan R, Angeli P, Caldwell SH, Fernández J, Francoz C, Garcia-tsao G, Ginès P, Ison MG, Kramer DJ, Mehta RL, Moreau R, Mulligan D, Olson JC, Pomfret EA, Senzolo M, Steadman RH, Subramanian RM, Vincent J, Genyk YS. Management of the critically ill patient with cirrhosis: A multidisciplinary perspective. Journal of Hepatology 2016;64:717-35. [DOI: 10.1016/j.jhep.2015.10.019] [Cited by in Crossref: 150] [Cited by in F6Publishing: 111] [Article Influence: 25.0] [Reference Citation Analysis]
458 Kumar R, Husain M, Gupta RK, Hasan KM, Haris M, Agarwal AK, Pandey CM, Narayana PA. Serial changes in the white matter diffusion tensor imaging metrics in moderate traumatic brain injury and correlation with neuro-cognitive function. J Neurotrauma 2009;26:481-95. [PMID: 19196176 DOI: 10.1089/neu.2008.0461] [Cited by in Crossref: 117] [Cited by in F6Publishing: 119] [Article Influence: 9.0] [Reference Citation Analysis]
459 Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. J Gastroenterol Hepatol. 2016;31:1203-1209. [PMID: 26716736 DOI: 10.1111/jgh.13283] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
460 Aller MA, Arias JL, Cruz A, Arias J. Inflammation: a way to understanding the evolution of portal hypertension. Theor Biol Med Model 2007;4:44. [PMID: 17999758 DOI: 10.1186/1742-4682-4-44] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.7] [Reference Citation Analysis]
461 Parekh PJ, Balart LA. Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy. Clin Liver Dis. 2015;19:529-537. [PMID: 26195206 DOI: 10.1016/j.cld.2015.05.002] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
462 Zhang Y, Feng Y, Cao B, Tian Q. The effect of small intestinal bacterial overgrowth on minimal hepatic encephalopathy in patients with cirrhosis. Arch Med Sci. 2016;12:592-596. [PMID: 27279853 DOI: 10.5114/aoms.2015.55675] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
463 Agarwal A, Taneja S, Chopra M, Duseja A, Dhiman RK. Animal Naming Test - a simple and accurate test for diagnosis of minimal hepatic encephalopathy and prediction of overt hepatic encephalopathy. Clin Exp Hepatol 2020;6:116-24. [PMID: 32728628 DOI: 10.5114/ceh.2019.95105] [Reference Citation Analysis]
464 Al Sibae MR, McGuire BM. Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag. 2009;5:617-626. [PMID: 19707277 DOI: 10.2147/tcrm.s4443] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
465 Tornai T, Vitalis Z, Sipeki N, Dinya T, Tornai D, Antal-Szalmas P, Karanyi Z, Tornai I, Papp M. Macrophage activation marker, soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection. Liver Int. 2016; Epub ahead of print. [PMID: 27031405 DOI: 10.1111/liv.13133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
466 Legaz I, Navarro-Noguera E, Bolarín JM, García-Alonso AM, Luna Maldonado A, Mrowiec A, Campillo JA, Gimeno L, Moya-Quiles R, Álvarez-López Mdel R, Minguela Puras A, Miras M, Sánchez-Bueno F, Muro M. Epidemiology, Evolution, and Long-Term Survival of Alcoholic Cirrhosis Patients Submitted to Liver Transplantation in Southeastern Spain. Alcohol Clin Exp Res 2016;40:794-805. [PMID: 27012317 DOI: 10.1111/acer.13013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
467 Huang GQ, Xie YY, Zhu PW, Wang XD, Lin Z, Wang Y, Ye JP, Wang YM, Chen YX, Jin XZ, Van Poucke S, Chen YP, Zheng MH. Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure. Expert Rev Gastroenterol Hepatol 2018;12:295-302. [PMID: 29300103 DOI: 10.1080/17474124.2018.1424540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
468 Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl. 2009;15:184-192. [PMID: 19177446 DOI: 10.1002/lt.21593] [Cited by in Crossref: 107] [Cited by in F6Publishing: 91] [Article Influence: 8.2] [Reference Citation Analysis]
469 Felipo V, Urios A, Giménez-Garzó C, Cauli O, Andrés-Costa MJ, González O, Serra MA, Sánchez-González J, Aliaga R, Giner-Durán R, Belloch V, Montoliu C. Non invasive blood flow measurement in cerebellum detects minimal hepatic encephalopathy earlier than psychometric tests. World J Gastroenterol 2014; 20(33): 11815-11825 [PMID: 25206287 DOI: 10.3748/wjg.v20.i33.11815] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
470 Yamamoto M, Iwasa M, Matsumura K, Nakagawa Y, Fujita N, Kobayashi Y, Kaito M, Takeda K, Adachi Y. Improvement of regional cerebral blood flow after oral intake of branched-chain amino acids in patients with cirrhosis. World J Gastroenterol 2005; 11(43): 6792-6799 [PMID: 16425386 DOI: 10.3748/wjg.v11.i43.6792] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
471 Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL, Morgan MY. L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev. 2018;5:CD012410. [PMID: 29762873 DOI: 10.1002/14651858.cd012410.pub2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
472 Nardelli S, Allampati S, Riggio O, Mullen KD, Prakash R, Gioia S, Unser A, White MB, Fagan AC, Wade JB, Farcomeni A, Gavis EA, Bajaj JS. Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study. Dig Dis Sci 2017;62:794-800. [PMID: 28039670 DOI: 10.1007/s10620-016-4425-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
473 Baumgarten TJ, Neugebauer J, Oeltzschner G, Füllenbach ND, Kircheis G, Häussinger D, Lange J, Wittsack HJ, Butz M, Schnitzler A. Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients. Neuroimage Clin 2018;20:347-56. [PMID: 30109194 DOI: 10.1016/j.nicl.2018.08.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
474 Poh Z, Chang PE. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol. 2012;2012:480309. [PMID: 23133760 DOI: 10.1155/2012/480309] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
475 Bjerring PN, Morgan MY, Vilstrup H, Nielsen SM, Christensen R, Gluud LL; Cochrane Hepato-Biliary Group. Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews. [DOI: 10.1002/14651858.cd013241] [Reference Citation Analysis]
476 Metcalfe EL, Avenell A, Fraser A. Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: systematic review. Clin Nutr. 2014;33:958-965. [PMID: 24656171 DOI: 10.1016/j.clnu.2014.02.011] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
477 Montagnese S, Russo FP, Amodio P, Burra P, Gasbarrini A, Loguercio C, Marchesini G, Merli M, Ponziani FR, Riggio O, Scarpignato C. Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF). Dig Liver Dis. 2019;51:190-205. [PMID: 30606696 DOI: 10.1016/j.dld.2018.11.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
478 Talikoti AT, Sindhu B, Kavyashree S, Kumar KK. Alcoholic delirium tremens with hollow viscus perforation scheduled for emergency laparotomy. Indian J Anaesth 2012;56:189-92. [PMID: 22701216 DOI: 10.4103/0019-5049.96334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
479 Giménez-Garzó C, Garcés JJ, Urios A, Mangas-Losada A, García-García R, González-López O, Giner-Durán R, Escudero-García D, Serra MA, Soria E, Felipo V, Montoliu C. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. PLoS One 2017;12:e0171211. [PMID: 28146589 DOI: 10.1371/journal.pone.0171211] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
480 Michitaka K, Hiraoka A, Kume M, Uehara T, Hidaka S, Ninomiya T, Hasebe A, Miyamoto Y, Ichiryu M, Tanihira T. Amino acid imbalance in patients with chronic liver diseases. Hepatol Res. 2010;40:393-398. [PMID: 20236360 DOI: 10.1111/j.1872-034x.2009.00614.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
481 Luo M, Li L, Yang EN, Cao WK. Relationship between interleukin-6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis. Hepatol Res. 2012;42:1202-1210. [PMID: 22646055 DOI: 10.1111/j.1872-034x.2012.01047.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
482 Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 2004;39:739-45. [DOI: 10.1002/hep.20095] [Cited by in Crossref: 215] [Cited by in F6Publishing: 181] [Article Influence: 11.9] [Reference Citation Analysis]
483 Hirode G, Vittinghoff E, Wong RJ. Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample. Dig Dis Sci 2019;64:1448-57. [PMID: 30863953 DOI: 10.1007/s10620-019-05576-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 5.7] [Reference Citation Analysis]
484 Agusti A, Dziedzic JL, Hernandez-Rabaza V, Guilarte TR, Felipo V. Rats with minimal hepatic encephalopathy due to portacaval shunt show differential increase of translocator protein (18 kDa) binding in different brain areas, which is not affected by chronic MAP-kinase p38 inhibition. Metab Brain Dis 2014;29:955-63. [PMID: 24307181 DOI: 10.1007/s11011-013-9461-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
485 Tseng Y, Ma L, Luo T, Zeng X, Li N, Wei Y, Zhou J, Li F, Chen S. Non-invasive predictive model for hepatic venous pressure gradient based on a 3-dimensional computed tomography volume rendering technology. Exp Ther Med 2018;15:3329-35. [PMID: 29545851 DOI: 10.3892/etm.2018.5816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
486 Bajaj JS, Saeian K, Hafeezullah M, Hoffmann RG, Hammeke TA. Patients with minimal hepatic encephalopathy have poor insight into their driving skills. Clin Gastroenterol Hepatol. 2008;6:1135-9; quiz 1065. [PMID: 18928938 DOI: 10.1016/j.cgh.2008.05.025] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
487 Casula EP, Bisiacchi PS, Corrias M, Schiff S, Merkel C, Amodio P, Montagnese S. Acute hyperammonaemia induces a sustained decrease in vigilance, which is modulated by caffeine. Metab Brain Dis 2015;30:143-9. [DOI: 10.1007/s11011-014-9590-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
488 Alfawaz HA, Aljumah AA. What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides? Saudi J Gastroenterol 2012;18:153-4. [PMID: 22626793 DOI: 10.4103/1319-3767.96443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
489 Solga S. Probiotics can treat hepatic encephalopathy. Medical Hypotheses 2003;61:307-13. [DOI: 10.1016/s0306-9877(03)00192-0] [Cited by in Crossref: 59] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
490 Bhanji RA, Carey EJ, Watt KD. Review article: maximising quality of life while aspiring for quantity of life in end-stage liver disease. Aliment Pharmacol Ther. 2017;46:16-25. [PMID: 28464346 DOI: 10.1111/apt.14078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
491 Frank Y, Ashwal S. Neurologic Disorders Associated with Gastrointestinal Diseases and Nutritional Deficiencies. Swaiman's Pediatric Neurology. Elsevier; 2012. pp. 1821-66. [DOI: 10.1016/b978-1-4377-0435-8.00079-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
492 Li GJ, Sun P, Wang Q, Qian Y, Zhu K, Zhao X. Dendrobium candidum Wall. ex Lindl. attenuates CCl4-induced hepatic damage in imprinting control region mice. Exp Ther Med 2014;8:1015-21. [PMID: 25120640 DOI: 10.3892/etm.2014.1834] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
493 Weissenborn K, Bokemeyer M, Ahl B, Fischer-Wasels D, Giewekemeyer K, van den Hoff J, Köstler H, Berding G. Functional imaging of the brain in patients with liver cirrhosis. Metab Brain Dis 2004;19:269-80. [PMID: 15554422 DOI: 10.1023/b:mebr.0000043976.17500.8e] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
494 Miranda AS, Rodrigues DH, Vieira LB, Lima CX, Rachid MA, Vidigal PV, Gomez MV, Reis HJ, Guatimosim C, Teixeira AL. A thioacetamide-induced hepatic encephalopathy model in C57BL/6 mice: a behavioral and neurochemical study. Arq Neuropsiquiatr. 2010;68:597-602. [PMID: 20730316 DOI: 10.1590/S0004-282X2010000400022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
495 Jain L, Sharma BC, Srivastava S, Puri SK, Sharma P, Sarin S. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. J Gastroenterol Hepatol. 2013;28:1187-1193. [PMID: 23425082 DOI: 10.1111/jgh.12160] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
496 Seo YS, Yim SY, Jung JY, Kim CH, Kim JD, Keum B, An H, Yim HJ, Lee HS, Kim CD, Ryu HS, Um SH. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterol Hepatol. 2012;27:1695-1704. [PMID: 22743001 DOI: 10.1111/j.1440-1746.2012.07217.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
497 Frey R, Becker C, Unger S, Schmidt A, Wensing G, Mück W. Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521). Pulm Circ 2016;6:S5-S14. [PMID: 27162628 DOI: 10.1086/685015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
498 Ahluwalia V, Wade JB, Thacker L, Kraft KA, Sterling RK, Stravitz RT, Fuchs M, Bouneva I, Puri P, Luketic V, Sanyal AJ, Gilles H, Heuman DM, Bajaj JS. Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis. J Hepatol. 2013;59:467-473. [PMID: 23665182 DOI: 10.1016/j.jhep.2013.04.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
499 Eltawil KM, Laryea M, Peltekian K, Molinari M. Rifaximin vs conventional oral therapy for hepatic encephalopathy: A meta-analysis. World J Gastroenterol 2012; 18(8): 767-777 [PMID: 22371636 DOI: 10.3748/wjg.v18.i8.767] [Cited by in CrossRef: 50] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
500 Tao R, Zhang J, You Z, Wei L, Fan Y, Cui J, Wang J. The thalamus in cirrhotic patients with and without hepatic encephalopathy: a volumetric MRI study. Eur J Radiol. 2013;82:e715-e720. [PMID: 23981388 DOI: 10.1016/j.ejrad.2013.07.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
501 Kasztelan-Szczerbinska B, Surdacka A, Slomka M, Rolinski J, Celinski K, Smolen A, Szczerbinski M. Association of serum adiponectin, leptin, and resistin concentrations with the severity of liver dysfunction and the disease complications in alcoholic liver disease. Mediators Inflamm. 2013;2013:148526. [PMID: 24259947 DOI: 10.1155/2013/148526] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
502 Vidot H, Kline K, Cheng R, Finegan L, Lin A, Kempler E, Strasser SI, Bowen DG, McCaughan GW, Carey S, Allman-Farinelli M, Shackel NA. The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation. Nutrients. 2019;11. [PMID: 31487854 DOI: 10.3390/nu11092097] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
503 Datar S, Wijdicks EF. Neurologic manifestations of acute liver failure. Handb Clin Neurol 2014;120:645-59. [PMID: 24365344 DOI: 10.1016/B978-0-7020-4087-0.00044-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 1.9] [Reference Citation Analysis]
504 Nikolov P, Baumgarten TJ, Hassan SS, Meissner SN, Füllenbach ND, Kircheis G, Häussinger D, Jördens MS, Butz M, Schnitzler A, Groiss SJ. Altered motor cortical plasticity in patients with hepatic encephalopathy: A paired associative stimulation study. Clin Neurophysiol 2021;132:2332-41. [PMID: 34454259 DOI: 10.1016/j.clinph.2021.07.019] [Reference Citation Analysis]
505 Caturelli E, Ghittoni G, Niro G, Clemente R, Accadia L, Nardella M, Andriulli A, Anti M. Multiple intrahepatic vascular shunts causing hyperammoniaemic encephalopathy in a patient without liver cirrhosis. Digestive and Liver Disease 2006;38:347-51. [DOI: 10.1016/j.dld.2005.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
506 Li SW, Wang K, Yu YQ, Wang HB, Li YH, Xu JM. Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. World J Gastroenterol 2013; 19(46): 8745-8751 [PMID: 24379595 DOI: 10.3748/wjg.v19.i46.8745] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
507 Schiano TD. Clinical Management of Hepatic Encephalopathy. Pharmacotherapy 2010;30:10S-5S. [DOI: 10.1592/phco.30.pt2.10s] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
508 Zhang Z, Zhai H, Geng J, Yu R, Ren H, Fan H, Shi P. Large-scale survey of gut microbiota associated with MHE via 16S rRNA-based pyrosequencing. Am J Gastroenterol. 2013;108:1601-1611. [PMID: 23877352 DOI: 10.1038/ajg.2013.221] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
509 Coubard OA, Ober KM, Gaumet M, Urbanski M, Amato JN, Chapron V, Weiss N, Kinugawa K, Weissenborn K, Thabut D. Standardization of the psychometric hepatic encephalopathy score in a French population. PLoS One 2021;16:e0257136. [PMID: 34506569 DOI: 10.1371/journal.pone.0257136] [Reference Citation Analysis]
510 Toris GT, Bikis CN, Tsourouflis GS, Theocharis SE. Hepatic encephalopathy: an updated approach from pathogenesis to treatment. Med Sci Monit 2011;17:RA53-63. [PMID: 21278704 DOI: 10.12659/msm.881387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
511 Tivers MS, Handel I, Gow AG, Lipscomb VJ, Jalan R, Mellanby RJ. Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. PLoS One 2014;9:e82303. [PMID: 24392080 DOI: 10.1371/journal.pone.0082303] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
512 Blei AT. Albumin dialysis for the treatment of hepatic encephalopathy. J Gastroenterol Hepatol 2004;19:S224-8. [DOI: 10.1111/j.1440-1746.2004.03678.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
513 Ashkani Esfahani S, Esmaeilzadeh E, Bagheri F, Emami Y, Farjam M. The effect of co-enzyme q10 on acute liver damage in rats, a biochemical and pathological study. Hepat Mon 2013;13:e13685. [PMID: 24130601 DOI: 10.5812/hepatmon.13685] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
514 Gao F, Li X, Wan G, Li Y, Zhang Q, Liu Y, Liu H, Li H, Wang X. Development and external validation of a prognostic nomogram for acute decompensation of chronic hepatitis B cirrhosis. BMC Gastroenterol. 2018;18:179. [PMID: 30509201 DOI: 10.1186/s12876-018-0911-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
515 Dominguez C, Romero E, Graciano J, Fernandez JL, Viola L. Prevalence and risk factors of acute-on-chronic liver failure in a single center from Argentina. World J Hepatol 2016; 8(34): 1529-1534 [PMID: 28008344 DOI: 10.4254/wjh.v8.i34.1529] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
516 Urios A, Mangas-losada A, Gimenez-garzó C, González-lópez O, Giner-durán R, Serra MA, Noe E, Felipo V, Montoliu C. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits. Liver Int 2017;37:1013-22. [DOI: 10.1111/liv.13345] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
517 Sunil HV, Mittal BR, Kurmi R, Chawla YK, Dhiman RK. Brain perfusion single photon emission computed tomography abnormalities in patients with minimal hepatic encephalopathy. J Clin Exp Hepatol 2012;2:116-21. [PMID: 25755420 DOI: 10.1016/S0973-6883(12)60099-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
518 Martino ME, Fernández-Lorente J, Romero-Vives M, Bárcena R, Gaztelu JM. Brain oscillatory activity during sleep shows unknown dysfunctions in early encephalopathy. J Physiol Biochem 2014;70:821-35. [PMID: 25074827 DOI: 10.1007/s13105-014-0351-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
519 Salman T, Elsabaawy M, Omar M, Afify M, Elezawy H, Ghanem S, Abdelraouf O, Rewisha E, Shebl N. Evaluation of different diagnostic modalities of minimal hepatic encephalopathy in cirrhotic patients: case-control study. Clin Exp Hepatol 2021;7:312-9. [PMID: 34712834 DOI: 10.5114/ceh.2021.109292] [Reference Citation Analysis]
520 Nicaise C, Prozzi D, Viaene E, Moreno C, Gustot T, Quertinmont E, Demetter P, Suain V, Goffin P, Devière J. Control of acute, chronic, and constitutive hyperammonemia by wild-type and genetically engineered Lactobacillus plantarum in rodents. Hepatology. 2008;48:1184-1192. [PMID: 18697211 DOI: 10.1002/hep.22445] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
521 Kuang Y, Wu X, Lai H, Wang Z, Lei Q, Zhong W, Yang Y, Deng C, Zhou Z. Abnormal corpus callosum induced by overt hepatic encephalopathy impairs interhemispheric functional coordination in cirrhosis patients. Ann Transl Med 2021;9:1579. [PMID: 34790785 DOI: 10.21037/atm-21-5109] [Reference Citation Analysis]
522 Kim EK, Park H. Predictors of Emergency Room Admission in Patients With Liver Cirrhosis: A Prospective, Descriptive Study. Gastroenterol Nurs 2020;43:65-75. [PMID: 31990874 DOI: 10.1097/SGA.0000000000000399] [Reference Citation Analysis]
523 Al-Busafi SA, McNabb-Baltar J, Farag A, Hilzenrat N. Clinical manifestations of portal hypertension. Int J Hepatol. 2012;2012:203794. [PMID: 23024865 DOI: 10.1155/2012/203794] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
524 Gao F, Wang R, Deng H, Hou F, Romeiro FG, Qi X. Liver-to-abdominal area ratio for predicting the in-hospital mortality in advanced liver cirrhosis. Postgraduate Medicine 2017;129:756-61. [DOI: 10.1080/00325481.2017.1327781] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
525 Allampati S, Mullen KD. Hepatic Encephalopathy. Handbook of Liver Disease. Elsevier; 2018. pp. 207-16. [DOI: 10.1016/b978-0-323-47874-8.00015-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
526 Gundling F, Seidl H, Schmidt T, Schepp W. Blood ammonia level in liver cirrhosis: a conditio sine qua non to confirm hepatic encephalopathy? Eur J Gastroenterol Hepatol 2008;20:246-7. [PMID: 18301310 DOI: 10.1097/MEG.0b013e3282f1d00c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
527 Müller M, Schefold JC, Leichtle AB, Srivastava D, Lindner G, Exadaktylos AK, Pfortmueller CA. qSOFA score not predictive of in-hospital mortality in emergency patients with decompensated liver cirrhosis. Med Klin Intensivmed Notfmed 2019;114:724-32. [PMID: 30132026 DOI: 10.1007/s00063-018-0477-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
528 Pietrosi G, Vizzini G, Gerlach J, Chinnici C, Luca A, Amico G, D'amato M, Conaldi PG, Petri SL, Spada M, Tuzzolino F, Alio L, Schmelzer E, Gridelli B. Phases I-II Matched Case-Control Study of Human Fetal Liver Cell Transplantation for Treatment of Chronic Liver Disease. Cell Transplant 2015;24:1627-38. [DOI: 10.3727/096368914x682422] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
529 Wang T, Suzuki K, Kakisaka K, Onodera M, Sawara K, Takikawa Y. L‐carnitine prevents ammonia‐induced cytotoxicity and disturbances in intracellular amino acid levels in human astrocytes. Journal of Gastroenterology and Hepatology 2019;34:1249-55. [DOI: 10.1111/jgh.14497] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
530 Bajaj JS, Gillevet PM, Patel NR, Ahluwalia V, Ridlon JM, Kettenmann B, Schubert CM, Sikaroodi M, Heuman DM, Crossey MM. A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metab Brain Dis. 2012;27:205-215. [PMID: 22527995 DOI: 10.1007/s11011-012-9303-0] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 6.7] [Reference Citation Analysis]
531 Sun Q, Fan W, Ye J, Han P. Abnormal Regional Homogeneity and Functional Connectivity of Baseline Brain Activity in Hepatitis B Virus-Related Cirrhosis With and Without Minimal Hepatic Encephalopathy.Front Hum Neurosci. 2018;12:245. [PMID: 29988437 DOI: 10.3389/fnhum.2018.00245] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
532 Yang D, Yang J, Shi D, Deng R, Yan B. Scoparone potentiates transactivation of the bile salt export pump gene and this effect is enhanced by cytochrome P450 metabolism but abolished by a PKC inhibitor. Br J Pharmacol 2011;164:1547-57. [PMID: 21649640 DOI: 10.1111/j.1476-5381.2011.01522.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
533 Bohra A, Worland T, Hui S, Terbah R, Farrell A, Robertson M. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World J Gastroenterol 2020; 26(18): 2221-2231 [PMID: 32476788 DOI: 10.3748/wjg.v26.i18.2221] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
534 Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut. 2006;55:1617-1623. [PMID: 16571635 DOI: 10.1136/gut.2005.089482] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
535 Paz-Delgadillo J, Monreal-Robles R, Villarreal-Pérez JZ, Maldonado-Garza HJ, Bosques-Padilla FJ, Lavalle-González FJ. Algorithm for Screening of Adrenal Function in Stable Patients with Cirrhosis. Ann Hepatol 2017;16:788-96. [PMID: 28809735 DOI: 10.5604/01.3001.0010.2797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
536 Weiss N, Jalan R, Thabut D. Understanding hepatic encephalopathy. Intensive Care Med. 2017; Epub ahead of print. [PMID: 28547522 DOI: 10.1007/s00134-017-4845-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
537 Bao ZJ, Qiu DK, Ma X, Fan ZP, Zhang GS, Huang YQ, Yu XF, Zeng MD. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007; 13(21): 3003-3008 [PMID: 17589955 DOI: 10.3748/wjg.v13.i21.3003] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
538 Bjerre M, Holland-Fischer P, Grønbæk H, Frystyk J, Hansen TK, Vilstrup H, Flyvbjerg A. Soluble membrane attack complex in ascites in patients with liver cirrhosis without infections. World J Hepatol 2010; 2(6): 221-225 [PMID: 21161000 DOI: 10.4254/wjh.v2.i6.221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
539 Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol. 2008;20:1064-1070. [PMID: 19047837 DOI: 10.1097/meg.0b013e328302f470] [Cited by in Crossref: 72] [Cited by in F6Publishing: 18] [Article Influence: 5.1] [Reference Citation Analysis]
540 Marrero J, Martinez FJ, Hyzy R. Advances in Critical Care Hepatology. Am J Respir Crit Care Med 2003;168:1421-6. [DOI: 10.1164/rccm.200303-361up] [Cited by in Crossref: 26] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
541 Qi R, Zhang LJ, Xu Q, Zhong J, Wu S, Zhang Z, Liao W, Ni L, Zhang Z, Chen H, Zhong Y, Jiao Q, Wu X, Fan X, Liu Y, Lu G. Selective impairments of resting-state networks in minimal hepatic encephalopathy.PLoS One. 2012;7:e37400. [PMID: 22662152 DOI: 10.1371/journal.pone.0037400] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
542 Dharel N, Bajaj JS. Definition and nomenclature of hepatic encephalopathy. J Clin Exp Hepatol. 2015;5:S37-S41. [PMID: 26041955 DOI: 10.1016/j.jceh.2014.10.001] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 5.9] [Reference Citation Analysis]
543 Mittal VV, Sharma BC, Sharma P, Sarin SK. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. Eur J Gastroenterol Hepatol. 2011;23:725-732. [PMID: 21646910 DOI: 10.1097/meg.0b013e32834696f5] [Cited by in Crossref: 118] [Cited by in F6Publishing: 49] [Article Influence: 10.7] [Reference Citation Analysis]
544 Bleibel W, Al-Osaimi AM. Hepatic encephalopathy. Saudi J Gastroenterol. 2012;18:301-309. [PMID: 23006457 DOI: 10.4103/1319-3767.101123] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
545 Oliver JB, Merchant AM, Koneru B. The Impact of Chronic Liver Disease on Postoperative Outcomes and Resource Utilization. J Invest Surg 2021;34:617-26. [PMID: 31661332 DOI: 10.1080/08941939.2019.1676846] [Reference Citation Analysis]
546 Giannini E, Botta F, Fumagalli A, Malfatti F, Testa E, Chiarbonello B, Polegato S, Bellotti M, Milazzo S, Borgonovo G, Testa R. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients? Liver Int 2004;24:465-70. [PMID: 15482344 DOI: 10.1111/j.1478-3231.2004.0949.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
547 Srivastava A, Yadav SK, Yachha SK, Thomas MA, Saraswat VA, Gupta RK. Pro-inflammatory cytokines are raised in extrahepatic portal venous obstruction, with minimal hepatic encephalopathy. J Gastroenterol Hepatol 2011;26:979-86. [PMID: 21362045 DOI: 10.1111/j.1440-1746.2011.06706.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
548 Thompson JR. Special issues related to pharmacists in the Management of Hepatic Encephalopathy Advisory Board Meeting held in Las Vegas, Nevada, December 5, 2009. Introduction. Pharmacotherapy 2010;30:1S-3S. [PMID: 20412033 DOI: 10.1592/phco.30.pt2.1S] [Reference Citation Analysis]
549 Rahimi RS, Rockey DC. Hepatic encephalopathy: how to test and treat. Current Opinion in Gastroenterology 2014;30:265-71. [DOI: 10.1097/mog.0000000000000066] [Cited by in Crossref: 10] [Article Influence: 1.3] [Reference Citation Analysis]
550 Nasehi M, Amin Yavari S, Zarrindast MR. Synergistic effects between CA1 mu opioid and dopamine D1-like receptors in impaired passive avoidance performance induced by hepatic encephalopathy in mice. Psychopharmacology 2013;227:553-66. [DOI: 10.1007/s00213-013-2987-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
551 Sharma BC, Sharma P, Agrawal A, Sarin SK. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 2009; 137: 885-891, 891. e1. [PMID: 19501587 DOI: 10.1053/j.gastro.2009.05.056] [Cited by in Crossref: 191] [Cited by in F6Publishing: 145] [Article Influence: 14.7] [Reference Citation Analysis]
552 Akahane T, Yoshiji H. Role of serum albumin in hepatic encephalopathy. Hepatol Res 2021;51:353-4. [PMID: 33797845 DOI: 10.1111/hepr.13632] [Reference Citation Analysis]
553 Ortiz M, Córdoba J, Alonso J, Rovira A, Quiroga S, Jacas C, Esteban R, Guardia J. Oral glutamine challenge and magnetic resonance spectroscopy in three patients with congenital portosystemic shunts. J Hepatol 2004;40:552-7. [PMID: 15123374 DOI: 10.1016/j.jhep.2004.01.013] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
554 Méndez M, Méndez-lópez M, Lopez L, Aller MA, Arias J, Arias JL. Mammillary body alterations and spatial memory impairment in Wistar rats with thioacetamide-induced cirrhosis. Brain Research 2008;1233:185-95. [DOI: 10.1016/j.brainres.2008.07.040] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
555 Perazzo JC, Arnaiz SL, Fernández MA, Lago N, Lemberg A. Prehepatic portal hypertension and mitochondrial dysfunction in brain hippocampus. In: Häussinger D, Kircheis G, Schliess F, editors. Hepatic Encephalopathy and Nitrogen Metabolism. Dordrecht: Springer Netherlands; 2006. pp. 194-201. [DOI: 10.1007/1-4020-4456-9_14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
556 Velissaris D, Karanikolas M, Kalogeropoulos A, Solomou E, Polychronopoulos P, Thomopoulos K, Labropoulou-Karatza C. Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy. World J Gastroenterol 2008; 14(26): 4190-4195 [PMID: 18636665 DOI: 10.3748/wjg.14.4190] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
557 Rose C, Jalan R. Is minimal hepatic encephalopathy completely reversible following liver transplantation? Liver Transpl. 2004;10:84-87. [PMID: 14755783 DOI: 10.1002/lt.20030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
558 Garcovich M, Zocco MA, Roccarina D, Ponziani FR, Gasbarrini A. Prevention and treatment of hepatic encephalopathy: Focusing on gut microbiota. World J Gastroenterol 2012; 18(46): 6693-6700 [PMID: 23239905 DOI: 10.3748/wjg.v18.i46.6693] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
559 Chen QF, Chen HJ, Liu J, Sun T, Shen QT. Machine Learning Classification of Cirrhotic Patients with and without Minimal Hepatic Encephalopathy Based on Regional Homogeneity of Intrinsic Brain Activity. PLoS One 2016;11:e0151263. [PMID: 26978777 DOI: 10.1371/journal.pone.0151263] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
560 Costa BP, Castro Sousa F, Serôdio M, Carvalho C. Value of MELD and MELD-Based Indices in Surgical Risk Evaluation of Cirrhotic Patients: Retrospective Analysis of 190 Cases. World J Surg 2009;33:1711-9. [DOI: 10.1007/s00268-009-0093-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
561 Feltracco P, Brezzi M, Barbieri S, Milevoj M, Galligioni H, Cillo U, Zanus G, Vitale A, Ori C. Intensive care unit admission of decompensated cirrhotic patients: prognostic scoring systems. Transplant Proc. 2011;43:1079-1084. [PMID: 21620058 DOI: 10.1016/j.transproceed.2011.01.153] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
562 Ferenci P, Kramer L. MARS and the failing liver-Any help from the outer space? Hepatology 2007;46:1682-4. [PMID: 18046718 DOI: 10.1002/hep.22031] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
563 Larson AM. Diagnosis and management of acute liver failure. Curr Opin Gastroenterol 2010;26:214-21. [PMID: 20216412 DOI: 10.1097/MOG.0b013e32833847c5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
564 DellaVolpe JD, Garavaglia JM, Huang DT. Management of Complications of End-Stage Liver Disease in the Intensive Care Unit. J Intensive Care Med 2016;31:94-103. [PMID: 25223828 DOI: 10.1177/0885066614551144] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
565 McPhail MJ, Taylor-Robinson SD. The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy. Metab Brain Dis. 2010;25:65-72. [PMID: 20221679 DOI: 10.1007/s11011-010-9171-4] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
566 Weissenborn K. Challenges in diagnosing hepatic encephalopathy. Neurochem Res 2015;40:265-73. [PMID: 25142937 DOI: 10.1007/s11064-014-1416-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
567 Cai X, Wang L, Hu C. Retracted : Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta‐analysis involving 826 patients based on 10 randomized controlled trials. J Cell Biochem 2018;119:8336-45. [DOI: 10.1002/jcb.26886] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
568 Ramanathan S, Khandelwal N, Kalra N, Bhatia A, Dhiman RK, Duseja AK, Chawla YK. Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients. Saudi J Gastroenterol 2016;22:109-15. [PMID: 26997216 DOI: 10.4103/1319-3767.164185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
569 Huang S, Huang GQ, Zhu GQ, Liu WY, You J, Shi KQ, Wang XB, Che HY, Chen GL, Fang JF, Zhou Y, Zhou MT, Chen YP, Braddock M, Zheng MH. Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection. PLoS One. 2015;10:e0129000. [PMID: 26057656 DOI: 10.1371/journal.pone.0129000] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
570 Laleman W, Simon-Talero M, Maleux G, Perez M, Ameloot K, Soriano G, Villalba J, Garcia-Pagan JC, Barrufet M, Jalan R, Brookes J, Thalassinos E, Burroughs AK, Cordoba J, Nevens F; EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57:2448-2457. [PMID: 23401201 DOI: 10.1002/hep.26314] [Cited by in Crossref: 143] [Cited by in F6Publishing: 105] [Article Influence: 15.9] [Reference Citation Analysis]
571 Duan ZJ, Zhang CL. Progress in developing rat models of hepatic encephalopathy. Shijie Huaren Xiaohua Zazhi 2010; 18(30): 3204-3209 [DOI: 10.11569/wcjd.v18.i30.3204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
572 Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC. Hepatitis C viral infection and the risk of dementia. Eur J Neurol. 2014;21:1068-1e59. [PMID: 24313931 DOI: 10.1111/ene.12317] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 4.9] [Reference Citation Analysis]
573 Getsuwan S, Lertudomphonwanit C, Tanpowpong P, Thirapattaraphan C, Tim-Aroon T, Wattanasirichaigoon D, Treepongkaruna S. Etiologies, Prognostic Factors, and Outcomes of Pediatric Acute Liver Failure in Thailand. Pediatr Gastroenterol Hepatol Nutr 2020;23:539-47. [PMID: 33215025 DOI: 10.5223/pghn.2020.23.6.539] [Reference Citation Analysis]
574 Gencdal G, Gunsar F, Meral CE, Salman E, Gürsel B, Oruç N, Karasu Z, Ersoz G, Akarca US. Diurnal changes of critical flicker frequency in patients with liver cirrhosis and their relationship with sleep disturbances. Dig Liver Dis 2014;46:1111-5. [PMID: 25192605 DOI: 10.1016/j.dld.2014.08.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
575 Shawcross D, Sharifi Y, Canavan J, Yeoman A, Abeles R, Taylor N, Auzinger G, Bernal W, Wendon J. Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis. Journal of Hepatology 2011;54:640-9. [DOI: 10.1016/j.jhep.2010.07.045] [Cited by in Crossref: 154] [Cited by in F6Publishing: 136] [Article Influence: 14.0] [Reference Citation Analysis]
576 Reza Zarrindast M, Eslimi Esfahani D, Oryan S, Nasehi M, Torabi Nami M. Effects of dopamine receptor agonist and antagonists on cholestasis-induced anxiolytic-like behaviors in rats. European Journal of Pharmacology 2013;702:25-31. [DOI: 10.1016/j.ejphar.2013.01.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
577 Strebel H, Haller B, Sohn M, Schepp W, Gundling F. Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE Port J Gastroenterol 2020;27:391-403. [PMID: 33251288 DOI: 10.1159/000507225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
578 Peck-Radosavljevic M. Portal hypertension--old problem, new therapeutic solutions. Wien Med Wochenschr 2006;156:397-403. [PMID: 16937042 DOI: 10.1007/s10354-006-0315-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
579 Mechtcheriakov S, Graziadei IW, Kugener A, Wiedemann J, Galbavy C, Hinterhuber H, Marksteiner J, Vogel W. Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: A clinical rating scale. World J Gastroenterol 2005; 11(37): 5893-5898 [PMID: 16270405 DOI: 10.3748/wjg.v11.i37.5893] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
580 Barone C, Koeberle D, Metselaar H, Parisi G, Sansonno D, Spinzi G. Multidisciplinary approach for HCC patients: hepatology for the oncologists. Ann Oncol. 2013;24 Suppl 2:ii15-ii23. [PMID: 23715939 DOI: 10.1093/annonc/mdt053] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
581 Lin WC, Chou KH, Chen CL, Chen HL, Lu CH, Li SH, Huang CC, Lin CP, Cheng YF. Longitudinal brain white matter alterations in minimal hepatic encephalopathy before and after liver transplantation. PLoS One. 2014;9:e105887. [PMID: 25166619 DOI: 10.1371/journal.pone.0105887] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
582 Michitaka K, Tokumoto Y, Uesugi K, Kisaka Y, Hirooka M, Konishi I, Mashiba T, Abe M, Hiasa Y, Matsuura B, Horiike N, Shoda T, Onji M. Neuropsychiatric dysfunction in patients with chronic hepatitis and liver cirrhosis. Hepatology Research 2008;38:1069-75. [DOI: 10.1111/j.1872-034x.2008.00374.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
583 Rocco A, Sgamato C, Compare D, Coccoli P, Nardone OM, Nardone G. Gut Microbes and Hepatic Encephalopathy: From the Old Concepts to New Perspectives. Front Cell Dev Biol 2021;9:748253. [PMID: 34900994 DOI: 10.3389/fcell.2021.748253] [Reference Citation Analysis]
584 Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2010;51:1062-1069. [PMID: 19890967 DOI: 10.1002/hep.23367] [Cited by in Crossref: 118] [Cited by in F6Publishing: 113] [Article Influence: 9.8] [Reference Citation Analysis]
585 Sreevallabhan S, Mohanan R, Jose SP, Sukumaran S, Jagmag T, Tilwani J, Kulkarni A. Hepatoprotective effect of essential phospholipids enriched with virgin coconut oil (Phoscoliv) on paracetamol-induced liver toxicity. J Food Biochem 2021;45:e13606. [PMID: 33458835 DOI: 10.1111/jfbc.13606] [Reference Citation Analysis]
586 Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73:1526-1547. [PMID: 33097308 DOI: 10.1016/j.jhep.2020.07.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
587 Zhuge W, Wen F, Ni Z, Zheng Z, Zhu X, Lin J, Wang J, Zhuge Q, Ding S. Dopamine Burden Triggers Cholesterol Overload Following Disruption of Synaptogenesis in Minimal Hepatic Encephalopathy. Neuroscience 2019;410:1-15. [PMID: 31078686 DOI: 10.1016/j.neuroscience.2019.04.056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
588 Altamirano J, Fagundes C, Dominguez M, García E, Michelena J, Cárdenas A, Guevara M, Pereira G, Torres-Vigil K, Arroyo V. Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis. Clin Gastroenterol Hepatol. 2012;10:65-71.e3. [PMID: 21946124 DOI: 10.1016/j.cgh.2011.09.011] [Cited by in Crossref: 92] [Cited by in F6Publishing: 83] [Article Influence: 8.4] [Reference Citation Analysis]
589 Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: Role of inflammation and oxidative stress. World J Gastroenterol 2010; 16(27): 3347-3357 [PMID: 20632436 DOI: 10.3748/wjg.v16.i27.3347] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
590 García-martínez R, Córdoba J. Brain Imaging in Hepatic Encephalopathy. In: Mullen KD, Prakash RK, editors. Hepatic Encephalopathy. Totowa: Humana Press; 2012. pp. 123-37. [DOI: 10.1007/978-1-61779-836-8_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
591 Sugimoto R, Iwasa M, Maeda M, Urawa N, Tanaka H, Fujita N, Kobayashi Y, Takeda K, Kaito M, Takei Y. Value of the apparent diffusion coefficient for quantification of low-grade hepatic encephalopathy. Am J Gastroenterol. 2008;103:1413-1420. [PMID: 18510613 DOI: 10.1111/j.1572-0241.2008.01788.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
592 Zhang M, Duan ZJ. Retrospective analysis of factors influencing the development and progression of hepatic encephalopathy in patients with hepatitis B virus-related cirrhosis. Shijie Huaren Xiaohua Zazhi 2012; 20(13): 1148-1155 [DOI: 10.11569/wcjd.v20.i13.1148] [Reference Citation Analysis]
593 Kodali S, Mcguire BM. Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure. Clinics in Liver Disease 2015;19:565-76. [DOI: 10.1016/j.cld.2015.04.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
594 Bajaj JS, Thacker LR, Heuman DM, Sterling RK, Stravitz RT, Sanyal AJ, Luketic V, Fuchs M, Gilles HC, Wade JB. Cognitive performance as a predictor of hepatic encephalopathy in pretransplant patients with cirrhosis receiving psychoactive medications: a prospective study. Liver Transpl. 2012;18:1179-1187. [PMID: 22674517 DOI: 10.1002/lt.23484] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
595 Reuter B, Walter K, Bissonnette J, Leise MD, Lai J, Tandon P, Kamath PS, Biggins SW, Rose CF, Wade JB, Bajaj JS. Assessment of the spectrum of hepatic encephalopathy: A multicenter study. Liver Transpl 2018;24:587-94. [PMID: 29457869 DOI: 10.1002/lt.25032] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
596 Oeltzschner G, Butz M, Baumgarten TJ, Hoogenboom N, Wittsack H, Schnitzler A. Low visual cortex GABA levels in hepatic encephalopathy: links to blood ammonia, critical flicker frequency, and brain osmolytes. Metab Brain Dis 2015;30:1429-38. [DOI: 10.1007/s11011-015-9729-2] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
597 Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, Angeli P, Gatta A. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol. 2008;49:346-353. [PMID: 18602716 DOI: 10.1016/j.jhep.2008.04.022] [Cited by in Crossref: 126] [Cited by in F6Publishing: 113] [Article Influence: 9.0] [Reference Citation Analysis]
598 Bettinger D, Knüppel E, Euringer W, Spangenberg HC, Rössle M, Thimme R, Schultheiß M. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Aliment Pharmacol Ther 2015;41:126-36. [PMID: 25329493 DOI: 10.1111/apt.12994] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
599 Allegritti M, Enrico B, Basile E, de Vito L, Morabito A, Cirocchi R, Giustozzi M, Passalacqua G. Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure. Dig Dis Sci 2020;65:946-51. [PMID: 31900714 DOI: 10.1007/s10620-019-06024-4] [Reference Citation Analysis]
600 Ekerfors U, Sunnerhagen KS, Westin J, Jakobsson Ung E, Marschall HU, Josefsson A, Simrén M. Muscle performance and fatigue in compensated chronic liver disease. Scand J Gastroenterol 2019;54:925-33. [PMID: 31287334 DOI: 10.1080/00365521.2019.1635638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
601 Bajaj JS, Frederick RT, Bass NM, Ghabril M, Coyne K, Margolis MK, Santoro M, Coakley DF, Mokhtarani M, Jurek M, Scharschmidt BF. Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary. Metab Brain Dis 2016;31:1081-93. [PMID: 27278222 DOI: 10.1007/s11011-016-9851-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
602 Bouzbib C, El Mourabit H, Wendum D, Lasnier E, Mouri S, Housset C, Thabut D, Weiss N, Rudler M. ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy. Clin Res Hepatol Gastroenterol 2021;:101784. [PMID: 34384925 DOI: 10.1016/j.clinre.2021.101784] [Reference Citation Analysis]
603 Heidari R, Jamshidzadeh A, Niknahad H, Mardani E, Ommati MM, Azarpira N, Khodaei F, Zarei A, Ayarzadeh M, Mousavi S, Abdoli N, Yeganeh BS, Saeedi A, Najibi A. Effect of taurine on chronic and acute liver injury: Focus on blood and brain ammonia. Toxicol Rep 2016;3:870-9. [PMID: 28959615 DOI: 10.1016/j.toxrep.2016.04.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
604 Torres DS, Abrantes J, Brandão-Mello CE. Cognitive assessment of patients with minimal hepatic encephalopathy in Brazil. Metab Brain Dis 2013;28:473-83. [PMID: 23625323 DOI: 10.1007/s11011-013-9405-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
605 Bamidele OF, Olokoba AB, Bojuwoye MO, Akintayo RO, Bamidele O. Prevalence of minimal hepatic encephalopathy among patients with chronic liver disease in Ilorin, Nigeria. Ghana Med J 2019;53:299-303. [PMID: 32116342 DOI: 10.4314/gmj.v53i4.8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
606 Foster KJ, Lin S, Turck CJ. Current and emerging strategies for treating hepatic encephalopathy. Crit Care Nurs Clin North Am. 2010;22:341-350. [PMID: 20691385 DOI: 10.1016/j.ccell.2010.04.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
607 Huo TI, Hsu CY, Huang YH, Hsia CY, Lin HC, Lee PC, Loong CC, Chiang JH, Chiou YY, Lee SD. Diabetes mellitus as an independent prognostic predictor and its association with renal dysfunction in patients with hepatocellular carcinoma. Liver Int 2010;30:198-207. [PMID: 19849777 DOI: 10.1111/j.1478-3231.2009.02143.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
608 Le Sueur-Maluf L, Viana MB, Nagaoka MR, Amorim AL, Cardoso AN, Rodrigues BC, Mendes NF, Bittencourt JC, Céspedes IC. Behavioral alterations and Fos protein immunoreactivity in brain regions of bile duct-ligated cirrhotic rats. An Acad Bras Cienc 2015;87:331-493. [PMID: 25714078 DOI: 10.1590/0001-3765201420130262] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
609 Nasehi M, Piri M, Abbolhasani K, Zarrindast MR. Involvement of opioidergic and nitrergic systems in memory acquisition and exploratory behaviors in cholestatic mice. Behav Pharmacol 2013;24:180-94. [PMID: 23604167 DOI: 10.1097/FBP.0b013e3283618aab] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
610 Lauridsen MM, Thacker LR, White MB, Unser A, Sterling RK, Stravitz RT, Matherly S, Puri P, Sanyal AJ, Gavis EA, Luketic V, Siddiqui MS, Heuman DM, Fuchs M, Bajaj JS. In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving. Clin Gastroenterol Hepatol 2016;14:747-52. [PMID: 26601613 DOI: 10.1016/j.cgh.2015.11.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
611 Sung CM, Lin YF, Chen KF, Ke HM, Huang HY, Gong YN, Tsai WS, You JF, Lu MJ, Cheng HT, Lin CY, Kuo CJ, Tsai IJ, Hsieh SY. Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From the Fecal Microbiome. Cell Mol Gastroenterol Hepatol. 2019;8:301-318.e2. [PMID: 31004827 DOI: 10.1016/j.jcmgh.2019.04.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 10.7] [Reference Citation Analysis]
612 Krismer F, Roos JC, Schranz M, Graziadei IW, Mechtcheriakov S, Vogel W, Carpenter RH, Zoller H. Saccadic latency in hepatic encephalopathy: a pilot study. Metab Brain Dis 2010;25:285-95. [PMID: 20852922 DOI: 10.1007/s11011-010-9210-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
613 Bourgoin P, Merouani A, Phan V, Litalien C, Lallier M, Alvarez F, Jouvet P. Molecular Absorbent Recirculating System therapy (MARS®) in pediatric acute liver failure: a single center experience. Pediatr Nephrol 2014;29:901-8. [DOI: 10.1007/s00467-013-2691-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
614 Dhiman RK, Jain S, Maheshwari U, Bhalla A, Sharma N, Ahluwalia J, Duseja A, Chawla Y. Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814-821. [PMID: 17370333 DOI: 10.1002/lt.21050] [Cited by in Crossref: 97] [Cited by in F6Publishing: 75] [Article Influence: 6.5] [Reference Citation Analysis]
615 DiMartini A, Chopra K. The importance of hepatic encephalopathy: pre-transplant and post-transplant. Liver Transpl 2009;15:121-3. [PMID: 19177448 DOI: 10.1002/lt.21638] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
616 Ong JP, Aggarwal A, Krieger D, Easley KA, Karafa MT, Van Lente F, Arroliga AC, Mullen KD. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188-193. [PMID: 12637132 DOI: 10.1016/s0002-9343(02)01477-8] [Cited by in Crossref: 330] [Cited by in F6Publishing: 104] [Article Influence: 17.4] [Reference Citation Analysis]
617 Amodio P, Schiff S, Piccolo FD, Mapelli D, Gatta A, Umiltà C. Attention Dysfunction in Cirrhotic Patients: An Inquiry on the Role of Executive Control, Attention Orienting and Focusing. Metab Brain Dis 2005;20:115-27. [DOI: 10.1007/s11011-005-4149-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 3.2] [Reference Citation Analysis]
618 O’carroll RE. Neuropsychological Aspects of Liver Disease and its Treatment. Neurochem Res 2008;33:683-90. [DOI: 10.1007/s11064-007-9522-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
619 Sharma P, Sharma BC, Puri V, Sarin SK. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction. Am J Gastroenterol 2009;104:885-90. [PMID: 19293781 DOI: 10.1038/ajg.2009.84] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
620 Marchetti P, D'Avanzo C, Orsato R, Montagnese S, Schiff S, Kaplan PW, Piccione F, Merkel C, Gatta A, Sparacino G. Electroencephalography in patients with cirrhosis. Gastroenterology. 2011;141:1680-1689.e1-2. [PMID: 21763244 DOI: 10.1053/j.gastro.2011.06.085] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
621 Bajaj JS, Schubert CM, Heuman DM, Wade JB, Gibson DP, Topaz A, Saeian K, Hafeezullah M, Bell DE, Sterling RK. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology. 2010;138:2332-2340. [PMID: 20178797 DOI: 10.1038/ajg.2011.490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
622 Sundaram V, Shaikh OS. Hepatic encephalopathy: pathophysiology and emerging therapies. Med Clin North Am. 2009;93:819-836, vii. [PMID: 19577116 DOI: 10.1016/j.mcna.2009.03.009] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
623 Prakash RK, Brown TA, Mullen KD. Minimal Hepatic Encephalopathy and Driving: Is the Genie Out of the Bottle? American Journal of Gastroenterology 2011;106:1415-6. [DOI: 10.1038/ajg.2011.154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
624 Stefoni S, Colì L, Bolondi L, Donati G, Ruggeri G, Feliciangeli G, Piscaglia F, Silvagni E, Sirri M, Donati G, Baraldi O, Soverini ML, Cianciolo G, Boni P, Patrono D, Ramazzotti E, Motta R, Roda A, Simoni P, Magliulo M, Borgnino LC, Ricci D, Mezzopane D, Cappuccilli ML. Molecular adsorbent recirculating system (MARS) application in liver failure: clinical and hemodepurative results in 22 patients. Int J Artif Organs 2006;29:207-18. [PMID: 16552668 DOI: 10.1177/039139880602900207] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
625 Gomez EV, Bertot LC, Oramas BG, Soler EA, Navarro RL, Elias JD, Jiménez OV, Vazquez MDRA. Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease. World J Gastroenterol 2009; 15(22): 2768-2777 [PMID: 19522028 DOI: 10.3748/wjg.15.2768] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
626 Barone M, Shahini E, Iannone A, Viggiani MT, Corvace V, Principi M, Di Leo A. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis. Digestive and Liver Disease 2018;50:496-500. [DOI: 10.1016/j.dld.2018.01.133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
627 Wang SH, Wang JY, Lin PY, Lin KH, Ko CJ, Hsieh CE, Lin HC, Chen YL. Predisposing risk factors for delirium in living donor liver transplantation patients in intensive care units. PLoS One 2014;9:e96676. [PMID: 24811254 DOI: 10.1371/journal.pone.0096676] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
628 Grover VP, Tognarelli JM, Massie N, Crossey MM, Cook NA, Taylor-Robinson SD. The why and wherefore of hepatic encephalopathy. Int J Gen Med 2015;8:381-90. [PMID: 26719720 DOI: 10.2147/IJGM.S86854] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
629 Méndez M, Méndez-López M, López L, Aller MA, Arias J, Arias JL. Basal and learning task-related brain oxidative metabolism in cirrhotic rats. Brain Res Bull 2009;78:195-201. [PMID: 19015011 DOI: 10.1016/j.brainresbull.2008.10.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
630 Yamada K, Suda T, Komoro YS, Kanefuji T, Kubota T, Murayama T, Nakayama H, Aoyagi Y. Low fat intake is associated with pathological manifestations and poor recovery in patients with hepatocellular carcinoma. Nutr J 2013;12:79. [PMID: 23758691 DOI: 10.1186/1475-2891-12-79] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
631 Wang L, Yu W, Cao W, Lu W. The abnormality of thyroid hormones in patients with type A hepatic encephalopathy. Oncotarget 2017;8:67821-8. [PMID: 28978075 DOI: 10.18632/oncotarget.18869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
632 Li Y, Mei LH, Qiang JW, Ji CX, Ju S. Reduction of manganese intake improves neuropsychological manifestations in rats with minimal hepatic encephalopathy. Neuroscience 2017;347:148-55. [DOI: 10.1016/j.neuroscience.2017.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
633 Merli M, Riggio O. Dietary and nutritional indications in hepatic encephalopathy. Metab Brain Dis 2009;24:211-21. [PMID: 19052853 DOI: 10.1007/s11011-008-9127-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
634 Giménez-Garzó C, Urios A, Agustí A, Mangas-Losada A, García-García R, Escudero-García D, Kosenko E, Ordoño JF, Tosca J, Giner-Durán R, Serra MA, Felipo V, Montoliu C. Cirrhotic patients with minimal hepatic encephalopathy have increased capacity to eliminate superoxide and peroxynitrite in lymphocytes, associated with cognitive impairment. Free Radic Res 2018;52:118-33. [PMID: 29262736 DOI: 10.1080/10715762.2017.1420183] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
635 Chiu CG, Zaghiyan KN, Silberman AW. Hyperammonemic Encephalopathy Associated With GI Stromal Tumor. J Clin Oncol 2016;34:e51-3. [PMID: 24982462 DOI: 10.1200/JCO.2013.48.9302] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
636 Torres-vega MA, Vargas-jerónimo RY, Montiel-martínez AG, Muñoz-fuentes RM, Zamorano-carrillo A, Pastor AR, Palomares LA. Delivery of glutamine synthetase gene by baculovirus vectors: a proof of concept for the treatment of acute hyperammonemia. Gene Ther 2015;22:58-64. [DOI: 10.1038/gt.2014.89] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
637 Montagnese S, Schiff S, De Rui M, Crossey MM, Amodio P, Taylor-Robinson SD. Neuropsychological tools in hepatology: a survival guide for the clinician. J Viral Hepat. 2012;19:307-315. [PMID: 22497809 DOI: 10.1111/j.1365-2893.2012.01592.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
638 Chojnacki C, Romanowski M, Winczyk K, Błasiak J, Chojnacki J. Melatonin levels in serum and ascitic fluid of patients with hepatic encephalopathy. Gastroenterol Res Pract 2012;2012:510764. [PMID: 23346104 DOI: 10.1155/2012/510764] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
639 Als-nielsen B, Koretz RL, Gluud LL, Gluud C, Als-nielsen B. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database of Systematic Reviews. Chichester: John Wiley & Sons, Ltd; 1996. [DOI: 10.1002/14651858.cd001939] [Cited by in Crossref: 67] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
640 Han MK, Hyzy R. Advances in critical care management of hepatic failure and insufficiency: . Critical Care Medicine 2006;34:S225-31. [DOI: 10.1097/01.ccm.0000231882.85350.71] [Cited by in Crossref: 40] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
641 Brito-azevedo A, Perez RM, Maranhão PA, Coelho HS, Fernandes ES, Castiglione RC, de Souza MD, Villela-nogueira CA, Bouskela E. Organ dysfunction in cirrhosis: a mechanism involving the microcirculation. European Journal of Gastroenterology & Hepatology 2019;31:618-25. [DOI: 10.1097/meg.0000000000001366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
642 Agrawal A, Sharma BC, Sharma P, Sarin SK. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. Am J Gastroenterol. 2012;107:1043-1050. [PMID: 22710579 DOI: 10.1038/ajg.2012.113] [Cited by in Crossref: 138] [Cited by in F6Publishing: 114] [Article Influence: 13.8] [Reference Citation Analysis]
643 McPhail MJ, Montagnese S, Villanova M, El Hadi H, Amodio P, Crossey MM, Williams R, Cox IJ, Taylor-Robinson SD. Urinary metabolic profiling by 1H NMR spectroscopy in patients with cirrhosis may discriminate overt but not covert hepatic encephalopathy. Metab Brain Dis 2017;32:331-41. [PMID: 27638475 DOI: 10.1007/s11011-016-9904-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
644 Liu A, Yoo ER, Siddique O, Perumpail RB, Cholankeril G, Ahmed A. Hepatic encephalopathy: what the multidisciplinary team can do. J Multidiscip Healthc. 2017;10:113-119. [PMID: 28392702 DOI: 10.2147/jmdh.s118963] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
645 American Association for the Study of Liver Diseases. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. J Hepatol. 2014;61:642-659. [PMID: 25015420 DOI: 10.1016/j.jhep.2014.05.042] [Cited by in Crossref: 212] [Cited by in F6Publishing: 164] [Article Influence: 26.5] [Reference Citation Analysis]
646 Wong RJ, Aguilar M, Gish RG, Cheung R, Ahmed A. The impact of pretransplant hepatic encephalopathy on survival following liver transplantation. Liver Transpl. 2015;21:873-880. [PMID: 25902933 DOI: 10.1002/lt.24153] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
647 Rudler M, Marois C, Weiss N, Thabut D, Navarro V; Brain-Liver Pitié-Salpêtrière Study Group (BLIPS). Status epilepticus in patients with cirrhosis: How to avoid misdiagnosis in patients with hepatic encephalopathy. Seizure 2017;45:192-7. [PMID: 28092846 DOI: 10.1016/j.seizure.2016.12.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
648 Maruyama H, Kondo T, Kiyono S, Sekimoto T, Takahashi M, Yokosuka O. Influence of splenorenal shunt on long-term outcomes in cirrhosis. Scand J Gastroenterol. 2015;50:593-600. [PMID: 25635924 DOI: 10.3109/00365521.2014.1003401] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
649 Sarin SK, Kedarisetty CK, Abbas Z, Amarapurkar D, Bihari C, Chan AC, Chawla YK, Dokmeci AK, Garg H, Ghazinyan H, Hamid S, Kim DJ, Komolmit P, Lata S, Lee GH, Lesmana LA, Mahtab M, Maiwall R, Moreau R, Ning Q, Pamecha V, Payawal DA, Rastogi A, Rahman S, Rela M, Saraya A, Samuel D, Saraswat V, Shah S, Shiha G, Sharma BC, Sharma MK, Sharma K, Butt AS, Tan SS, Vashishtha C, Wani ZA, Yuen MF, Yokosuka O;  APASL ACLF Working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014. Hepatol Int. 2014;8:453-471. [PMID: 26202751 DOI: 10.1007/s12072-014-9580-2] [Cited by in Crossref: 354] [Cited by in F6Publishing: 306] [Article Influence: 44.3] [Reference Citation Analysis]
650 Kerbert AJC, Reverter E, Verbruggen L, Tieleman M, Navasa M, Mertens BJA, Rodríguez-Tajes S, de Vree M, Metselaar HJ, Chiang FWT, Verspaget HW, van Hoek B, Bosch J, Coenraad MJ. Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation rates. Clin Transplant 2018;32:e13412. [PMID: 30230613 DOI: 10.1111/ctr.13412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
651 Jia B, Yu Z, Duan Z, Lü X, Li J, Liu X, Sun R, Gao X, Wang Y, Yan J, Kan Q. Hyperammonaemia induces hepatic injury with alteration of gene expression profiles. Liver Int 2014;34:748-58. [DOI: 10.1111/liv.12365] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
652 Hassanein TI, Tofteng F, Brown RS Jr, McGuire B, Lynch P, Mehta R, Larsen FS, Gornbein J, Stange J, Blei AT. Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis. Hepatology 2007;46:1853-62. [PMID: 17975845 DOI: 10.1002/hep.21930] [Cited by in Crossref: 278] [Cited by in F6Publishing: 207] [Article Influence: 19.9] [Reference Citation Analysis]
653 Weissenborn K, Giewekemeyer K, Heidenreich S, Bokemeyer M, Berding G, Ahl B. Attention, Memory, and Cognitive Function in Hepatic Encephalopathy. Metab Brain Dis 2005;20:359-67. [DOI: 10.1007/s11011-005-7919-z] [Cited by in Crossref: 120] [Cited by in F6Publishing: 112] [Article Influence: 7.1] [Reference Citation Analysis]
654 Wright G, Jalan R. Management of hepatic encephalopathy in patients with cirrhosis. Best Pract Res Clin Gastroenterol. 2007;21:95-110. [PMID: 17223499 DOI: 10.1016/j.bpg.2006.07.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
655 Cohen SM, Kim A, Metropulos M, Ahn J. Legal Ramifications for Physicians of Patients Who Drive With Hepatic Encephalopathy. Clinical Gastroenterology and Hepatology 2011;9:156-60. [DOI: 10.1016/j.cgh.2010.08.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
656 Elsaid MI, Rustgi VK. Epidemiology of Hepatic Encephalopathy. Clinics in Liver Disease 2020;24:157-74. [DOI: 10.1016/j.cld.2020.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
657 Ventura-Cots M, Concepción M, Arranz JA, Simón-Talero M, Torrens M, Blanco-Grau A, Fuentes I, Suñé P, Alvarado-Tapias E, Gely C, Roman E, Mínguez B, Soriano G, Genescà J, Córdoba J. Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients. Therap Adv Gastroenterol 2016;9:823-35. [PMID: 27803737 DOI: 10.1177/1756283X16658252] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
658 D’antiga L, Dacchille P, Boniver C, Poledri S, Schiff S, Zancan L, Amodio P. Clues for Minimal Hepatic Encephalopathy in Children With Noncirrhotic Portal Hypertension. Journal of Pediatric Gastroenterology & Nutrition 2014;59:689-94. [DOI: 10.1097/mpg.0000000000000537] [Cited by in Crossref: 14] [Article Influence: 1.8] [Reference Citation Analysis]
659 Bajaj JS, Thacker LR, Heuman DM, Gibson DP, Sterling RK, Stravitz RT, Fuchs M, Sanyal AJ, Wade JB. Driving simulation can improve insight into impaired driving skills in cirrhosis. Dig Dis Sci 2012;57:554-60. [PMID: 21901255 DOI: 10.1007/s10620-011-1888-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
660 Kawaguchi T, Taniguchi E, Sata M. Effects of oral branched-chain amino acids on hepatic encephalopathy and outcome in patients with liver cirrhosis. Nutr Clin Pract. 2013;28:580-588. [PMID: 23945292 DOI: 10.1177/0884533613496432] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
661 Barboza KC, Salinas LM, Sahebjam F, Jesudian AB, Weisberg IL, Sigal SH. Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients. Metab Brain Dis 2016;31:869-80. [DOI: 10.1007/s11011-016-9817-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
662 Khungar V, Poordad F. Hepatic encephalopathy. Clin Liver Dis. 2012;16:301-320. [PMID: 22541700 DOI: 10.1016/j.cld.2011.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
663 Carroll JB, Bates GP, Steffan J, Saft C, Tabrizi SJ. Treating the whole body in Huntington's disease. Lancet Neurol 2015;14:1135-42. [PMID: 26466780 DOI: 10.1016/S1474-4422(15)00177-5] [Cited by in Crossref: 91] [Cited by in F6Publishing: 52] [Article Influence: 15.2] [Reference Citation Analysis]
664 White A. Outpatient interventions for hepatology patients with fluid retention: a review and synthesis of the literature. Gastroenterol Nurs 2014;37:236-44. [PMID: 24871669 DOI: 10.1097/SGA.0000000000000051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
665 Hansen L, Lyons KS, Dieckmann NF, Chang MF, Hiatt S, Solanki E, Lee CS. Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study. Res Nurs Health 2017;40:398-413. [PMID: 28666053 DOI: 10.1002/nur.21807] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
666 Bajaj JS. Management options for minimal hepatic encephalopathy. Expert Rev Gastroenterol Hepatol. 2008;2:785-790. [PMID: 19090738 DOI: 10.1586/17474124.2.6.785] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
667 Lin WC, Hsu TW, Chen CL, Wu CW, Lu CH, Chen HL, Li SH, Yeh PY, Cheng YF, Lin CP. Connectivity of default-mode network is associated with cerebral edema in hepatic encephalopathy. PLoS One. 2012;7:e36986. [PMID: 22623966 DOI: 10.1371/journal.pone.0036986] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
668 Mallet M, Weiss N, Thabut D, Rudler M. Why and when to measure ammonemia in cirrhosis? Clin Res Hepatol Gastroenterol 2018;42:505-11. [PMID: 29551609 DOI: 10.1016/j.clinre.2018.01.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
669 Hanafy AS, Bassiony MA, Basha MAA. Management of HCV-related decompensated cirrhosis with direct-acting antiviral agents: who should be treated? Hepatol Int. 2019;13:165-172. [PMID: 30758786 DOI: 10.1007/s12072-019-09933-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
670 Nevah MI, Fallon MB. Hepatic Encephalopathy, Hepatorenal Syndrome, Hepatopulmonary Syndrome, and Systemic Complications of Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1543-1555.e6. [DOI: 10.1016/b978-1-4160-6189-2.00092-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
671 Hosseini N, Nasehi M, Radahmadi M, Zarrindast MR. Effects of CA1 glutamatergic systems upon memory impairments in cholestatic rats. Behav Brain Res 2013;256:636-45. [PMID: 24050889 DOI: 10.1016/j.bbr.2013.08.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
672 Huo TI, Lin HC, Wu JC, Lee FY, Hou MC, Lee PC, Chang FY, Lee SD. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl. 2006;12:65-71. [PMID: 16382473 DOI: 10.1002/lt.20560] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.5] [Reference Citation Analysis]
673 Campagna F, Montagnese S, Schiff S, Ruzzoli M, Biancardi A, Iannizzi P, Pujatti PL, Angeli P, Gatta A, Merkel C, Leandro G, Mapelli D, Amodio P. Confounders in the detection of minimal hepatic encephalopathy: a neuropsychological and quantified EEG study. Liver Int. 2015;35:1524-1532. [PMID: 25040245 DOI: 10.1111/liv.12635] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
674 Shah NJ, Neeb H, Zaitsev M, Steinhoff S, Kircheis G, Amunts K, Häussinger D, Zilles K. Quantitative T1 mapping of hepatic encephalopathy using magnetic resonance imaging. Hepatology 2003;38:1219-26. [PMID: 14578860 DOI: 10.1053/jhep.2003.50477] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
675 Qi R, Xu Q, Zhang LJ, Zhong J, Zheng G, Wu S, Zhang Z, Liao W, Zhong Y, Ni L. Structural and functional abnormalities of default mode network in minimal hepatic encephalopathy: a study combining DTI and fMRI. PLoS One. 2012;7:e41376. [PMID: 22911787 DOI: 10.1371/journal.pone.0041376] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
676 Cabrera-Pastor A, Llansola M, Montoliu C, Malaguarnera M, Balzano T, Taoro-Gonzalez L, García-García R, Mangas-Losada A, Izquierdo-Altarejos P, Arenas YM, Leone P, Felipo V. Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: Underlying mechanisms and therapeutic implications. Acta Physiol (Oxf) 2019;226:e13270. [PMID: 30830722 DOI: 10.1111/apha.13270] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis